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Abstract 
The success of forensic investigation very often depends on the establishment of 
the correct timeline of events. In the investigation of fatalities, this depends 
greatly on the estimation of the time since death of the victim. Current methods 
lead to inaccurate results and depend greatly on the experience of the 
investigator. Pathologists estimate the time since death based on visual 
inspection of the bodies as well as body temperature measurement. Only very 
short post-mortem intervals (PMIs) can be evaluated with some degree of 
certainty.  
This investigation used untargeted proteomic and metabolomic approaches to 
identify potential molecular markers (proteins, metabolites) which could help to 
quantify post-mortem changes and aid PMI estimation. 
Animal models were used in the initial stages of the project. Aged beef meat 
(stored at 4°C for 13 days) and rat muscle samples (intact cadavers stored at 
ambient temperature for 3 days) were sampled at 24 h time intervals. In the 
final stages of the project, human tissue samples were collected at the Forensic 
Anthropology Centre at Texas State University (San Marcos, Texas). Muscle 
samples were collected at various times post-mortem from 6 different subjects 
over the period of two weeks. For the proteomics experiment, 0.5g of tissue was 
homogenized in extraction buffer consisting of urea, thiourea and 3-((3-
cholamidopropyl) dimethylammonio)-1-propanesulfonate (CHAPS). Protein 
separation was carried out using two-dimensional gel electrophoresis. Protein 
identification was performed using liquid chromatography-tandem mass 
spectrometry. For the metabolomics experiment, 0.5g of tissue was 
homogenized in chloroform/methanol/water solution. The extracted samples 
were analysed using liquid chromatography-mass spectrometry as well as gas 
chromatography – mass spectrometry.  
The investigation allowed the identification of potential biomarker candidates. 
The proteins of interest varied between the sampled mammals. However, 
myosin and actin appear as promising candidates for all three species. The 
metabolomics experiments yielded a large number of possible biomarker 
candidates. Both liquid and gas chromatography approaches were successfully 
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applied, pointing towards various compounds. Proteogenic amino acids were 
identified as main compounds of interest in all species using both methods. 
The study has shown that both proteomic and metabolomic approaches can be 
successfully applied in forensic medical science and can help to find PMI 
markers. Using the untargeted approach gives the advantage of looking at a 
whole range of detected molecules and choosing the most appropriate ones for 
the task. Furthermore, the combination of these two approaches gives a deeper 
insight into the post-mortem biological processes. The biomarker candidates 
proposed in this study require further validation in a larger cohort of subjects. 
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1 INTRODUCTION 
1.1 Human decomposition 
Decomposition begins rapidly after death and is driven by the process of 
autolysis. Once there is no more oxygen delivered to tissues, levels of carbon 
dioxide increase in the blood, pH decreases and waste products begin to 
accumulate, poisoning the cells. The integrity of lipid membranes is disrupted 
once there is insufficient energy to maintain transmembrane ion gradients and 
cellular and subcellular organisation is corrupted. Proteolytic enzymes are no 
longer controlled by sequestration and start degrading proteins. During this 
process the body cools down to ambient temperature (algor mortis), blood 
settles in lower parts of the body, which causes skin discolouration (livor mortis) 
and muscles become stiff due to increased acidity and depletion of ATP (rigor 
mortis). Eventually, putrefaction begins, where soft tissues are destroyed due to 
microbial action (Gill-King 1997). Decay is a continuous process which is 
inherently disorder; however, many studies have attempted to classify 
mammalian decomposition into certain stages. Various numbers of distinctive 
stages were proposed, varying between 1 and 9 (Goff 2009), but discrimination 
of 4 main stages seems to be the most popular (Swann et al. 2010; Vass 2011). 
These 4 stages include fresh, bloated, active decay and dry phases of 
decomposition. Table 1-1 describes these stages in more detail. Human 
decomposition is a complicated process, subject to many influencing factors, 
which make it very difficult to relate the stage of the decomposition to the time 
that passed since death occurred. Nevertheless, living tissue is highly organised 
and is protected from microbial activity by the immune system. Thus the early 
stages of decomposition (autolysis) result from the activity of endogenous 
processes such as proteolysis, and are followed in later stages by the activity of 
exogenous players, such as bacteria and fungi (putrefaction). 
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Table 1-1. Overview of mammalian decomposition. (Swann et al. 2010) 
Permission to reproduce this table has been granted by Elsevier publishing company, 
license Number: 3946500286695. 
Stage of decomposition Description 
Fresh Commences immediately after death 
Autolysis 
Fluid filled blisters on the skin, skin slippage 
Marbling of skin due to livor mortis 
Bloating Putrefaction – destruction of soft tissues by 
microorganisms 
Greenish discolouration of the skin 
Gas and fluid accumulation followed by purging 
Anaerobic fermentation 
Active decay Bloating has ceased 
Skin usually broken in one or more places 
Rapid leaching from body 
Large numbers of aerobic and anaerobic bacteria 
Extensive insect activity 
Possible carnivore activity 
Collapse of abdominal activity 
Loss of internal organs through insect activity or 
autolysis 
Possible adipocere formation 
Dry Diagenesis  
No carrion fauna remaining 
Small amount of decaying tissue 
Mummification of remaining skin 
Bone exposure and skeletonisation 
 
 
1.2 Estimation of Post-mortem Interval (PMI) 
Estimation of the time of death is central to the course of many forensic 
investigations. Knowing when death occurred may help to clarify the 
circumstances of a death and to assess the alibis of any potential suspects 
(Kaliszan et al. 2009). However, estimation of the post-mortem interval (PMI) 
may only be accurate up until 24-48 hours post-mortem (Fatteh 1973). Currently 
used methods include temperature measurement (algor mortis), assessment of 
rigor mortis, lividity (livor mortis) and morphological changes of the body (Swift 
2006). The first description of body temperature changes as a means of time of 
death estimation was published by Rainy in 1868 (Rainy 1868). This method has 
been successfully applied in forensic cases over the years; however, its 
usefulness is limited to a very short PMI before the temperature of the body 
equilibrates with the temperature of the surroundings. Furthermore, it has very 
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little use in places with high average temperatures, as the body temperature can 
increase after death. Similarly to algor mortis, rigor mortis and livor mortis 
reach a steady state before 48 h after death (Ith et al. 2002). Observation of 
rigor mortis also dates back to the 19th century where it was first investigated by 
Pierre-Hubert Nysten (Swift 2006). Rigor mortis describes a state of constant 
muscle contraction, which is caused by the depletion of ATP source in post-
mortem tissue (this phenomenon will be described in detail in section 1.3 of this 
chapter). Living muscle contracts through the formation of the actin-myosin 
complex, which requires ATP to release the contraction. After death ATP is no 
longer produced and the actin-myosin complex cannot be broken – muscles 
remain contracted, up until the process of autolysis starts degrading the muscle 
tissue (Henssge et al. 2002). Livor mortis, or otherwise hypostasis, describes the 
purplish-blue discolouration of the skin resulting from the cessation of the blood 
circulation and gravitational settling of the blood in the lower parts of the body. 
However, it will not form in cases where the deceased suffered a significant 
blood loss (Perper 2006).The final method of time since death estimation is the 
assessment of morphological changes of the body. This method relies solely on 
the experience and knowledge of the forensic investigator. Furthermore, it can 
be quite subjective as the rate of decomposition depends on many ante mortem 
factors (as, for example, the health of the deceased) as well as the 
circumstances surrounding death and the environmental conditions in which the 
body had been discovered (Swift 2006). 
Four main factors can affect the rate of the decomposition process: 
temperature, moisture, pH and partial pressure of oxygen (Clark et al. 1997). 
The pH determines the type of chemical reactions that occur during 
decomposition. An alkaline environment is usually created when aerobic surface 
decomposition takes place and an acidic environment is formed when anaerobic 
decomposition occurs (due to bacterial fermentation). Lack of oxygen slows 
down the decomposition process. Other minor factors affecting the rate of 
decomposition include the presence or lack of clothing, injuries, carnivore 
activity, insect activity, disease, percent body fat, introduction of chemicals 
etc. (Vass 2011). Recent studies have shown that also the size of the individual 
influences the decomposition rate (Sutherland et al. 2013; Matuszewski et al. 
2014). 
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Currently used methods of time of death prediction depend greatly on the 
experience of the medical examiner. Aydin and colleagues tested this by asking 
56 pathologists and forensic medicine specialists to estimate PMI in various cases 
based on the same set of information (post-mortem changes, time, environment 
and geographical information where the individual was found) and found that 
the estimations varied greatly between specialists, especially in cases of 
advanced decomposition (Aydin et al. 2010). Finding a more objective, 
laboratory based method would allow removing human perception from the task, 
potentially making the estimation more accurate. A large amount of research 
has been dedicated over the last hundred years to finding new methods to 
estimate PMI. However, there is still much room for improvement. Margins of 
error are still very significant, even when using a few of the methods combined. 
The longer the PMI the bigger the error: a 6 hour PMI can have an error of at 
least 2 hours, rising to a 4.5 hour error for a 10 hour PMI (Kaliszan et al. 2009).  
Increasing numbers of researchers are trying to find a more accurate way of 
estimating the time since death, for example through biochemical indicators 
(biomarkers). Biomarkers are molecules which indicate a certain biological 
state, for example a diseased state. It has been previously suggested that 
certain substances could serve as post-mortem biomarkers, helping to estimate 
time of death. Chemical methods, which are used for this purpose, fall under 
the name of thanatochemistry (Madea 2005). The following literature review has 
been divided into different groups of possible biomarkers presented in the past. 
1.2.1 Vitreous humour chemistry 
Potassium is one of the elements thoroughly researched in this area. It has been 
known for years that the potassium concentration [K+] in vitreous humour 
increases post-mortem and that those levels can be correlated with PMI (Sturner 
1963). Vitreous humour is a forensic specimen of choice due to its isolated and 
confined anatomy, which slows down the metabolic and autolytic processes with 
respect to other specimens such as blood (Madea 2005). Various studies have 
correlated the relationship between the PMI and potassium levels in vitreous 
humour by linear regression (Sturner 1963; Adelson et al. 1963; Sturner & 
Gantner 1964; Madea et al. 1990; Lange et al. 1994). However, as Muñoz et al. 
suggested, previously proposed equations contain some major flaws, which lead 
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to erroneous results. This group proposed a correction to the existing formulae 
by switching the variables (Muñoz et al. 2001) as well as including the cause of 
death as a variable (Muñoz Barús et al. 2002). Up until that point, the PMI was 
used as the independent variable and potassium as the dependent one in the 
linear regression models. Muñoz suggested using potassium as the independent 
value, as a means of reducing the margins of error in the calculations. This 
hypothesis was tested by Madea and Rödig, who showed that changing the 
variables does in fact increase the accuracy of the result, reducing the error 
from ±25.96 h to ±23.27 h (over a post-mortem interval up to 130 h) (Madea & 
Rödig 2006). The increase in accuracy is small, however it is statistically 
significant. The authors concluded that this method is correct for statistical 
analysis.  
Muñoz and colleagues did not stop there and tried to improve the PMI 
calculations from vitreous potassium even further. Instead of using linear 
regression models, they have applied flexible regression models to data obtained 
from 201 cadavers (Muñoz Barús et al. 2008). They have shown that the 
relationship of potassium levels and time since death is not linear and concluded 
that it was a false assumption. Flexible regression, which models nonlinearities, 
should be used instead of linear regression. Authors showed that using two 
flexible regression models: generalized additive models (GAMs) and support 
vector machines (SVMs) brought the mean square error of 0.20 for linear 
regression down to 0.16 for flexible regression models. GAMs are an extension of 
traditional linear models, but more flexible than them. The researcher does not 
need to assume a parametric form for the effects of the continuous covariates, 
but only assumes that these effects can be represented by unknown smooth 
functions (Muñoz Barús et al. 2008). SVMs (also support vector networks) are 
supervised learning models, which given a set of training samples belonging to 
one of two categories, builds a model which then can assign new samples to one 
of the given categories (Cortes & Vapnik 1995). On that basis they have 
produced R-based software, which can be used to calculate the time since death 
from potassium and hypoxanthine levels in vitreous humour – PMICALC (Muñoz-
Barús et al. 2010). 
Potassium is not the only element being investigated for the time of death 
estimation in vitreous humour. The changes in levels of sodium, calcium and 
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chloride were also investigated. Jashnani et al. found a linear relationship 
between potassium levels and PMI as well as inverse relationship between 
sodium/potassium ratio and PMI (Jashnani et al. 2010). Sodium alone, as well as 
calcium and chloride levels showed no relationship. Chandrakanth et al. 
confirmed these findings, as their research showed no correlation between PMI 
and sodium, chloride, or even potassium levels (Chandrakanth et al. 2013), while 
Siddamsetty et al. like many other researchers found a relationship with vitreous 
potassium, as well as weak correlation with levels of sodium and glucose 
(Siddamsetty et al. 2014). Hypoxanthine is also believed to be a good marker for 
PMI estimation in vitreous (Rognum et al. 1991; Muñoz Barús et al. 2002; Muñoz 
Barús et al. 2008; Muñoz-Barús et al. 2010), in some cases considered more 
suitable than potassium (Rognum et al. 1991). Other substances shown to have a 
relationship with PMI include free amino acids (Patrick & Logan 1988b; Girela et 
al. 2008), especially taurine, glutamate and aspartate (Girela et al. 2008), 
lactate (Mihailovic et al. 2011) and iron (Santos Júnior et al. 2014). Odriozola et 
al. investigated the miRNA content in vitreous humour and while no relationship 
was found with time elapsed since death, the investigators were able to 
distinguish whether the individual died during day or night time (Odriozola et al. 
2013). Similar finding was later presented by Corradini et al. (Corradini et al. 
2015). Considerable amount of research has shown the value of vitreous humour 
and its chemistry as an indicator of PMI. However, some researchers raise 
concern over this method of PMI estimation. Balasooriya et al. found differences 
in levels of potassium, sodium and urate measured in the right and the left eye 
of the same individual (Balasooriya et al. 1984), while other studies raised 
concerns over different sample preparation methods (Thierauf et al. 2009; 
Camba et al. 2014) and low precision and high standard deviation when 
measurements were repeated (Thierauf et al. 2009). Being aware of these 
issues, researchers carry on re-evaluating and testing new and existing 
approaches to improve this methodology (Bocaz-Beneventi et al. 2002; Passos et 
al. 2009; Bortolotti et al. 2011; Lendoiro et al. 2012). Moreover, Tumram et al. 
published a comparative study of post-mortem analysis in vitreous humour and 
synovial fluid (Tumram et al. 2011). Both substances were analysed for 
potassium, chloride, calcium, creatinine, glucose and urea. Levels of potassium 
and glucose were comparable in both vitreous humour and synovial fluid. The 
authors concluded that post-mortem analysis of synovial fluid is as accurate as 
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vitreous humour. Swain et al. carried out a very similar comparison in vitreous 
humour and cerebrospinal fluid; however, this time vitreous was deemed a much 
better medium for PMI estimation (Swain et al. 2015). 
1.2.2 Electrolytes 
Changes in levels of electrolytes post-mortem were also investigated in other 
media than vitreous humour. Querido showed a linear relationship between the 
log of sodium/potassium concentration ratio and log of PMI (Querido 1990a) as 
well as log of chloride concentration and log of PMI (Querido 1990b), both in rat 
plasma. Yadav et al. found correlations between sodium, potassium as well as 
sodium/potassium ratio and PMI in cerebrospinal fluid (Yadav et al. 2007). 
Potassium, sodium/potassium ratio as well as phosphorus levels were also found 
to be correlated with PMI in pericardial fluid by Singh et al. (Singh et al. 2006), 
while Kawamoto et al. did not find these or other electrolytes (chloride, calcium 
and magnesium) to be useful in PMI estimation in this post-mortem specimen 
(Kawamoto et al. 2013). However, the levels of these electrolytes did seem to 
correlate with the cause of death, which might be very useful in its 
determination. Tavichakorntrakool et al. reported an increase of potassium, 
sodium, magnesium and calcium levels over time in post-mortem muscle tissue 
(Tavichakorntrakool et al. 2008). 
1.2.3 Creatinine  
Gallois-Montbrun et al. showed a relationship between creatinine concentration 
and PMI in bird muscle (Gallois-Montbrun et al. 1988). This theory was later 
tested and confirmed by Brion et al. in human psoas muscle (Brion et al. 1991). 
The authors suggested that creatinine concentration measurement could be a 
useful tool in estimating longer PMIs (weeks). On the other hand, Donaldson et 
al. suggested that this compound could be a useful marker in a shorter PM period 
of 96 h measured in rat plasma (Donaldson & Lamont 2014). However, two other 
studies of creatinine levels in post-mortem synovial fluid and vitreous humour 
(Tumram et al. 2011), as well as pericardial fluid (Kawamoto et al. 2013) did not 
find it a useful marker. 
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1.2.4 Amino acids 
Over 30 years ago, Perry et al. determined that the levels of most proteogenic 
amino acids increased over time in PM brain (Perry et al. 1981). However, this 
work did not concern PMI estimation. Later, Patrick and Logan showed a 
relationship between the levels of amino acids and PMI in vitreous humour in 
cases of sudden infant death syndrome (SIDS) (Patrick & Logan 1988b). A few 
years later, Kärkelä and Scheinin documented the increase of tryptophan in 
post-mortem cisternal fluid (Kärkelä & Scheinin 1992). Girela et al. also 
investigated how free amino acids behaved in PM vitreous humour and 
cerebrospinal fluid (CSF) (Girela et al. 2008). The CSF results were inconclusive, 
as the fluid was contaminated with blood, however, in vitreous humour, the 
levels of most amino acids increased, especially aspartate, glutamate and 
taurine. Vass et al. investigated amino acid levels in various post-mortem organs 
and tissues (liver, kidney, heart, brain, muscle) (Vass et al. 2002). He found 
different amino acids to be useful biomarkers for each organ, with proline and 
methionine being useful in all organs tested. Finally, two very recent studies 
presented various amino acids as useful markers in PMI estimation using rat 
plasma (Donaldson & Lamont 2014; Sato et al. 2015). 
1.2.5 Biogenic amines 
Biogenic amines, especially putrescine, cadaverine, indole and skatole (3-
methylindole), are well known decomposition products, associated with the 
post-mortem process of putrefaction (Vass 2001; Janaway et al. 2009). They 
seem to be likely candidates for PMI estimation, as they are produced post-
mortem. Many studies regarding detection of volatile organic compounds (VOCs) 
released from decomposing bodies have investigated these amines 
(Statheropoulos et al. 2005; Statheropoulos et al. 2007; Statheropoulos et al. 
2011; Zang et al. 2009; Dekeirsschieter et al. 2012). However, they remained 
undetected. In two other studies, only indole was successfully detected 
(Hoffman et al. 2009; Dekeirsschieter et al. 2009). This is most probably due to 
the low volatility of these amines. Vass et al. detected these compounds in 
various organs using gas chromatography, however, concluded that they were 
not useful as PMI biomarkers. 
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1.2.6 Adenosine triphosphate (ATP) 
Sun et al. presented a relationship between ATP and PMI in post-mortem rabbit 
blood (Sun et al. 2013; Sun et al. 2014). The ATP level increased in the first few 
hours after death and then showed a steady decrease over the period of 72 h. 
Mao et al. investigated the relationship between the levels of ATP and its 
degradation products (adenosine-5’-diphosphate (ADP), adenosine-5’-
monophosphate (AMP), inosine-5’-monophosphate (IMP), inosine (HxR), 
hypoxanthine (Hx) and xanthine (X)) (Mao et al. 2013). The authors used a 
parameter called K which measures the speed of ATP degradation based on the 
concentration of ATP itself and its degradation products. As a result they found 
that the K value could be a potential indicator of PMI. Liu et al. showed a 
relationship between microbial ATP and PMI in various tissues of rats (muscle, 
liver, spleen and kidney) (Liu et al. 2009) and Schmidt et al. suggested the ratio 
between the signal intensities of α-ATP and inorganic phosphorous (α-ATP/Pi) as 
means of PMI estimation (Schmidt et al. 2014). The authors used 31P magnetic 
resonance spectroscopy (31P MRS) to scan human muscle tissue every hour, over 
the period of 4.5 to 24 h after death. 
1.2.7 DNA/RNA 
Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) are essential 
components of any organism and their degradation post-mortem was also 
suggested as means of PMI estimation. Larkin et al. investigated the changes in 
the yield (amount measured) of skeletal muscle DNA of pigs (Larkin et al. 2010). 
The authors attempted to use the relationship between accumulated degree 
days (ADD, the cumulative total of average daily temperatures) to estimate PMI. 
However, no clear trend between the DNA yield and ADD was found. Initial 
decrease in DNA yield was observed and the authors concluded that after further 
testing, this could potentially be used for PMI estimation. The RNA route appears 
to be the more successful one in PMI estimation. Inoue et al. studied the 
degradation of messenger RNA (mRNA) post-mortem in rat brain, lung, heart and 
liver; however, PMI estimation was not the end goal of the study (Inoue et al. 
2002).  The authors concluded that mRNA is most stable in the brain and 
therefore, it would be best to study mRNA degradation in this organ and also 
that real time polymerase chain reaction (RT-PCR) is a reliable method of 
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measuring the levels of mRNA post-mortem. Later Bauer et al. showed that 
mRNA degradation could be used as a method of PMI estimation (Bauer et al. 
2003). The group investigated the change in levels of mRNA in whole blood 
collected from live individuals stored in vitro over a particular length of time as 
well as post-mortem blood and brain samples collected during autopsies. In the 
case of both types of blood samples they found a relationship between mRNA 
and the time elapsed since death or collection. Additionally, they concluded 
that brain tissue can be equally useful in the absence of blood. However, the 
method requires further research due to large confidence intervals. Sampaio-
Silva et al. investigated the total RNA instead of mRNA in post-mortem heart, 
muscle and liver (Sampaio-Silva et al. 2013). The authors found a significant 
correlation between PMI and RNA degradation in all three tissue types. The 
degradation was organ dependent. Additionally, they synthesised 
complementary DNA (cDNA, from the extracted RNA) and discovered 4 genes in 
muscle tissue that correlated with PMI. This finding was then used to create a 
mathematical model for PMI estimation. The relationship between RNA and PMI 
was linear, which was not the case in the study carried out by Li et al. However, 
this group investigated the relationship between 18S-rRNA (main ribosomal RNA) 
and microRNA with regards to PMI estimation (Li et al. 2014). Their results 
showed a parabolic relationship between RNAs and PMI, which according to 
authors could potentially be used in PMI estimation. However, a parabolic curve 
could result in the same marker level at two different time points, which might 
make the result of the estimation unclear. 
1.2.8 Metabolites 
“Metabolites” is a general term describing any compounds involved in 
metabolism, whether in a role of a product or an intermediate. It is also used to 
collectively describe any number or kind of small molecules present in an 
organism. Various metabolites have been suggested as possible PMI markers over 
the years. Harada et al. investigated metabolite changes in rat liver, spleen, 
brain, heart and dorsal muscle (Harada et al. 1984). The authors concluded that 
lactate and pyruvate could be related to PMI in heart and muscle tissue. Post-
mortem changes in brain metabolites were extensively studied by three different 
groups (Ith et al. 2002; Scheurer et al. 2005; Banaschak et al. 2005; Ith et al. 
2011; Musshoff et al. 2011). Free trimethylammonium was suggested as a 
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suitable marker in all but one of the five studies carried out by these groups. 
Other common metabolites included propionate, butyrate, alanine and acetate. 
Less common ones included lactate, creatine, succinate, GABA, myo-inositol and 
some amino acids. Meanwhile, Donaldson and Lamont looked at changes in post-
mortem blood and suggested lactic acid, hypoxanthine, uric acid, ammonia, 
NADH and formic acid as potential markers (Donaldson & Lamont 2013). Over the 
recent years, the study of metabolites evolved into a unique branch of science, 
called metabolomics, which attempts to characterise the metabolome of any 
given organism (described in more detail later on in this chapter). This 
approach, very often untargeted and termed metabolic profiling, has also been 
applied to PMI estimation through the means of various techniques 1H-NMR 
(Hirakawa et al. 2009), LC-MS/MS (Kang et al. 2012) and GC-MS (Donaldson & 
Lamont 2014; Sato et al. 2015; Kaszynski et al. 2016). Due to the nature of the 
untargeted approach, large numbers of metabolites have been identified and 
suggested as PMI markers using these techniques; therefore, they will be 
discussed in detail in the metabolomics section of this thesis (chapters 4 and 5) 
as relevant. 
1.2.9 Proteins 
Post-mortem protein degradation has been extensively studied in animal tissue, 
with regards to meat production and tenderisation (Yates et al. 1983; Anderson 
et al. 2012; Picard et al. 2014; Koohmaraie & Geesink 2006; Nowak 2011). The 
change in levels and activity with PMI of various proteins and proteases was 
studied as a result. Some of these changes were also suggested as possible 
indicators of PMI. Main protein markers of interest are troponin (Sabucedo & 
Furton 2003; Kumar, Ali, Bhattacharya, et al. 2015; Kumar, Ali, Singh, et al. 
2015; Pittner et al. 2015; Pittner et al. 2016), actin (Xiao & Chen 2005; Y. Liu et 
al. 2008) and calmodulin binding proteins (Kang et al. 2003; Poloz & O’Day 
2009). Various other protein markers were suggested (Kominato et al. 1989; 
Kikuchi et al. 2010; Zapico et al. 2014; Finehout et al. 2006), as well as certain 
enzymes (Gos & Raszeja 1993) and lipids (Shirley & Wood 2013). These protein 
markers and post-mortem protein degradation will be discussed in detail in the 
proteomics chapter of this thesis (chapter 3). 
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1.2.10 Other markers 
Various biological markers have been proposed over the years, as can be seen 
above. However, some of them are quite unique and difficult to classify within a 
general group. Sasaki et al. investigated the changes in non-protein nitrogen 
(NPN) in human brain, lung, liver and kidney (Sasaki et al. 1983). He found that 
the correlation of NPN and PMI was best in brain tissue in comparison to other 
tissues and this could potentially become a method of PMI estimation. Liu et al. 
investigated trimethylamine-nitrogen (TMA-N) content in rat muscle, liver and 
kidneys and found that it is positively correlated with PMI (Q. Liu et al. 2008). 
Kimura et al. suggested the use of the biological clock to estimate PMI (Kimura 
et al. 2011). RT-PCR analysis of certain gene expressions was carried out in 
mouse and human. The circadian oscillation of these gene expressions was 
detectable up to 48 h post-mortem. The ratio of hRev-Erbα/hBmal1 was found 
useful in PMI estimation. Bilheux et al. found a correlation between hydrogen 
abundance levels in tissue and PMI (Bilheux et al. 2015). Muscle tissue, lung and 
bone collected from canine cadavers were tested using neutron radiography. 
Wehner et al. investigated the immunohistochemical response of insulin in 
pancreatic β-cells; however, the method can only be used for PMI delimination 
and not estimation (Wehner et al. 1999). Various types of cells were also 
suggested as possible PMI indicators. Alibegović suggested that cartilage cells 
(chondrocytes) could be used as their viability gradually decreases post-mortem 
(Alibegović 2014). Dokgöz et al. investigated the morphological changes in white 
blood cells post-mortem and concluded that cellular changes in leukocytes can 
help to estimate PMI until 120 h (Dokgöz et al. 2001). Finally, Boehm et al. 
investigated the post-mortem loss of enzymatic activity in bone marrow 
osteoclasts (Boehm et al. 2012). However, the results were very variable and the 
authors concluded that it does not correlate with PMI. 
1.2.11 Examples of other methods 
As can be seen from the above review, most of the research regarding PMI 
estimation is looking for an endogenous element, molecule or cell which could 
be correlated with the progression of human decomposition. However, various 
other, non-biomarker methods, have also been proposed. Estracanholli et al. 
suggested in situ tissue optical fluorescence, where the fluorescence of the skin 
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in the abdominal area of rat cadavers was measured at various PMIs 
(Estracanholli et al. 2009). Prieto-Bonete et al. investigated morphological and 
histological changes in the eye lens and reported that the loss of structure, 
sphericity and absorbance of the rabbit eye lens decreased with PMI  (Prieto-
Bonete et al. 2015). Hauther et al. suggested the use of certain strains of gut 
microbial communities, which decreased in abundance with time (Hauther et al. 
2015), while Ishikawa et al. showed by means of computed tomography (CT) 
imaging that the abdominal aorta is gradually narrowing post-mortem (Ishikawa 
et al. 2013). Electrical impedance tissue measurement was also suggested for 
PMI estimation. Querido and Phillips measured electrical impedance of intact rat 
abdomen (Querido & Phillips 2001) and Mao et al. used electrical impedance 
spectroscopy to test rat spleens at various temperatures and PMIs (Mao et al. 
2011). In both cases the measured impedance decreased with time. Warther et 
al. suggested idiomuscular contraction (muscle contraction following a 
mechanical stimulation) as means of PMI estimation, however, this method can 
only be applied within the first 13 h post-mortem (Warther et al. 2012). A 
slightly more unusual method presented by Romanelli et al. involved the 
measurement of the ciliary motility in the nasal cavity: the movement of the 
cilia decreased over time (Romanelli et al. 2012). Megyesi et al. published a PMI 
estimation method based on ADD and total body score (TBS) (Megyesi et al. 
2005). TBS is a point based system which allows a numerical description of the 
extent of decomposition and ADD is a unit of PMI which accounts for the daily 
temperatures which the cadaver has been exposed to. This method was later 
tested by Myburgh et al. using pig cadavers, but poor results led the authors to 
conclude that the method had a very limited use (Myburgh et al. 2013). The use 
of ADD as a PMI estimation tool was also investigated by Dabbs, who tested the 
use of temperature data collected by a National Weather Service (NWS) station 
(Dabbs 2010). The author compared data from two nearby stations with the data 
collected by instruments on the research site and found significant differences 
between the readings. She also showed how a seemingly small difference in 
temperature introduces error into the final estimation. Meanwhile, Arpad Vass 
suggested that PMI can be estimated based solely on two mathematical formulas 
(Vass 2011). He created two formulas derived from empirical data collected over 
20 years of research, one for bodies decomposing on the surface and another for 
buried cadavers. The formulae are based on temperature, moisture and partial 
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pressure of oxygen and he claimed that these universal formulae can be applied 
anywhere in the world. This was later disputed by Cockle and Bell, who tested 
these formulae using a set of 42 bodies decomposing on the surface and 22 
buried (Cockle & Bell 2015). Neither of the formulae performed well and the 
authors suggested that ‘universality’ cannot be applied to PMI estimation. 
Finally, it should be noted that the current research is not only focused on new 
ways of PMI estimation, but also on improving the well-established methods, 
which have been used for years. For example, the nomogram method created by 
Henssge (Henssge 1988) based on the two-exponential term of Marshall and 
Hoare (Marshall & Hoare 1962), which estimates PMI using a rectal temperature 
measurement, was further evaluated by the author (Henssge et al. 2000) as well 
as other researchers, in the case of sudden temperature increase (Bisegna et al. 
2008) and the error associated with the model (Hubig et al. 2011; Hubig et al. 
2015). Other researchers also attempted to improve PMI estimation based on 
body cooling by multiple measurement sites (Morgan et al. 1988), creating new 
algorithms (Nelson 2000) and reference databases (Muggenthaler et al. 2012). 
Anders et al. further investigated the re-establishment of rigor mortis and re-
evaluated the time span in which this phenomenon can occur (Anders et al. 
2013), while Vanezis and Trujillo used colorimetry to assess the advancement of 
post-mortem hypostasis (Vanezis & Trujillo 1996) and Usumoto et al. used 
spectrophotometric analysis on lividity to estimate PMI (Usumoto et al. 2010). 
As can be seen from the above literature review, the list of proposed methods of 
PMI estimation is extensive and a considerable amount of work has already been 
done. However, all of the methods so far still have a large error and are limited 
in their use. Much of the work described is targeted to specific classes of 
molecules, but emerging proteomic and metabolomics approaches permit the 
comparative analysis of large numbers of molecules, originating from diverse 
areas of metabolism, and might be exploited to screen for new, previously 
unobserved changes that are correlated with PMI. 
1.3 Muscle composition and structure 
Muscle tissue is one of the main components of the human body. It makes up 
about 40 to 50% of the total body weight and fulfils three very important 
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functions: movement, posture support and heat production. Three types of this 
tissue are distinguished: skeletal (attached to bones), cardiac (within the walls 
of the heart) and smooth (making up hollow organs, such as the intestinal tract 
and vasculature) (Wingerd 2014). This section will refer to skeletal muscle only, 
which was used as a specimen in the study described in this thesis. 
Skeletal muscle (also known as voluntary muscle) is composed of muscle fibers 
encased in a plasma membrane called the sarcolemma. Sarcolemma can be 
electrically excited and therefore, receive a nerve impulse to initiate the 
process of contraction. The muscle fibers are made up of myofibrils, which are 
further divided into sarcomeres that repeat along the length of the fibril (Zubay 
et al. 1995). A detailed schematic of muscle organisation is shown in Figure 1-1.  
 
Figure 1-1. The hierarchy of muscle organisation. 
A voluntary muscle such as the bicep is a composite of many fibers connected to tendons 
at both ends. Each muscle fiber is composed of several myofibrils that are surrounded by 
an electrically excitable membrane (sarcolemma). Myofibrils exhibit longitudinally repeating 
structures called sarcomeres. (Zubay et al. 1995) 
Muscle tissue is mainly composed of proteins; the most important ones include 
actin, myosin, troponin and tropomyosin. These proteins make up filaments, 
which in turn, make up the sarcomeres. Two types of filaments are present, thin 
(made of actin, troponin and tropomyosin) and thick (made of myosin). Actin 
molecules form a double helix with repeating subunits. Each actin unit is 
connected with troponin on each side and surrounded by tropomyosin molecules 
along the length of each unit. The thick filaments are composed of two identical 
heavy chain myosin molecules and two different light chain myosin molecules 
(Zubay et al. 1995). Figure 1-2 shows the structure of those two filaments, as 
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well as how they are organised within the sarcomere. The thick and thin 
filaments are arranged interchangeably along the length of the myofibril, which 
gives it the striated look which can be seen in Figure 1-1. Thick filaments create 
a dark band and thin filaments alone a light band (Figure 1-3). 
 
Figure 1-2. A molecular view of muscle structure. 
Image a) segment of actin-tropomyosin-troponin, b) segment of myosin, c) integration of 
thin filaments (actin) and thick filaments (myosin) in a muscle fiber. (Zubay et al. 1995) 
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Figure 1-3. The organisation of the sarcomere. 
The sarcomere is the region between one Z line and another. This is the functional unit of 
muscle tissue. When the contraction occurs, the Z lines are brought closer together and the 
A band region remains the same. Thick filament: myosin, thin filament: actin, troponin and 
tropomyosin (OpenStax 2013). Image licensed under a Creative Commons Attribution 4.0 
International License. 
Figure 1-3 shows a more detailed organisation of the sarcomere. Two lines are 
highlighted in that schematic, Z line, which defines the start and the end of 
each sarcomere unit and M line, which is located in the centre of the unit. These 
lines are made up of two other proteins, myomesin (M) and α-actinin (Z) (Zubay 
et al. 1995). The A band describes the region in the middle of the sarcomere, 
where the thick filament is extended on both sides of the M line, including the 
area where the thick and thin filaments overlap. When contraction occurs the 
thin filaments move along the thick filaments and pull the Z lines closer towards 
the centre. The A band remains the same, i.e. the thick filament does not move 
(OpenStax 2013). 
Figure 1-4 illustrates the sequence of events involved in muscle contraction, also 
known as the cross-bridge cycle. The muscle cell needs to receive a nerve 
impulse from the central nervous system, in order to contract. That signal is 
received by the sarcolemma, which triggers the sarcoplasmic reticulum to 
release Ca2+ ions. Calcium binds to troponin in the troponin-tropomyosin 
complex, which surrounds the actin molecule (thin filament). This causes the 
complex to expose myosin binding sites on the actin molecule (which are 
unavailable in the state of muscle rest). Then, the myosin heads bind to actin, at 
the same time releasing inorganic phosphate (Pi), which is bound to myosin, 
INTRODUCTION, 41 
 
allowing a stronger bond between actin and myosin (Figure 1-4 a, b). Next, so 
called power stroke occurs, where the myosin head pulls the actin molecule 
closer to the M line of the sarcomere, causing the filaments to slide and the cell 
to contract. At the same time, the ADP molecule is released and the ATP binding 
site on the myosin head is exposed (Figure 1-4 c). The myosin will not detach 
from actin in the absence of ATP. If there is ATP available, it attaches to myosin 
and causes the contraction to release (Figure 1-4 d). The hydrolysis of ATP into 
ADP and Pi reconfigures myosin heads position and it is available for another 
binding cycle (Figure 1-4 e). As long as there is calcium and ATP available to 
make and break the binding between actin and myosin molecules the cycle will 
repeat and the muscle contractions will continue. It should be noted that many 
myosin heads are present in a muscle cell; therefore, many cross-bridges form 
simultaneously (OpenStax 2013). 
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Figure 1-4. Overview of the cross-bridge cycle. 
(a) The active site on actin is exposed as calcium binds to troponin. (b) The myosin head is 
attracted to actin, and myosin binds actin at its actin-binding site, forming the cross-bridge. 
(c) During the power stroke, the phosphate generated in the previous contraction cycle is 
released. This results in the myosin head pivoting toward the centre of the sarcomere, after 
which the attached ADP and phosphate group are released. (d) A new molecule of ATP 
attaches to the myosin head, causing the cross-bridge to detach. (e) The myosin head 
hydrolyses ATP to ADP and phosphate, which returns the myosin to the cocked position. 
(OpenStax 2013) Licensed under a Creative Commons Attribution 4.0 International License. 
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In the absence of ATP, the muscle will remain contracted. This is the process 
which causes the state of post-mortem rigor mortis, briefly mentioned in section 
1.2 of this chapter. As the cellular compartmentalisation disintegrates and the 
normal cellular processes and safety mechanisms cease in a decomposing body, 
the calcium sequestered in the sarcoplasmic reticulum is released and causes 
the muscles to contract. No more ATP is available to release the contraction 
after death; therefore, the muscles remain contracted until the process of 
proteolysis, i.e. protein breakdown, will cleave the proteins that are involved in 
the contraction. 
1.4 Proteomics 
Proteomics “is the study of protein properties (expression level, post-
translational modification, interactions etc.) on a large scale to obtain a global, 
integrated view of disease processes, cellular processes and networks at the 
protein level” (Blackstock & Weir 1999). In other words, this branch of science 
aims to characterise all the proteins that comprise a given system at a given 
time. The term “proteome” was first introduced by Wilkins et al. and is defined 
as “the entire PROTein complement expressed by a genOME, or by a cell or 
tissue type” (Wilkins et al. 1995). It is a relatively new branch of science, 
emerging and fast-developing over the past 20 years. Proteomics has a very 
challenging task of defining the whole proteome, which, as of yet, has not been 
achieved (Nesvizhskii et al. 2007). This is due to the fact that the proteome is a 
very dynamic and complex entity, which rapidly changes depending on the 
environment, through various processes of protein transcription, translation, 
turnover and post-translational modification. There is only one genome in an 
organism, but it is coding for many different proteomes (Abdallah et al. 2012). 
Proteins are directly involved in many functions of the body; hence, many 
researchers think that proteomic analysis of an organism presents more useful 
knowledge about the underlying biological processes than genomic information 
(Anderson & Anderson 1998; Blackstock & Weir 1999; Abdallah et al. 2012). 
Proteomic studies help us understand protein function, protein interaction, as 
well as their involvement in many processes and pathways within a cell (Dhingra 
et al. 2005). Most drug targets are proteins (Blackstock & Weir 1999) and various 
proteomic studies, presented in recent years, have discovered prognostic and 
diagnostic indicators of a disease state (Pena et al. 2015) as well as new therapy 
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targets (Satelli & Li 2011). The proteomic approaches that are employed to 
characterise living organisms, or to highlight markers for disease state or 
progression, might also be applied to look at changes occurring post-mortem, 
with a view to discovering markers for PMI. 
1.4.1 Proteomic techniques: gel-based vs. gel-free 
Various proteomic approaches are currently available. They can be divided into 
two general categories, gel-based and gel-free approaches. A standard gel-based 
proteomic workflow includes sample preparation, where the proteins are 
extracted from a tissue or cell. Then the proteins are separated using a one-
dimensional (according to molecular weight) or two-dimensional (according to 
isoelectric point and molecular weight) polyacrylamide gel. The proteins of 
interest are then excised from the gel and digested into peptides with an 
appropriate enzyme (most commonly trypsin) and analysed using mass 
spectrometry (MS). This is illustrated in Figure 1-5. Sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE, one dimension separation) and 
two-dimensional gel electrophoresis (2DE, two dimension separation) are the 
main gel-based approaches used. The latter will be discussed in more detail in 
the next section, as this approach was used in this study. 
The gel free approach is quite similar, with the exclusion of the gel-based 
separation. Proteins are extracted from a tissue or cell and the whole protein 
content extracted from the sample is digested prior to MS analysis. Optionally, 
to reduce the complexity of the sample, a gel-free fractionation method can be 
applied prior to analysis to separate out different classes of proteins (i.e. 
membrane proteins etc.). This is illustrated in Figure 1-6. The main difference 
between these two approaches is that in the gel-based approach a resolved, 
intact protein is digested into peptides which are then matched back to that 
protein. In a gel free approach a pool of various peptide spectra, coming from 
different proteins has to be analysed and matched back to them. The digestion 
is a very important step which makes the MS analysis of the proteins possible. 
The protein molecules are otherwise too large to be analysed using this 
instrumentation. 
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Figure 1-5. Overview of a gel-based proteomics workflow (2DE). (Dhingra et al. 2005) 
Permission to reproduce this image has been granted by Elsevier publishing company, 
license Number: 3944091100757. 
One of the most popular gel-free strategies employed, is so called “shotgun 
proteomics”. Tandem mass spectrometry is required in this approach: the first 
analysis is a survey scan which detects all of the features in the sample and then 
the instrument automatically selects a few precursor ions for fragmentation, 
usually the most abundant ones. However, this is also one of the drawbacks of 
the method as the complexity of the sample makes it impossible to fragment all 
of the ions present and only a few are selected. In this setting low abundance 
ions that could be of interest can be missed from the analysis. This also causes 
issues with the reproducibility between analyses. Both of these issues can be 
improved upon when using one of the other two known approaches, direct or 
targeted. In a direct approach the principle is the same, however at least two 
analyses are performed. First analysis is again a survey scan which creates a list 
of all peptides, from which a list of peptides of interest is created and only the 
peptides present on the list are selected for fragmentation. In the targeted 
approach a prior knowledge of the sample is required, as this method is 
hypothesis driven. No survey scan is performed in this approach, as the 
INTRODUCTION, 46 
 
instrument is set up to target particular ions, pre-selected based on the created 
hypothesis (Domon & Aebersold 2010). The selection of the approach used, 
depends greatly on the resources available, as well as the purpose of the 
research conducted. 
 
Figure 1-6. Overview of a shotgun workflow. (Ahmad & Lamond 2014) 
Image licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) 
https://creativecommons.org/licenses/by/4.0/ 
1.4.2 Two-dimensional gel electrophoresis (2DE) 
Since this technique was developed by O’Farrell in 1975 (O’Farrell 1975), it has 
remained one of the most popular protein separation methods until today. It is 
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most often chosen to analyse differential protein expression (Abdallah et al. 
2012). As mentioned in the previous section, this technique separates the 
proteins in two steps, based on two characteristics, isoelectric point (pI) and 
molecular weight. An extracted and cleaned up protein sample is first added to 
an electrofocusing strip (of a certain pH range), where an electric potential is 
applied and the proteins align along the strip based on their pI (first dimension). 
Next, the strip is secured on a polyacrylamide gel and the second separation 
step is carried out as proteins travel down the gel at varying speed dependent on 
their molecular weight (a detailed protocol is described in chapter 2). This 
method was initially used for protein separation of a single sample per gel. 
However, in 1997, Unlϋ et al. modified the method enabling a comparison of two 
different samples on one gel (Unlü et al. 1997). This was achieved by 
fluorescently tagging the samples with two different dyes and running them 
together on one gel. Two images of the gel are then created, visualising each of 
the samples separately. The images can be superimposed and compared to pin-
point the differences between the samples. The dyes do not affect the protein 
separation, which means that proteins common to both samples will be resolved 
in the same parts of the gel. This modification improves the reproducibility 
between the samples and significantly simplifies this technique for comparative 
studies. The approach was given the name of difference gel electrophoresis 
(DIGE). A few years later, this technique was further improved by Alban et.al., 
by the inclusion of an internal standard in the DIGE experiment (Alban et al. 
2003). The modification involves adding an aliquot of a pooled standard (created 
by mixing equal amounts of all of the samples to be analysed) to each gel. The 
standard is also labelled with a fluorescent dye, different from the two dyes 
used to label the samples. As a result, two samples and the pooled standard are 
loaded onto each gel, differentially labelled. Up until this modification was 
introduced, only two samples could be compared on one gel and comparing more 
samples between the gels was quite difficult and unreliable due to experimental 
variability between the gels. This improvement allows for normalization 
between separate gels and reduces the error associated with experimental 
variation. The software, used to process the gel images, compares the 
abundance of spots on each gel with the abundance of the corresponding spot 
from the pooled standard, and these differences are then compared between 
gels. For schematic of this workflow see Figure 1-7. This allows detecting the 
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biological variation between the spots in a more reliable way. This modification 
enables the comparison of multiple samples within a single DIGE experiment and 
reduces the number of gels required to complete this task. 
 
Figure 1-7. Gel analysis workflow (Decyder software).  
Spot detection is carried out on image pairs consisting of the pooled standard and a sample 
from the same gel. The two images overlay perfectly allowing direct measurement of volume 
ratios of spots between the standard and a sample. The standard spot maps are matched 
together and the standard: sample volume ratio values are compared enabling the 
calculation of abundance ratio between samples from different gels, followed by the 
application of statistical tests. (Alban et al. 2003). Permission to reproduce this image has 
been granted by John Wiley and Sons publishing group, license Number: 3944071191832. 
The 2DE approach is a perfect methodology to separate proteins in a complex 
mixture. Additionally, it makes the protein identification slightly easier as intact 
proteins are separated within the gel and (at least in theory) those single 
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proteins are excised from the gel, digested and analysed by mass spectrometry. 
Trying to identify proteins from a single protein peptide mix is more 
straightforward than a multiple protein mix. Furthermore, no prior knowledge of 
the sample is required and the differences in protein expression can be easily 
found, with the MS analysis limited to the proteins of interest. Finally, since the 
approach separates the proteins based on their pI, post-translational protein 
modifications can be detected using 2DE (Jensen 2004). The method has 
significantly improved over the years in efficiency, reproducibility and decreased 
experimental variation, through the modifications in experimental set-up. 
However, this method is not without its limitations. This approach is quite 
expensive, due to requirement of high quality reagents and many pieces of 
equipment. Moreover, the approach is time consuming, a single experiment can 
take up to a week, if not more to complete, and there is not much room for 
automation (aside from robotically picking the gel spots). Additionally, proteins 
of low abundance, highly hydrophobic, acidic or basic, as well as very large 
proteins will not be well represented on a 2DE gel. Finally, proteins might co-
elute and merge into detected protein spots, which can introduce an error to 
the measured protein abundance and complicate the protein identification 
(Abdallah et al. 2012). Nevertheless, this method, with its many advantages, still 
remains a method of choice for many researchers, as it was in the case of this 
research project. The proteins of interest discovered using this approach were 
analysed by LC-MS/MS, which is described in detail in section 1.5.1 of this 
chapter. Chapter 3 describes the results of the proteomic part of this study and 
how protein research was previously applied in PMI estimation.  
1.5 Metabolomics 
“Occasionally, a new idea emerges that has the potential to 
revolutionize an entire field of scientific endeavour. It is now within 
our grasp to be able to detect subtle perturbations within the 
phenomenally complex biochemical matrix of living organisms. The 
discipline of metabonomics promises an all-encompassing approach to 
understanding total, yet fundamental, changes occurring in disease 
processes, drug toxicity and cell function.” (Mitchell et al. 2002) 
Metabolomics (or metabonomics) is a large scale study, aiming to measure the 
whole metabolome of a given organism at a given point of time, under given 
circumstances – a metabolic snapshot, so to speak. It is a relatively new branch 
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of science, even though many researchers have investigated various metabolites 
in the past; they did not look at the metabolism from a global perspective. 
Metabolic profiling (term often used for metabolomics studies) has been 
discussed in the literature since the 1950s. However, it developed very slowly 
and only in the last decade or so it has become a major research interest. 
Numbers of publications involving metabolomics saw a sudden escalation around 
the years 2003-2005 (Rochfort 2005). Metabolomics followed on from other 
global approaches: genomics, transcriptomics and proteomics and complements 
the other ‘omics’ datasets. 
The term metabolome was first introduced by Oliver et al. in 1998 (Oliver et al. 
1998) as the quantitative total of all small molecules present in cells at a 
particular developmental or physiological state. However, Beecher later stated, 
that the metabolome only includes the native small molecules, which partake in 
general metabolism and are necessary for cellular functions (Beecher 2003). 
Slight discrepancies also occurred when it comes to name the science of 
investigating the metabolome. Two terms are used, metabolomics and 
metabonomics. Some researchers use these terms interchangeably, while others 
see a particular distinction, where metabonomics deals with a metabolic 
response occurring due to a pathophysiological stimuli or genetic modification 
(Nicholson et al. 1999; Lindon et al. 2003), while metabolomics deals with any 
changes in the metabolome. There is an overlap between both definitions and 
the metabolomics terminology includes the specifics of metabonomics testing, 
therefore, in this thesis the term ‘metabolomics’ will be used to define this 
approach. 
As mentioned above, metabolomics aims to detect compounds of low molecular 
weight (up to ~1000 Da), which include amino acids, oligopeptides, sugars, bile 
acids, simple fatty acids, and intermediates of many biochemical pathways 
(Clarke & Haselden 2008). The size of the entire metabolome is debatable, as it 
would require a specific definition of which small molecules should be included 
or not. Numbers ranging from a few thousand to tens of thousands of compounds 
have been suggested (Kaddurah-Daouk et al. 2008). This makes this task quite 
difficult as various molecules, with various chemistries need to be detected, 
ideally, with a single analytical method. Even though the analytical platforms 
available are fast developing, it is still not possible to measure the entire 
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metabolome using a single analytical platform. This is why, where possible, 
scientists combine different methods in order to increase the possible coverage 
of the metabolome. Three main analytical platforms are available for 
metabolomics experiments: Nuclear Magnetic Resonance (NMR) Spectroscopy and 
Mass Spectrometry (MS), the latter coupled either to Liquid (LC-MS) or Gas (GC-
MS) Chromatography. The choice of the analytical method often depends on the 
available resources, but more importantly, it depends on the type of sample 
(Goodacre et al. 2004). NMR spectroscopy is often used in metabolic profiling of 
biofluids (e.g. urine or plasma) and does not require any complicated sample 
preparation steps, as an intact sample can be analysed using this approach (Lenz 
& Wilson 2007). Additionally, it has an advantage of being non-destructive; the 
sample is not used up in the analysis and can be later used for other analyses. 
However, mass spectrometry is capable of creating a more comprehensive 
metabolic profile, especially when combined with chromatographic techniques. 
Liquid and gas chromatography coupled to MS will be discussed in more detail in 
the following sections. 
Metabolomics analysis can be divided into untargeted (discovery) and targeted 
approach. An untargeted approach is used in cases where there is no prior 
knowledge of how the metabolome will be affected in given circumstances. For 
example, in comparative studies, disease state versus healthy control. This gives 
an insight into which pathways (if any) are affected. It is often called a 
hypothesis-generating approach. This knowledge can be then used to focus on 
particular aspects of the biological question. A diagram of typical untargeted 
approach workflow is presented in Figure 1-8. Targeted approach, as the name 
suggests, is used when a particular target (compound, pathway) is investigated. 
The same methodologies are used for both approaches, with the differences in 
sample preparation (extraction of specific components of the sample, 
fractionation) and how the data is acquired at the sample analysis stage (e.g. 
looking for particular ions as opposed to collecting a general sample spectrum in 
MS) This approach usually requires prior knowledge of the subject and a specific 
hypothesis to be tested. In the study described in this thesis, an untargeted 
metabolomics approach was used to discriminate the metabolites affected by 
the decomposition process. 
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Figure 1-8. Overview of an untargeted metabolomics approach workflow. 
The examples of the graphical outcomes of data analysis were from MetaboAnalyst 
software (Xia et al. 2009). Permission to reproduce these images has been granted by 
Oxford University Press, license Number: 3944100710749. 
Data analysis is a very important aspect of metabolomics experiments. 
Especially, when dealing with an untargeted approach. A vast amount of data is 
collected and bioinformatics tools are required to simplify it. Bioinformatics is a 
fast developing branch of science, where informatics is used to understand 
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biological data. It is an integral part of all of the ‘omics’ sciences and many 
computational platforms have been developed to help understand the 
metabolomics data collected, for example MetaboAnalyst (Xia et al. 2009; Xia et 
al. 2012), ASCA (Smilde et al. 2005) or IDEOM (Creek et al. 2012). The latter 
program was used in this study. These bioinformatics tools can process, 
normalize and perform statistical analysis, as well as graph and map 
metabolomics data onto pathways. More importantly, with the help of various 
databases (e.g. HMDB (Wishart et al. 2007), KEGG (Kanehisa & Goto 2000) or 
MetaCyc (Karp et al. 2002)), they also identify the detected metabolites. 
Metabolomics approach is very universal and can be applied in many areas of 
study. One of the most popular ones is medicine. Metabolomics is a perfect tool 
for this task, as a metabolomics approach shows a broad image of the changes 
and the pathways affected under certain circumstances. Diet, illness, lifestyle 
and many more factors affecting living systems can be detected at the metabolic 
level. Therefore, a lot of metabolomics research is dedicated to health and 
nutrition (Watkins & German 2002; German et al. 2003; Arab 2004; German et 
al. 2004), prognostic and diagnostic biomarker discovery (Hunter et al. 2016; Fan 
et al. 2016), drug development, as well as their effects and toxicity (Cuperlovic-
Culf & Culf 2016; Hoerr et al. 2016; Dinis-Oliveira 2016). However, metabolomics 
approach is versatile and is applied in many other areas, as for example food, 
plant and agricultural studies (Eloh et al. 2016; Gillis et al. 2016). 
1.5.1 Liquid Chromatography – Mass Spectrometry (LC-MS) 
Liquid chromatography is a separation technique, where compounds present in 
the sample are separated between two phases: a mobile phase and a stationary 
phase. The compounds are separated based on their varying chemistries and as a 
result, different affinity for the stationary phase. The sample analytes, in 
solution, are passed through the column, where they can interact with the 
stationary phase. Analytes will be retained by the stationary phase according to 
their chemistry, so that separation of mixed analytes can be achieved. Typical 
solvents include acetonitrile, methanol, or dichloromethane, often mixed with 
particular buffers, for example trifluoroacetic acid or formic acid.  The process 
by which analytes are released from the column is called elution. Different 
compounds elute at different times, referred to as retention time (RT). The RT 
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of a compound in a specific chromatographic configuration is one of the criteria 
used to identify it. A schematic of an LC system is presented in Figure 1-9. 
 
Figure 1-9. Basic components of a liquid chromatography (LC) system. 
 
The most commonly used type of chromatography in metabolomics experiments 
is reversed phase chromatography (Lenz & Wilson 2007), used for separation of 
non-polar compounds (Tolstikov & Fiehn 2002) (also used for the proteomic 
analysis in this study). In this setting the solid phase lining the chromatographic 
column is hydrophobic, with a polar mobile phase. As a result, hydrophobic 
compounds present in the sample are bound to it and hydrophilic ones just pass 
through the column. The compounds are eluted by decreasing the polarity of the 
mobile phase. This is opposed to ‘normal’ phase chromatography, where 
hydrophilic stationary phase is used and hydrophilic compounds bind to the 
column. In this case, they are eluted by increasing the polarity of the mobile 
phase. The separation of polar compounds, has been significantly improved with 
the development of hydrophilic interaction chromatography (HILIC) (Tolstikov & 
Fiehn 2002), which has been used in the metabolomics part of this study. This is 
a special type of normal phase chromatography, where hydrophilic stationary 
phase is used together with eluents normally used in reversed phase 
chromatography. However, in contrast to reversed phase, the mobile phase 
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starts with a solvent of low polarity and elutes the compounds by increasing the 
polarity of the mobile phase (Cubbon et al. 2007). 
In LC-MS, following separation using the LC system, the sample is introduced to a 
mass spectrometer. The mass spectrometer measures the mass to charge ratio 
(m/z) of ions in a gas phase (Griffiths & Wang 2009). The molecules introduced 
into the MS by coupling to an LC system are in a liquid phase, therefore, they 
have to be vaporised and ionised in an ion source. Then they are sorted 
according to their m/z ratios in the mass analyser and finally detected in the 
mass detector. A plot of ion abundance against m/z is created from the 
collected data, which is called the mass spectrum of the sample. A schematic of 
the basic components of a mass spectrometer are presented in Figure 1-10. 
Tandem MS is often used (MS/MS) in the ‘omics’ sciences. It typically includes 
two mass analysers, separated with a collision cell. MS/MS is capable of 
collecting a much more detailed mass spectrum of the sample, which aids 
compound identification in cases of unknown metabolites.  
 
Figure 1-10. Basic components of a mass spectrometer. 
 
The most commonly used ionisation method in LC-MS metabolomics is 
electrospray ionisation (ESI) (Lenz & Wilson 2007), however, atmospheric 
pressure chemical ionisation (APCI) or matrix-assisted laser desorption/ionisation 
(MALDI) can also be used (Griffiths & Wang 2009). ESI, as the name suggests, 
uses an electrospray which converts the mobile phase into aerosol and at the 
same time adds charge to the analyte particles by applying voltage as they are 
sprayed out. The droplets evaporate until only charged particles are left. In the 
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APCI ionisation, the analyte solution is first, vaporised and desolvated, then, the 
particles are ionised by a corona pin (discharge electrode). In MALDI technique, 
an appropriate matrix must be added to the sample, which is placed on a metal 
plate. Then, a laser is used for ablation and desorption of the sample and finally 
hot gas ionises the analyte and directs it to the mass analyser. 
By carefully choosing the chromatography method, various analytes can be 
detected using the LC-MS based metabolomics. Therefore, it is often the method 
of choice of many scientists. However, there is one major drawback of this 
method, ion suppression (Lenz & Wilson 2007). Ion suppression occurs when 
compounds co-elute and as a result affect each other’s ionisation potential. In 
this case the signal detected for some molecules can be decreased (or increased) 
causing an error in the metabolite’s abundance. Therefore, scientists must be 
wary of this issue when analysing data collected using LC-MS. 
1.5.2 Gas Chromatography – Mass Spectrometry (GC-MS) 
Gas chromatography, works on a similar separation principle as liquid 
chromatography, however, in this case, the mobile phase is a carrier gas instead 
of liquid. Typical carrier gases used are helium, nitrogen or hydrogen. The 
column is very thin and long (up to 60m) and available with varying degrees of 
polarity of the stationary phase. The polarity selected should be similar to the 
polarity of the analyte for a better separation. The analytes present in the 
sample adsorb to the column as the sample passes through the column. How well 
they are absorbed depends on the chemistry of the compound and just like in 
the LC separation, different compounds take different lengths of time to pass 
through the column (retention time). The column in a GC system is situated in 
an oven, and the conditions of separation can be altered by the length of the 
column, oven temperature and gas flow rate. A schematic of basic components 
of a GC system is presented in Figure 1-11. 
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Figure 1-11. Basic components of gas chromatography (GC) system. 
 
The capabilities of GC as a separation technique have been significantly 
improved with the development of multidimensional GC (GC x GC) (Lenz & 
Wilson 2007). In this setting two GC columns are used, usually one 30m long and 
the second 1.5m long, with different selectivities. The analytes elute from the 
first column and then they are quickly separated and eluted from the other 
column. 
Different ionisation techniques are used in GC-MS compared to LC-MS, as the 
sample is introduced into the mass spectrometer in a gaseous and not liquid 
form, as well as the fact that the ion source operates under a vacuum and not at 
atmospheric pressure. Two most commonly used methods of ionisation for GC 
instruments are electron ionisation (EI) and chemical ionisation (CI) (Lenz & 
Wilson 2007). In the EI source, a heated filament is present, with voltage applied 
to it, which creates a flow of high energy electrons. This distorts the electric 
field of the analyte molecules passing through it, resulting in ionisation through 
the loss of an electron. The unstable molecules undergo fragmentation to 
achieve a more stable state. This process depends on the molecule and the 
fragmentation pattern is very predictable. It is a higher degree of fragmentation 
than in the LC-MS ionisation sources and more structural information about the 
compound can be obtained. CI ionisation uses a reagent gas (for example 
methane) to ionise the analyte. The ionisation occurs through collisions of the 
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analyte molecules with the ionised reagent gas molecules. In comparison with EI, 
very little or no fragmentation occurs in CI. However, this method is useful to 
detect parent ions, which can sometimes be missed in the EI fragmentation. 
This technique has a major drawback, as it is limited to the analysis of volatile 
compounds. If the intended analytes are not naturally volatile, additional 
derivatisation steps must be included in sample preparation, which makes it 
more complicated and can introduce error. Additionally, as the sample is in 
many cases injected in a liquid form, it must be immediately vaporised, which 
can be quite problematic and result in sample loss. However, GC-MS offers great 
sensitivity, high resolving power and is not susceptible to ion suppression. 
Additionally, the fragmentation patterns of the same compounds are highly 
reproducible, even between different laboratories, which allows for the creation 
of international compound databases, which aid metabolite identification 
(Garcia & Barbas 2011). 
1.6 Aims 
The human decomposition process is a complex biological phenomenon. It is 
known that after death, when normal physiological processes cease, there is a 
loss of homeostasis. This leads to a cascade of biological changes, inactive 
during life, which result in the breakdown of human tissue and other 
components of the body. Although this process was thoroughly studied in the 
past, it is still very difficult to assess the PMI. Other available PMI estimation 
methods (i.e. temperature measurement) can only be accurately used in a very 
short window of time after death. Studying the progression of post-mortem 
decomposition on a molecular level could yield the discovery of a biomarker or a 
panel of biomarkers, the levels of which change in a predictable manner with 
increasing time since death (for example, protein breakdown in muscle tissue). 
The discovery of a possible PMI biomarker could permit the development of an 
accurate, laboratory based method of PMI estimation. To test this hypothesis, 
this PhD project was set out with the following aims: 
 To apply state of the art proteomic and metabolomics technologies in 
forensic research for estimation of the PMI 
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 To optimise the analytical methods available for protein and metabolite 
extraction and analysis in post-mortem tissue 
 To use untargeted proteomic and metabolomics approaches to find 
potential biomarker candidates for the estimation of the PMI 
 To use animal tissue as model and test the PMI biomarker discovery 
approaches 
 To test the hypotheses developed using animal tissue, in human tissue 
 To test the capabilities of commercially available metabolic or protein 
assays in PMI estimation (according to the results of the study). 
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2 METHODOLOGY 
2.1 Sample collection 
2.1.1 Beef 
A sample of cow muscle (sternomandibularis) was collected from an abattoir by 
the project supervisor - Richard Burchmore and chilled over ice immediately 
post-slaughter (<5min). It was transported to the lab immediately after (<1 h). 
The time of death of the animal was recorded. First sample (time point 0) was 
collected immediately upon arrival. A small piece of the muscle was cut off 
using a scalpel and placed in a 50 mL Falcon tube (Corning, UK) and immediately 
frozen by placing it in a -80⁰C freezer. The time delay between the time of 
death of the cow to freezing the first sample was about 1.5 h. The rest of the 
meat was stored in a Tupperware container in a cold room at 4°C. Further 
samples were collected at daily intervals - a piece of the muscle was cut off and 
immediately frozen every 24 hours. Thirteen samples were collected in total, 
over thirteen days. Samples were labelled from T0 (time point/day 0) to T12 
(time point/day 12). 
2.1.2 Rat  
Eight male Wistar rats (283-309g, average weight 296.5g) were sacrificed 
through carbon dioxide asphyxiation. Two of the rats were immediately 
dissected and the biceps femoris muscle tissue (see Figure 2-1) was collected 
from both left and right side of the body. First, only one rat was sacrificed 
separately from the remaining seven and dissected. Then, the remaining rats 
were sacrificed and one of those was dissected. This was done in order to be 
able to dissect two of the rats immediately after their death. The six remaining 
rats were stored in a Tupperware box at room temperature. The remaining rats 
were dissected at 24 h intervals during three consecutive days (two rats per 
day). Tissue samples were collected from each rat, both left and right biceps 
femoris. The collected tissue was weighed and cut into 0.5g portions, placed in 
separate cryogenic vials (Nunc CryoTubes, 1.8 ml, Sigma-Aldrich, Dorset, UK) 
and immediately snap frozen in liquid nitrogen. Samples were then stored at -
80°C until analysis.  
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Figure 2-1. Rat muscle anatomy.  
A. Lateral view of superficial muscles of the rat (Wingerd & Stain 1988), B. Biceps femoris 
muscle exposed prior to dissection (author’s own photo). 
2.1.3 Human 
Human tissue samples were collected from individuals who donated their bodies 
to Forensic Anthropology Centre at Texas State University (FACTS) in San Marcos, 
Texas, US. Six donations were included in this study (see Table 2-1 for details). 
The post-mortem interval of each individual differed depending on the particular 
case. Medical examinations had to be carried out in some of the cases before the 
bodies were received at FACTS. Tissue samples were collected at regular daily 
intervals for a period of 2-5 days starting as soon as possible after the receipt of 
the bodies.  
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Table 2-1. Basic information of the individuals included in the study. 
 Abbreviations: COD – cause of death, GSW – gunshot wound, PMI – post-mortem interval 
(at the time of sampling). 
Subject 
no 
Gender Age COD Sampling 
period (days) 
PMI (days) 
1 Male 60 Haemorrhagic 
stroke 
4 7,8,9,10 
2 Male 62 Pulmonary 
embolism 
4 11,12,13,14 
3 Female 69 Suicide – GSW 
(chest) 
5 11,12,13,14,15 
4 Male 59 Acute respiratory 
distress syndrome 
3 3,4,5 
5 Male 69 Metastatic non-
small cell lung 
cancer 
5 12,13,14,15,16 
6 Male 60 Cardiovascular 
disease 
2 18,19 
 
 
Figure 2-2. Human leg anatomy. 
A. Posterior view of leg muscle - biceps femoris highlighted in red (by Mikael Häggström, 
used with permission), B. Biceps femoris muscle exposed prior to sampling (author’s own 
photo). 
 
Four of the six cadavers (subjects 1, 2, 3 and 5) were refrigerated (in body bags) 
throughout the period of sampling in a cooler set to 7.2⁰C (45⁰F). The lower 
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limbs of two of these subjects were incomplete. Subject 1 was a tissue donor 
(leg bone and skin), therefore the skin and bones from his legs were removed, 
leaving the intact muscle supported on wooden sticks (in place of bones) and 
wrapped in bandages. Subject 3 had incisions made at the back of her legs, all 
along their length, exposing muscle tissue. However, the documentation did not 
explain why that was done. Shortly before sampling, the bodies were removed 
from the cooler, the right leg of the cadaver was lifted up and a single incision 
was made at the back of the leg, along the biceps femoris muscle line (see 
Figure 2-2). The female was placed in the cooler facing down for an easier 
access to the tissue. The underlying muscle tissue (biceps femoris) was exposed 
and a piece of the muscle was cut out using a scalpel. The collected tissue was 
then weighed into six 1g (approximately) portions and put into separate screw 
top vials (micro tubes 2ml, PP – Sarstedt, Leicester, UK). The bodies were 
returned to the cooler immediately after sampling. Sample vials were labelled 
and placed in a container with dry ice to be transported to FACTS, where they 
were stored in a -80⁰C freezer until shipment. Mistakenly, a wrong type of 
muscle tissue was collected for subject 5 for the first 2 days of the sampling. 
The other two individuals (subjects 4 and 6) were placed outdoors, out in the 
field belonging to the facility. The bodies were placed facing down (for an easy 
access to the sampling site) and covered with a cage (to protect from vulture 
activity). Subject 4 was first sampled two days after placement outdoors and 
subject 6 was first sampled indoors before it was placed outdoors. An incision 
was made to expose the muscle and a piece of biceps femoris was collected. The 
tissue was immediately wrapped in a piece of aluminium foil and placed in a 
plastic Ziploc bag, to be transported to the lab (5-10min drive). The incision site 
was covered up with tape to prevent the development of insect activity in the 
wound. Back in the lab, the tissue was cut up and weighed into six portions of 
approximately 1g and placed in the vials. The vials were labelled and placed on 
dry ice together with other samples collected on that day and transported to the 
main university campus to be placed in the freezer. 
Once all of the samples were collected, they were shipped on dry ice to 
University of Glasgow using a courier service (CitySprint, UK). The muscle tissue 
was processed and analysed at the University of Glasgow. 
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2.2 Proteomic studies 
2.2.1 Commonly used reagents 
The reagents required for the two dimensional gel electrophoresis were acquired 
from two suppliers GE Healthcare, Buckinghamshire, UK (CHAPS, DTT, APS, 
TEMED, IPG-Buffer, agarose, glycine, Cye Dyes – yellow, blue and red) and 
Sigma-Aldrich, Dorset, UK (thiourea, SDS, BSA, Bromophenol Blue, glycerol, 
phosphoric acid, Coomassie Brilliant Blue, sypro orange stain). Urea and tris base 
were ordered from Fisher Scientific, Leicestershire, UK. Acrylamide and Bradford 
assay reagent were obtained from Bio-Rad, Hertfordshire, UK. Trypsin was 
provided by Promega, Southampton, UK. Solvents (methanol, ethanol, 
acetonitrile, chloroform, HPLC grade water) and acetic acid were acquired from 
VWR, Bedford, UK. 
2.2.2 Protein extraction 
2.2.2.1 Method development 
The first stage of the proteomics investigation involved developing an 
appropriate extraction method for the proteins present in muscle tissue. 
Initially, it was not possible to obtain post-mortem human or laboratory animal 
tissue to work with, due to ethical restrictions. Therefore, a sample of cow 
muscle was obtained from a slaughter house and used to optimise a protein 
extraction method from muscle tissue. 
Two extraction methods found in the literature were initially tested: deionised 
water extraction (volume of 20x weight of the sample) (Michalczyk et al. 2012) 
and buffer extraction (urea, thiourea, CHAPS) (Montowska & Pospiech 2012). 
Four out of thirteen samples were selected for the 2DE proteomics experiment. 
This was due to the limitation of the gel based separation approach – only two 
samples can be compared on one gel. Comparison of four samples results in an 
eight gel experiment, which significantly increases the complexity of the 
experiment. Tissue samples from time points 0, 3, 7 and 11 were selected to 
investigate the changes at equal time intervals across the length of the time 
course. In order to perform a successful 2DE experiment the protein 
concentration in the extracted sample should be equal to 5mg/ml. The water 
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extraction did not yield the required protein concentration. Three of the 
extracted samples contained only 1mg/ml of protein. The fourth sample 
contained 4mg/ml, which is significantly better than the others, however, still 
too low to carry on with the experiment. The samples were re-precipitated in 
acetone and re-suspended in a smaller amount of lysis buffer to increase the 
concentration of protein, resulting in the following concentrations: 4.46, 2.71, 
4.85, 1.33mg/ml for T0, T3, T7 and T11 respectively. It was decided to go ahead 
with the separation and analysis of samples T0 and T7 (highest protein 
concentrations) to test if the proteins can be successfully resolved using the 2DE 
approach. The two selected samples were labelled with two different 
fluorescent labels – Cy3 (T0) and Cy5 (T7) and compared on one gel (labelling 
protocol described in section 2.2.5.3 on page 71). Figure 2-3 shows two images 
obtained by scanning the gel using two different wavelengths, appropriate for 
each dye. 
The two dimensional separation of the proteins in the trial samples worked very 
well, therefore a few spots were picked for mass spectrometry analysis to 
complete the workflow of this experiment and check all of the steps involved. As 
the spots were excised by hand, the most visible (abundant) spots were picked 
for the analysis (see Figure 2-3). 
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Figure 2-3. Scanned images of fluorescently labelled samples. 
Differences in the spot intensities between the images can be observed. Protein spots 
circled in the top image were excised from the gel and identified through mass 
spectrometry: A – actin, B and C – serum albumin, D – lactate dehydrogenase B. 
The amount of the precipitated proteins was initially very low, most probably 
due to the low efficiency of the water extraction method. To test this 
assumption, the precipitation step was repeated with another aliquot of the 
homogenised sample. Again, the concentration of the protein was not high 
enough. In conclusion, this extraction method is not suitable for 2DE 
experiments as most proteins are not water-soluble. Additionally, the water 
extraction described by Michalczyk et al was used on ground beef samples, 
which is most probably the reason why the method worked in their investigation. 
It is possible that the mincing process would cause an initial break down of the 
proteins. Further grinding and denaturation steps would add to the initially 
released proteins. However, the authors did not state the protein concentration 
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in the samples following the extraction so it is difficult to say how well their 
method worked. Furthermore, they carried out their protein separation using 
SDS-PAGE for which the loading amount varies from 0.5 to 4µg of protein for 
purified samples (Grabski & Burgess 2001). This is significantly less than the 50µg 
required for 2DE gels.  
The buffer extraction performed much better and yielded much higher amounts 
of extracted protein – concentrations in the samples varied between 7.4 and 
8.2mg/ml. Therefore, it was selected as the extraction method for the 
proteomics workflow. However, the samples extracted with buffer were very 
viscous and gelatine-like in appearance, which put the accuracy of the measured 
protein concentration into question, as parts of the sample were hard to 
pipette. This was most probably due to presence of DNA in the samples, which 
should have been removed during the protein precipitation step of sample 
preparation. In order to break up any remaining DNA residues, the samples were 
sonicated using a probe sonicator. Following the sonication, the protein 
concentration measurement was repeated and more lysis buffer was added to 
adjust the concentration to the required 5mg/ml for 2DE analysis. 
2.2.2.2 Finalized protocol 
Tissue portions of 0.5g (for each time point) were used for each analysis. If 
tissue was weighed prior to freezing, it was homogenized while still frozen to 
minimise protein degradation. If it was not possible to weigh the tissue portions 
accurately before freezing, the samples had to be quickly thawed and weighed. 
The tissue was homogenized over ice, in 10 x weight volume (i.e. 5 ml) of the 
extraction buffer (7M urea, 2M thiourea and 4% CHAPS (Montowska & Pospiech 
2012)), until a uniform mixture was achieved. A handheld homogenizer was used 
for this process (LabGEN 7, 220 VAC - Cole-Parmer, IL, USA). Homogenized 
samples were then centrifuged at 3000rpm to remove any insoluble matter. 
Extracts were kept on ice at all times. 
2.2.3 Protein precipitation 
250µl aliquots of the extracts were pipetted into fresh Eppendorf tubes 
(Reaction tubes, 1.5ml, PP – Greiner Bio-One, Frickenhausen, Germany) and 1ml 
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(4 x sample volume) of 100% acetone was added and placed in a -20⁰C freezer 
for an overnight precipitation. Next day, the samples were centrifuged (10 min, 
13,000rpm) to pellet the precipitated protein. The pellet was then washed twice 
using 80% acetone (centrifuging the samples for 10 min at 13,000 rpm after each 
wash) and re-suspended in 200-250µl of the lysis buffer (6M urea, 2M thiourea 4% 
CHAPS and 25mM tris).  
2.2.4 Protein assay 
The protein concentration was measured using the Bradford protein assay. 
Protein standards of the following concentrations were used: 0, 0.1, 0.2, 0.3, 
0.4, and 0.5 mg/ml. 10µl of each of the standards and diluted samples (1:100) 
were pipetted onto a 96-well plate and 200µl of the diluted (1:5) Bio-Rad 
Bradford reagent was added to each. Plate was then shaken briefly and 
incubated for 30 min in the dark. A Tecan Genios plate reader and XFluor4 
software were used to measure sample absorbance. Finally, a calibration curve 
was created, using the absorbance values of the standards, which was used to 
calculate the protein concentrations of the tissue extracts. 
For the 2DE analysis the sample protein concentration was adjusted to 5mg/ml. 
2.2.5 Two dimensional gel electrophoresis (2DE) 
2.2.5.1 Gel preparation and casting 
Polyacrylamide gels were prepared freshly for each experiment. To prepare 6 
gels (550ml solution) the following reagents were required: 171.5ml acrylamide, 
137.5ml Tris, 5.5ml APS, 5.5ml SDS and 230ml H2O. All of the solutions were 
filtered prior to mixing. 77µl of TEMED was added to initiate the polymerisation 
reaction. The gels were poured into plate assemblies immediately after TEMED 
addition, then overlaid with 1ml of water-saturated butanol to ensure that each 
gel polymerised with a flat upper surface. The gels were prepared by laboratory 
technician – Alan Scott. Two types of gels were casted for each experiment: 
DiGE and preparative (prep) gels. Both types are prepared as described above; 
however, prep gels are secured to the glass plates with bind-silane. This is 
carried out, so that the prep gels can be safely handled and stained after the 
separation step. Additionally, prep gels contain unlabelled portions of the 
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sample mixture as these are later used for the mass spectrometric analysis of 
the proteins. DiGE gels contain sample mixtures labelled with fluorescent labels 
(cye dyes). Proteins of interest are selected using DiGE gels; corresponding spots 
are matched between DiGE and prep and excised from prep gels for analysis. 
2.2.5.2 Protein separation – trial experiment 
First, a trial proteomics experiment was carried out using four samples out of 
the 13-day time course. The trial 2DE experiment had a simpler set up, which 
was later modified (see Table 2-2 and Table 2-3). Initially, there was no internal 
standard used, only two samples were loaded onto each gel. This made it quite 
difficult to compare the samples across the gels. All of the gels were run in one 
tank at the exactly same conditions. However, that did not guarantee that the 
results were comparable between the gels. The sample mixture was separately 
labelled and prepared for each gel and also the protein spots had varying 
intensities between them. This created certain issues with data analysis as the 
software could not quantify or compare these changes without any normalisation 
method, e.g. (reference standard added to each gel). As a result, it was only 
possible to see and quantify the changes between the two samples compared 
within one gel. In order to analyse the protein spots, the images of all of the 
gels were printed off in 1:1 scale and compared by eye to match the same 
protein spots from the same samples on different gels (see Figure 2-4). The spots 
of interest were excised from the corresponding prep gels, i.e. if a significant 
change was observed between samples T0 and T3 the corresponding spot was cut 
out of the prep gel with sample T0 or T3. This was a very time-consuming 
process and mistakes could be made with the identification of the same protein 
spots in the corresponding gels. 
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Table 2-2. Experimental set up of the first trial 2DE experiment (beef tissue). 
 
GEL SAMPLE ID Cy Dye IEF STRIP NO 
1 DiGE T0 Cy3 84237 
T3 Cy5 
2 DiGE T3 Cy3 84238 
T7 Cy5 
3 DiGE T7 Cy3 84239 
T11 Cy5 
4 DiGE T11 Cy3 84240 
T0 Cy5 
5 Prep T0 N/A 84241 
6 Prep T3 N/A 84242 
7 Prep T7 N/A 84243 
8 Prep T11 N/A 84244 
 
 
Table 2-3. Example of an experimental set up of multiplex 2DE experiment (rat tissue). 
 
GEL SAMPLE ID Cy Dye IEF STRIP NO 
1 DiGE T0 Cy3 68534 
T1 Cy5 
Pooled std Cy2 
2 DiGE T1 Cy3 68535 
T2 Cy5 
Pooled std Cy2 
3 DiGE T2 Cy3 68536 
T3 Cy5 
Pooled std Cy2 
4 DiGE T3 Cy3 68537 
T0 Cy5 
Pooled std Cy2 
5 Prep Pooled std N/A 68538 
6 Prep Pooled std N/A 68539 
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Figure 2-4. An example of DiGE and preparative gels for the same sample. 
Image A – DiGE gel where samples T3 and T7 were separated. Image B – preparative gel 
where unlabelled T7 sample was separated. Protein spots highlighted in image A were 
selected as proteins of interest. Red spots show proteins that decreased in abundance 
between the two samples and green show ones that increased. Protein spots A-J were 
picked from the preparative gel by comparing and matching corresponding spots by eye. 
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The problems with processing and interpretation of the data from this 
experiment proved that it should include a way of normalizing the data across 
the separate gels. A multiplex 2DE experiment solves that issue, as it allows 
comparing multiple gels and at the same time, multiple samples, through the 
inclusion of a pooled standard. A pooled standard is created by mixing equal 
amounts of each of the tested samples. Therefore, this experiment was 
repeated using a slightly different set-up, where a pooled standard was run 
alongside the samples on each gel (see Table 2-3). The pooled standard (labelled 
with a third dye) allowed normalising the spot intensities between separate gels 
using the Decyder software. This significantly increased the accuracy of the 
matching. Additionally, in the first experiment, four different prep gels were 
used – one for each of the tested samples (see Table 2-2). This was amended to 
include only one prep gel, containing the pooled standard, i.e. a single mix of all 
of the tested samples. This simplified the process of excision and identification 
of the proteins of interest. Finally, an automated spot-picker was purchased, 
which allowed for a far more precise excision of spots of interest. The amended 
protocol is described in detail in the next section. 
2.2.5.3 Finalised protein separation protocol 
Two samples were compared on each 2D gel. To allow comparison between 
separate gels, a pooled standard was added to each gel. All three components of 
each gel were differentially labelled with fluorescent Cye dyes: yellow (pooled 
standard) and red and blue (samples). 1µl of dye was mixed with 10µl of sample 
(which is equivalent to 50µg of protein) and incubated in the dark for 30 min. 
Next, 1µl of 1mM lysine solution was added to stop the cross-linking reaction 
between the Cye dyes and proteins contained in the sample. The solution was 
still kept in the dark for another 10 min after adding the lysine. Finally, the 
differentially labelled samples were mixed according to which samples were to 
be compared on which gels (see Table 2-3) and made up to 460µl with 
rehydration buffer (7M Urea, 2M Thiourea, 4% CHAPS, 10mg/ml DTT, 5µl/ml IPG-
Buffer pH 4-7, 0.002% Bromophenol blue). Furthermore, 100µl of an unlabelled 
portion of pooled standard was also made up to 460µl with strip rehydration 
buffer to be run separately on preparative gels, which were used to excise gel 
spots with proteins of interest and identify them. 
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Once all of the samples were mixed with rehydration buffer, 450µl of each was 
pipetted onto an isoelectrofocusing (IEF) coffin. Then, an IEF strip was placed on 
top of each sample and allowed to mix. After 30 min 1ml of oil was added on top 
of the strips to seal them off and finally, the coffins were placed in an IEF 
instrument (IPGphor, Pharmacia Biotech, Buckinghamshire, UK) and set to run 
overnight. The instrument settings are shown in Table 2-4.  
Table 2-4. IEF instrument parameters (total time – 26 h). 
 
Voltage applied (V) Setting Time (h) 
30 Step and hold 10 
300 Step and hold 2 
600 Gradient 2 
1000 Gradient 2 
8000 Gradient 1 
8000 Step and hold 9 
1000 Step and hold - 
 
The IEF instrument separates the proteins out on the IEF strip based on their 
isoelectric point (pI). pI is defined as the pH value at which a molecule has no 
net charge (McNaught & Wilkinson 1997). Different proteins are differentially 
charged, therefore their pI values differ. Furthermore, the pI of a particular 
protein can change if the structure of the protein is modified in any way. The pH 
of the strip varies from pH 4 to 7 and the proteins line up accordingly along the 
strip. The pI values of most of the proteins lie within this pH range. This process 
is illustrated in Figure 2-5. 
Next day the strips were removed from the coffins and washed. First they were 
very briefly immersed in 0.1% SDS to wash off any remaining oil residue. Next 
the strips were washed twice with 10ml each of 10mg/ml DTT in SEB solution 
(Strip Equilibration Buffer - 6M Urea, 75mM Tris pH 8.8, 29.3% glycerol, 2% SDS, 
0.002% Bromophenol Blue) and 25 mg/ml iodoacetamide in SEB solution. Each of 
the four washes took 15 min. The strips were then secured on top of the gels 
with 1ml of agarose (0.5% in 1x SDS running buffer (1× Laemmli SDS 
electrophoresis buffer - 25mM Tris base, 192mM glycine, 0.1% SDS, 10L)). Finally, 
the gels were placed in an electrophoresis tank (Ettan Dalt II System, Amersham 
Biosciences, Buckinghamshire, UK) filled with x1 (lower chamber) and x2 (upper 
chamber) running buffer and run overnight at 1W per gel. 
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Figure 2-5. Diagram illustrating the two-dimensional gel electrophoresis protocol. 
 
This is the second step (the second dimension) of the 2DE process. In this part 
the proteins separated out on the IEF strip undergo a further separation based 
on their molecular weight (MW). Proteins travel down the polyacrylamide gel 
with various speeds. The larger proteins move through the gel much slower than 
the smaller proteins, resulting in the smaller ones travelling to the bottom of the 
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gel and larger ones remaining nearer the top. This process occurs when power is 
supplied to the tank (see Figure 2-5). 
The following day, all of the gels were removed from the tank. The DiGE gels 
were imaged on the same day. Meanwhile, the preparative gels were stained 
using two different stains: non-colloidal Coomassie stain (200ml of Coomassie 
Dye stock with 50ml of methanol added; Coomassie dye stock: 50g ammonium 
sulphate, 6ml 85% phosphoric acid, made up to 490 with deionised water and 
10ml of Coomassie blue stain added) and sypro orange fluorescent stain (0.0001% 
sypro stain in 7% acetic acid). Before staining, the gels were fixed to stop 
protein diffusion and preserve the state of the gel. The Coomassie stained gel 
was fixed for 1.5 h in a solution of 40% ethanol and 10% acetic acid in water 
(500ml per gel). The sypro stained gel was fixed in for 1 h in a solution of 7% 
acetic acid and 10% methanol in water (500ml per gel). After that 500ml of 
appropriate stain was added to each gel. Sypro orange staining time was 2 h and 
in the case of Coomassie blue the staining time was 4 days. Following the 
staining procedure, the gels were imaged using a fluorescence scanner (Typhoon 
9400, GE Healthcare, Buckinghamshire, UK), as were the unstained DiGE gels. 
Cy2 stained samples were scanned using the blue laser (488nm), Cy3 using green 
laser (532nm) and Cy5 using red laser (633nm). The obtained images were 
processed using DeCyder software (version 7, GE Healthcare, Buckinghamshire, 
UK). The above described protocol is illustrated in Figure 2-5. 
Protein spots of interest were selected from the software processed images and 
a map of these spots was created. With the help of the spot map, protein spots 
of interest were excised from the prep gels using a scalpel for beef samples and 
using an automated spot picker (Ettan, Amersham Biosciences, Buckinghamshire, 
UK) for rat and human samples. The gel pieces were then washed in 100mM 
ammonium bicarbonate and 50% acetonitrile/ammonium bicarbonate solutions 
respectively. Next, they were digested in trypsin solution overnight. The 
following day the digest (liquid surrounding the gel pieces) was transferred onto 
a new 96-well plate and the remaining gel pieces were washed in 5% formic acid 
and acetonitrile. The liquid from the gels was collected and added to the second 
plate with previously transferred gel digests. The plate containing the liquid 
extracted from the gel pieces was dried down in a vacuum centrifuge (Savant 
SPD1010, Thermo Scientific) and analysed using mass spectrometry; peptides 
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were solubilized in 2% acetonitrile with 0.1% trifluroacetic acid and fractionated 
on a nanoflow uHPLC system (RSLCnano Thermo Scientific, Hemel Hempstead, 
UK) before online analysis by ESI mass spectrometry on an Amazon Speed ion 
trap MS/MS (Bruker Daltonics, Coventry, UK). First, peptides were desalted and 
concentrated using a trap column (for 4 min). This was followed by peptide 
separation performed on a Pepmap C18 reversed phase column (Thermo 
Scientific): an acetonitrile gradient (in 0.1% v/v formic acid) (3.2 - 32% v/v 4 – 27 
min, 32% to 80% v/v 27 – 36 min, held at 80% v/v 36 – 41 min and re-equilibrated 
to 3.2%) for a total time of 45 min. A fixed solvent flow rate of 0.3µl/min was 
used for the analytical column.  The trap column solvent flows at a flow rate of 
25µl/min using 2% acetonitrile with 0.1% v/v trifluroacetic acid. MS analysis was 
performed using a continuous duty cycle of survey MS scan. 10 most abundant 
ions were selected for fragmentation in each survey scan, which is then 
continuously repeated. Only multiply charged peptides were chosen, with 
dynamic exclusion for 120 s. This means that each selected ion was added to an 
exclusion list for this length of time. 
MS data were processed using Data Analysis software (Bruker) and the 
automated Matrix Science Mascot Daemon server (v2.5.1). Protein identifications 
were assigned using the Mascot search engine used to interrogate protein 
sequences in the NCBI Genbank database, allowing a mass tolerance of 0.4Da for 
both MS and MS/MS analyses. 
Mascot software (Perkins et al. 1999) compared the experimental masses of 
peptides or fragment ions present in the sample with the calculated masses 
available in the database. By using specific algorithms the software could find 
the closest match or matches with the unknown. Furthermore, the algorithm 
employed a scoring system which reflected the confidence of the match 
(MOWSE® score, for MOlecular Weight SEarch). As a result, it created a list of 
proteins which were matched to the MS identified peptides. An example of a 
Mascot search result page can be seen in Figure 2-6. 
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Figure 2-6. Example of a Mascot search results page. 
 
Since different proteins can contain similar peptide chains, the software 
matches them to various possible proteins and ranks them in terms of 
probability. Matches containing the highest scores have the highest probability 
of being correctly identified. Only matches with a significance threshold of 0.05 
or lower are displayed, which means the matches are fairly confident. However, 
in cases where proteins had not been well resolved on the gel, more abundant 
protein spots could contain more than one protein. In this case, another 
parameter assigned to each match could be examined – emPAI value 
(Exponentially Modified Protein Abundance Index). This is an indication of how 
abundant the protein was in the spot - the higher the number, the higher the 
abundance of the protein. Therefore, matches with the highest scores and 
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highest emPAI values were most likely to be the correct identifications for the 
protein spots in question. The parameters discussed above are highlighted in 
Figure 2-7 showing another part of the Mascot search result page including a list 
of matched peptides. 
 
Figure 2-7. An example of Mascot search result, showing a list of matched peptides. 
 
2.3 Metabolomics experiments 
2.3.1 Sample preparation 
For the purpose of statistical analysis, 4 separate pieces of rat tissue (two rats, 
right and left leg) and 3 separate pieces of beef and human tissue were used for 
each time point. 
Tissue samples (0.5g) were homogenized in 5ml of chloroform/methanol/water 
solution 20:60:20 (v/v/v) (T’Kindt et al. 2010) using a handheld homogenizer 
(Cole-Palmer) and shaken on ice for 1 h using a rocking table (150 rpm, Lab-
METHODOLOGY, 79 
 
Shaker LS-X, Kuhner, Switzerland). Following extraction, samples were 
centrifuged at 3000 rpm for 30 min. 1ml of the supernatant was transferred into 
an Eppendorf tube and centrifuged again at 13 000 rpm for 10 min. Samples 
were then transferred to fresh Eppendorf tubes and stored at -80°C until 
analysis. 
2.3.2 Liquid Chromatography – Mass Spectrometry (LC-MS) 
analysis 
10µl of each sample was used for analysis using hydrophilic interaction liquid 
chromatography-mass spectrometry (UltiMate 3000 RSLC (Thermo Scientific, San 
Jose, California, USA) with a 150 x 4.6mm ZIC-pHILIC analytical column (Merck 
SeQuant, Umea, Sweden) running at 300µl/min, coupled to an Exactive mass 
spectrometer (Thermo Scientific, Waltham, Massachusetts, USA) for MS 
detection. Buffers consisted of A: 20mM ammonium carbonate (Sigma Aldrich) in 
H2O (LC-MS Grade, Rathburn, Walkerburn) and B: acetonitrile (LC-MS Grade, 
Rathburn, Walkerburn). The gradient ran from 80% B 20% B in 15 min, followed 
by a wash at 5% B for 3 min, and equilibration to initial conditions for 5 min. The 
Exactive mass spectrometer was used to detect ions using a HESI-II interface 
with a source temperature of 150°C and capillary temperature of 270°C. Sheath 
gas flow rate was set at 40, auxillary gas flow rate was 5 and sweep gas was 1. 
Each sample was analysed using alternating detection in positive ion and 
negative ion using polarity switching mode, the spray voltage was 4.5 kV and 
3.5kV respectively. Full scan MS detection was acquired for the range 70 to 1400 
m/z at 50000 (at 400 m/z) resolution for each polarity. 
For better detection and identification of different groups of compounds, the 
samples were also analysed using a ZIC-HILIC analytical column (150 x 4.6mm, 
Merck SeQuant) coupled to the same LC-MS system. Method parameters were the 
same as above with the exception of the buffers used – A: 0.1% formic acid and 
B: 0.08% formic acid, both in acetonitrile. 
Raw mass spectrometry data was processed using the Glasgow University 
Polyomics pipeline, consisting of XCMS (Smith et al. 2006) (for peak picking), 
MzMatch (Scheltema et al. 2011) (for filtering and grouping) and IDEOM (Creek et 
al. 2012) (for further filtering, post-processing and identification). Core 
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metabolite identifications were validated against a panel of unambiguous 
standards by accurate mass and retention time. Additional putative 
identifications were assigned by accurate mass along with a retention time 
prediction algorithm (Creek et al. 2011). Mean intensity relative to the control 
group (i.e. earliest time point in the given analysis) and standard errors of the 
mean were generated for all groups of picked peaks. 
2.3.3 Gas Chromatography – Mass Spectrometry (GC-MS) 
analysis 
GC-MS analysis was carried out by a Glasgow University Polyomics mass 
spectrometry specialist – Stefan Weidt. 
 
2.3.3.1 Preparation of calibrators, quality control standards (QC) and 
internal standards 
Eight concentrations ranging from 4.6nmole to 23pmole of amino acid standard 
mixture were prepared for calibration series calculation. Two QC amino acid 
concentrations were prepared at 1.6nmole and 160pmole. Internal standards 
13C6-glucose (2nmole), 
2H27-myristic Acid (2nmole) and scyllo-inositol (1nmole) 
were added to each sample aliquot, calibration standard and quality control 
standard. All of the above were purchased from Sigma-Aldrich, UK.   
2.3.3.2 Sample derivatisation 
10µl of extracted sample along with a pooled standard was transferred into a 
9mm screw cap borosilicate glass 1.5ml vial.  Samples were then dried in a 
Savant SPD1010 SpeedVac concentrator (Thermo Scientific) for 120 min. 50µl of 
20mg/ml (w/v) methoxyamine HCL in pyridine was added to each dried vial, 
vortexed for 10 s and incubated at 80°C for 15 min. Following the 
methoximation step, 50µl of N-Methyl-N-(trimethylsilyl) trifluoroacetamide + 1% 
trimethylchlorosilane (MSTFA + 1% TMCS) was added, followed by a further 30 s 
of vortexing.  Silylation was performed by incubation at 80°C for a further 15 
min.  Samples were cooled to room temperature and were then ready for 
injection on the GC-MS instrument.  
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2.3.3.3 Sample analysis 
The acquisition sequence started with one matrix blank injection of the 
derivatisation reagents, followed by 6 injections of the pooled standard. 
Samples, calibration standards and QC samples were injected in randomised 
order with a pooled standard injection every 6 injections. 1µl of derivatised 
sample was injected into a split/splitless (SSL) injector at 280°C using a 1 in 10 
split flow using a Trace 1310 gas chromatograph (Thermo Scientific).  Helium 
carrier gas at a flow rate of 1.0ml/min was used for separation on a TraceGOLD 
TG-5SILMS 30m length × 0.25mm inner diameter × 0.25µm film thickness column 
(Thermo Scientific). The initial oven temperature was held at 70°C for 4 min, 
followed by a temperature gradient of 20°C/min ramp rate to 300°C, which was 
held for 4 min. Eluting peaks were transferred through an auxiliary transfer 
temperature of 240°C into a QExactive-GC mass spectrometer (Thermo 
Scientific), with EI ionisation at 70 eV energy, emission current of 50µA and an 
ion source temperature of 250°C.  A filament delay of 4.5 min was used to 
prevent excess reagents from being ionised.  High resolution EI fragment spectra 
were acquired using 120,000 resolution with a mass range of 50-750 m/z. The 
best internal lock mass from the background peaks at m/z 207.0324, 281.0511 or 
355.0699 was used to maintain mass accuracy throughout the chromatogram. 
2.3.3.4 Data analysis 
Data processing was carried out using TraceFinder 4.0 General Quan (Thermo, 
UK). Untargeted screening was performed using a forward library search for 
unknown compound discovery. This involved a peak deconvolution step using a 
peak threshold of 2,000.000 with m/z signal-to-noise threshold of 20. National 
Institute of Standards and Technology (NIST) 2014 ‘mainlib’ and ‘replib’ low 
resolution libraries were used to annotate the peaks with a search index 
threshold of 500.  Chemical formulae were then assigned to the accurate mass of 
each deconvoluted fragment ion measured from the Q Exactive GC making use of 
the molecular formula of the match to the NIST low resolution library hits.  
Deconvoluted samples are then retention time aligned and peaks grouped for 
comparison. 
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The rat data was analysed without the inclusion of calibration standards, 
therefore, the amino acid concentrations were calculated from ion 
chromatogram peak areas matched to the reference standards included in the 
analysis (detailed in section 5.2.1). The retention times and quantification ions 
used for concentration calculations are shown in Table 2-5. In the case of human 
tissue, the analysis included a set of calibrators (see section 2.3.3.1) which were 
used to create a calibration curve and calculate the amino acid concentrations. 
Table 2-5. Amino acid retention times and quantification ion used for concentration 
calculation. 
 
Amino Acid RT (min) Quan Ion (m/z) 
Glycine 9.28 174.1128 
L-Alanine 10.11 116.089 
L-Asparagine 11.64 231.1343 
L-Aspartatic Acid 10.72 232.1184 
L-Cysteine 10.97 220.1006 
L-Cystine 14.78 411.1442 
L-Glutamic Acid 11.33 246.134 
L-Glutamine 12.23 156.0839 
L-Histidine 13.02 218.1027 
L-isoleucine 9.18 158.136 
L-Leucine 9.00 158.136 
L-Lysine 12.70 174.1129 
L-Methionine 10.75 176.0924 
L-Ornithine and L-Arginine 12.15 348.2079 
L-Phenylalanine 11.44 192.1203 
L-Proline 11.14 142.1047 
L-Serine 9.65 204.1234 
L-Threonine 9.83 219.1105 
L-Tryptophan 14.46 202.1047 
L-Tyrosine 13.12 218.1027 
L-Valine 8.54 218.1027 
Hydroxy-L-Proline 10.78 230.1391 
L-Homoserine 10.27 218.1391 
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2.3.4 Phenylalanine assay 
2.3.4.1 Preparation of standards and reagents 
Phenylalanine was one of the potential PMI markers. Therefore, a commercially 
available assay kit (Sigma-Aldrich, Dorset, UK) was used to quantify the amount 
of this amino acid in muscle tissue, to test it as a potential method of PMI 
estimation. The assay used was a coupled enzyme assay, which detects 
enzymatic activity by coupling of two enzymatic reactions. In the case of this 
particular assay, the first reaction was phenylalanine deamination, which results 
in production of the reduced form of nicotinamide adenine dinucleotide (NADH). 
Then the NADH reacts with the assay resulting in a fluorimetric product (not 
specified), which is proportional to the amount of phenylalanine. The kit 
included all of the reagents necessary to carry out the assay – assay buffer, 
phenylalanine standard 10µmole, enzyme mix, tyrosinase (used to control 
interference, which might be caused by tyrosine present in the sample) and 
assay developer. The enzyme mix and developer were prepared according to 
manufacturer’s guidelines by reconstituting in 220µl of the assay buffer. 
According to the provided method the phenylalanine standard was supposed to 
be reconstituted in 100µl of water to give 10nmole/µl solution. However, the 
standard was re-suspended in 1 ml of water by mistake with resulting 
concentration of 1nmole/µl solution. The standard was further diluted before 
carrying out the assay to a final concentration of 0.1nmol/µl, therefore the 
initially reconstituted standard was diluted 1 in 10 instead of 1 in 100 as the 
protocol dictates. 
2.3.4.2 Sample preparation 
Samples were prepared according to manufacturer’s guidelines – 20mg of tissue 
sample (exact weight 21mg) was homogenized in 100µl of the phenylalanine 
assay buffer. The tissue was homogenized in Eppendorf tubes by mashing it with 
a special pestle designed for this purpose. Finally, the samples were centrifuged 
at 13,000 rpm to remove any insoluble material. As the concentration of 
phenylalanine in the muscle tissue was unknown, various sample dilutions had to 
be tested to ensure the reading was within the range measured by the assay. To 
do this, different amounts of the sample, i.e. 1, 2, 5 and 10µl were pipetted 
onto a 96-well plate along with the standard (see Table 2-6) and made up to 50µl 
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with the assay buffer. All of the standards were pipetted in duplicate as stated 
in the guidelines. Samples were pipetted in quadruplicate to test the necessity 
of a sample blank (enzyme mix not added) required to correct for background 
signal coming from NADH and NADPH present in the sample. 
Table 2-6. Volumes of the phenylalanine standard used to prepare the calibration curve. 
 
Standard 1 2 3 4 5 6 
Volume used (µl) 0 2 4 6 8 10 
Resulting concentration (nmole) 0 0.2 0.4 0.6 0.8 1.0 
 
Once all of the standards and samples were pipetted onto the plate, the volumes 
of reagents added were as shown in Table 2-7.  
Table 2-7. Volumes of reagents used to develop the assay. 
 
Reagent Sample blank Samples and Standards 
Phenylalanine assay buffer 48µl 46µl 
Enzyme mix - 2µl 
Developer 2µl 2µl 
 
Once all of the standards, samples and reagents were pipetted on to the plate, 
it was incubated for 20 min at 37°C. The fluorescence intensity was then 
measured using an Infinite 2000 Pro plate reader (Tecan, Switzerland). The 
instrument settings used are shown in Table 2-8. 
Table 2-8. Tecan instrument settings used for fluorescence intensity measurement. 
 
Mode Fluorescence top reading 
Excitation wavelength 535nm 
Emission wavelength 587nm 
Excitation bandwidth 9nm 
Emission bandwidth 20nm 
Gain 76 optimal (100%) 
Number of flashes 25 
Integration time 20µs 
Lag time 0µs 
Settle time 0ms 
Z-position (Manual) 20000µm 
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Table 2-9. Readings of the trial phenylalanine assay test. 
 
 
  
 
 
Figure 2-8. Image showing the observed colour change in the trial phenylalanine assay. 
Top row contains the phenylalanine standard at various concentrations. The 4 rows below 
contain different aliquots of the homogenized tissue sample. Pink colour indicates that the 
concentration of phenylalanine is too high in comparison with the calibration standards in 
the top row. 
The phenylalanine levels were too high to be measured within the range of the 
calibration curve (see Table 2-9 and Figure 2-8). Therefore, the test was 
repeated using different dilutions of the homogenized tissue. 22mg of tissue was 
homogenized and 10µl of neat, 1 in 10, 1 in 100, 1 in 1000 and 1 in 10,000 
dilutions of the homogenate were pipetted onto the plate along with the 
standards and made up to 50µl with assay buffer. In this case no sample blank 
was used as the test was carried out just to work out the appropriate dilution of 
the sample. The neat and 1 in 10 dilutions were too concentrated, whereas 1 in 
1000 and 1 in 10,000 were too low to be measured. The 1 in 100 dilution was 
within the range of the calibrators, however, at the very low end (calculating at 
0.03nmole on a scale from 0 to 1nmole). Since only 10µl of the dilution was 
used, the addition of the assay buffer to make it up to 50µl would have diluted it 
further, resulting in a final dilution of 1 in 500. Therefore, to carry out the 
assay, the sample was diluted 1 in 100 with the buffer, and 50µl of that was 
pipetted onto the 96-well plate. 
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 1312 1092 3817 4110 6325 6629 9249 9266 11219 11238 13753 13608
B 27758 24571 28979 32346 1 2 2 2 2 1 2 2
C 33661 38932 40418 39820 2 1 3 2 2 2 2 2
D 40154 37858 41263 37469 2 2 1 2 2 1 2 1
E 36140 38033 37654 39215 2 1 2 2 2 1 2 2
F 3 2 3 2 2 2 3 2 1 1 1 2
G 2 3 2 1 3 2 2 3 2 2 2 2
H 3 3 2 2 2 2 2 2 3 2 2 2
METHODOLOGY, 86 
 
After the initial testing, the amount of reagents left was only sufficient to carry 
out one experiment involving tissue samples from two of the human subjects 
(the amount of phenylalanine tested at each time point). Subjects 2 and 5 were 
selected as they were both male, with overlapping PMI at the time of sampling.  
Table 2-10 shows the amount of tissue weighed out for each time point. 
Table 2-10. The weight of tissue used for each subject and time point for the assay. 
 
PMI (days) Subject 2 Subject 5 
11 21mg N/A 
12 21mg 22mg 
13 21mg 20mg 
14 21mg 22mg 
15 N/A 20mg 
16 N/A 20mg 
 
Three 50µl aliquots of each sample (1 sample blank and 2 including the enzyme 
mix) were pipetted onto the plate along with the two aliquots of each of the 
calibration standards. Only one sample blank was used, as there was not enough 
developer solution left for 4 aliquots of each time point (only one kit was 
purchased). Ideally, each blank, standard and sample should be measured in 
duplicate to give an average end result. Table 2-11 shows how the samples were 
situated in the 96-well plate. 
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Table 2-11. Layout of a 96-well plate showing the positions of all of the samples tested with 
the phenylalanine assay. 
Abbreviations used: Blk – blank, Std – standard, S2 – subject 2, S5 – subject 5, D followed 
by a number – indicates PMI (days since death), subject/day number followed by Blk – 
indicates sample blank for this particular sample, X – unused, empty wells. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Blk Blk Std 
1 
Std 
1 
Std 
2 
Std 
2 
Std 
3 
Std 
3 
Std 
4 
Std 
4 
Std 
5 
Std 
5 
B S2 
D11 
Blk 
S2 
D11 
S2 
D11 
X S5 
D15 
Blk 
S5 
D15 
S5 
D15 
X X X X X 
C S2 
D12 
Blk 
S2 
D12 
S2 
D12 
X S5 
D16 
Blk 
S5 
D16 
S5 
D16 
X X X X X 
D S2 
D13 
Blk 
S2 
D13 
S2 
D13 
X X X X X X X X X 
E S2 
D14 
Blk 
S2 
D14 
S2 
D14 
X X X X X X X X X 
F S5 
D12 
Blk 
S5 
D12 
S5 
D12 
X X X X X X X X X 
G S5 
D13 
Blk 
S5 
D13 
S5 
D13 
X X X X X X X X X 
H S5 
D14 
Blk 
S5 
D14 
S5 
D14 
X X X X X X X X X 
 
The standards, samples and appropriate reaction mix were added to the plate 
and after 20 min incubation the fluorescence intensity was measured. However, 
the buffer used for the assay became very foamy during the pipetting stage and 
it was impossible to remove the air bubbles by neither mixing it with a pipette 
tip nor shaking the plate using a plate shaker. As the accuracy of the plate 
reading could have been affected by the presence of the air bubbles in the 
wells, all of the samples were pipetted onto a new plate, avoiding the air 
bubbles and the plate was measured again. However, this could have affected 
the sample volume pipetted onto the second plate, which in turn could have had 
an effect on the obtained readings (see Figure 2-9). The results of this assay are 
presented in chapter 4. 
 
 
METHODOLOGY, 88 
 
 
Figure 2-9. Images representing already developed phenylalanine assay. 
Image A shows the air bubbles created via addition of the buffer mixture. Image B shows 
the samples after they were pipetted onto a new 96-well plate. The top row contains various 
concentrations of phenylalanine standard. Both standards and samples are of light 
blue/purple colour which blends in with the background. 
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3 PROTEOMICS 
3.1 Introduction 
Proteomics is a branch of science which belongs under the umbrella of “omics” 
approaches. It aims to identify and characterise the proteins that comprise a 
given biological system. The proteome is very complex, consisting of many large 
molecules, and requires protein separation or digestion steps in order to identify 
components by means of mass spectrometry. In untargeted approaches, the most 
commonly used protein separation techniques are SDS-PAGE or for more complex 
samples, 2DE (used in this study). These are often combined with liquid 
chromatography separation of peptides and mass spectrometry for protein 
identification. Other approaches, like western blotting, allow for a targeted 
analysis using protein-specific antibodies and also serve as protein identification 
confirmation techniques. The proteome is also very dynamic and would be 
expected to change rapidly and progressively once homeostasis breaks down 
upon death. 
Researchers have suggested various protein markers for PMI estimation over the 
years, with varying degrees of success. In 1986, Pla et al. measured the 
activities of rate limiting enzymes of glycolysis in post-mortem rat brains (Pla et 
al. 1986). However, they found that phosphofructokinase and hexokinase have 
very little value in PMI determinations. Not long after, Kominato et al. suggested 
the cleavage of the third component of complement (C3) as means of PMI 
estimation (Kominato et al. 1989). The percentage of C3 cleavage was positively 
correlated with PMI. A few years later, Gos and Raszeja investigated the activity 
of lactate and malate dehydrogenase in human liver up to 35 days post-mortem 
and reported a time dependent decrease (Gos & Raszeja 1993). More recently, 
Kikuchi et al. investigated post-mortem changes in high mobility group box-1 
protein (HMGB1) in rat serum up to 7 days post-mortem (Kikuchi et al. 2010). 
They reported that the protein levels increased throughout the investigated 
period when rat cadavers were stored at 4°C. Different trends were seen at 
higher temperatures. Another two independent studies, by Kang et al. (Kang et 
al. 2003) and Poloz and O’Day (Poloz & O’Day 2009) investigated the use of 
calmodulin binding proteins in both lung and skeletal muscle tissue of rats and 
mice, respectively. In both cases the PMI investigated was up to 96 h. The first 
PROTEOMICS, 90 
 
group reported that the levels calmodulin-dependent kinase II (CaMKII) did not 
change in either muscle or lung, however, myristoylated alanine-rich C-kinase 
substrate (MARCKS) and calcineurin A (CnA) showed a PMI dependent decrease in 
lung. MARCKS was not detected and CnA levels were very variable in muscle 
tissue. The second group did not find lung tissue to be useful for the purpose of 
PMI estimation and suggested that CnA could potentially be used as a marker for 
short PMI of up to 24 h and protein phosphatase 2A (PP2A), not included in the 
first study, for longer PMI. Recently, Zapico et al. looked at mRNA expression of 
Fas Ligand (FasL) and phosphatase and tensin homologue detected chromosome 
10 (PTEN) in rat muscle, however for a very short time period of up to 8 h post-
mortem (Zapico et al. 2014). They reported that expression of mRNA of both 
FasL and PTEN increased up to 6 h post-mortem. In the same year, Santos Junior 
et al. investigated the levels of metals and metallo-proteins in human vitreous 
humour (Santos Júnior et al. 2014). The authors reported a correlation between 
iron levels and PMI. 
This chapter presents the results of the application of an untargeted proteomics 
approach, to identify possible protein markers of PMI in skeletal muscle tissue. 
Initial experiments and method development were carried out using beef steak, 
followed by a controlled experiment using muscle tissue collected from rat. 
Finally, human cadavers were investigated as a preliminary test for PMI markers 
highlighted in the rat study. 
3.2 Methodology 
All of the methods used in the proteomics experiments, including method 
development and optimisation, were described in detail in Chapter 2. 
3.3 Results 
3.3.1 Beef tissue 
An initial experiment included four samples: T0, T3, T7 and T11. A pairwise 
comparison using a 2DE approach was carried out. Proteins that showed a 
significant change in magnitude of volume ratios (at least 2-fold) between the 
time points were selected for identification using mass spectrometry. Volume 
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ratio is a normalized ratio between the co-detected spots (more specifically, 
pixel spot volumes) in separate gel images. Twelve proteins of interest were 
selected. These included various forms of myosin, troponin and heat shock 
protein, as well as desmin, malate dehydrogenase, lactate dehydrogenase, 
NADH-ubiquinone and C->U-editing enzyme APOBEC-2. A full list of these 
proteins, including the links to the Mascot search results is attached in Appendix 
I. The changes occurring across the range of time points are presented in Table 
3-1. As this initial experiment was carried out without the inclusion of a pooled 
standard, the protein spots between the gels were compared and matched by 
naked eye. The protein spots were highlighted in DiGE gels and corresponding 
spots were excised from the appropriate prep gel. Each of the four samples was 
separated on a separate prep gel. Therefore, in order to see the change across 
all of the time points for a particular protein, this protein should be matched 
and identified in all four gels. Unfortunately, none of the spots of interest were 
successfully identified and matched in all four gels, which resulted in the missing 
data in Table 3-1. Additionally, it can be seen from the table that in some cases 
there are two trends noted for one time point. For example lactate 
dehydrogenase B in the T0→T3 column shows both decreasing (D) and no 
significant change (NSC) trend (volume ratio less than 2-fold). This occurred 
when the same protein was identified in two separate spots on one gel which 
showed different trends. In that case both results were presented. The spots 
with insignificant result were also included, as they were matched to 
corresponding spots that showed a significant result.  
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Table 3-1. Summary of the changes observed for proteins of interest at different time points. 
D – decreasing, I – increasing, NSC – no significant change. Protein spot matching between gels was carried out by naked eye as no standard was included 
between gels. The data shown below is for proteins which were identified through MS. Some of the protein spots remained unmatched and weren’t picked, 
which resulted in missing data – indicated by the grey areas in the table. Two numbers and results are presented where the same protein has been 
identified in two spots on the same gel – results are presented for both spots. 
Protein ID  T0 → T3 T3 → T7 T7 → T11 T0 → T11 
Accession no Change Fold change Change Fold change Change Fold change Change Fold change 
Myosin regulatory light chain 2 gi|115497166 D 2.28 I/I 28.88/12.67     I 35.14 
Troponin T (slow  type) gi|21039010 D/D 2.38/2.42 I 2.58     D/D 2.14/3.01 
Lactate dehydrogenase B chain gi|118572666 D/NSC 2.57/1.67 I 2.58     D 2.95 
Probable C->U-editing enzyme 
APOBEC-2 
gi|77735661     I 19.56     D 2.24 
Myosin light chain 6B gi|115496556 D/NSC 2.24/1.67 I/I 2.55/33.84 I 2.86     
Myosin-7  gi|41386711     D/I 3.11/2.23 I/I 2.67/2.15     
Myosin regulatory light chain 2, 
ventricular/cardiac muscle isoform 
gi|296478466             I/I 13.33/24.01 
Troponin T (fast type) gi|21038998             D 4.40 
Heat shock protein beta-1 gi|85542053             D 2.02 
Heat shock protein beta-6  gi|115496724             D 4.11 
Malate dehydrogenase gi|77736203 D 2.07             
Myosin-2 gi|261245063 D 2.81             
Heat shock cognate 71 kDa protein gi|148887198 D/D 2.17/2.12             
Desmin gi|2959452     D 2.54         
NADH-ubiquinone oxidoreductase 
75 kDa subunit 
gi|27807355     D 5.73         
Tripartite motif-containing protein 
72 
gi|119917044         I 2.26     
Myosin heavy chain (fetal) gi|22335457         I 2.57     
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This initial experiment served to establish an appropriate protocol for sample 
preparation and for 2DE separation, but the experimental design made it quite 
difficult to look at the overall change across all of the time points. Therefore 
this experiment was repeated with the addition of a pooled standard to each 
gel. This allowed normalising the results across all of the gels. Based on this, the 
Decyder software can graph the changes between the matched protein spots 
across all of the gels and show a general trend throughout the different time 
points. So in this case, the protein spots of interest were picked based on a 
graphical representation of how the levels of the protein change with time. The 
experiment yielded 105 protein spots of interest. Twenty-five of these, showing 
the most consistent trend of change, were excised from the gels and identified 
by mass spectrometry (see Table 3-2). Additional information on these 
identifications, including links to Mascot search results are attached in Appendix 
II. Figure 3-1 shows an image of one of the gels with the selected proteins of 
interest and their corresponding spot numbers (software assigned). The image 
only displays 14 out of the 25 of proteins of interest. This is due to the fact that 
not all of the proteins have been matched in all of the gels. The software does 
not always assign the spots in the same way on different gels. Poorly resolved or 
low intensity spots might be missed or incorrectly assigned. This is also the 
reason why some of the statistical data was not available for some of the 
proteins (Table 3-2). The proteins have to be matched in more than one gel, i.e. 
software needs data for more than one spot of each protein to be able to carry 
out the statistical analysis for it (mean protein volume at each time point and 
student’s t-test between time points). Figure 3-2 shows graphs of nine selected 
proteins of interest, which showed the most promising patterns of change over 
time. 
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Figure 3-1. Image of a DiGE gel showing the proteins of interest and their corresponding spot numbers (beef). 
One of four DiGE gels included in this experiment. This particular image represents sample T7 (7 days PM), labelled with Cy5 and scanned with red laser 
(633nm). 14 out of 25 proteins of interest were matched in this particular gel. Proteins were separated using pH gradient 4-7 (from left to right).
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Table 3-2. List of proteins of interest identified using a single multiplex 2DE experiment in 
beef tissue. 
Spot numbers correspond to Figure 3-1 (software assigned by Decyder software). NCBI 
database was used for Mascot search. Accession number given in the NCBI database. T-test 
indicates the significance of the change observed. Mascot search result shows the ID 
assigned by Mascot search engine and its corresponding MOWSE probability score. A 
score of 36 or higher indicates a significant match, with the significance threshold of 
p<0.05. N/A – not available.  
Spot 
no 
Accession no T-test Mascot search result MOWSE 
score 
910 gi|119917044 N/A tripartite motif-containing protein 72  124 
938 gi|157832112 0.35 Chain A, Structural Basis Of The 70-
kilodalton Heat Shock Cognate Protein  
1180 
940 gi|157832110 0.55 Chain A, Structural Basis Of The 70-
Kilodalton Heat Shock Cognate Protein  
983 
948 gi|157832110 0.84 Chain A, Structural Basis Of The 70-
Kilodalton Heat Shock Cognate Protein  
588 
975 gi|157832112 N/A Chain A, Structural Basis Of The 70-
kilodalton Heat Shock Cognate Protein  
619 
985 gi|1351907 0.78 serum albumin 338 
1141 gi|116004023 0.54 phosphoglucomutase-1  769 
1147 gi|27806321 0.36 retinal dehydrogenase 1 1168 
1161 gi|41386711 0.25 myosin-7  1498 
1161 gi|119917044 0.25 tripartite motif-containing protein 72 1738 
1201 gi|2959452 0.25 desmin  428 
1341 gi|27819614 0.6 actin, alpha skeletal muscle 284 
1341 gi|296481810 0.6 succinyl-CoA ligase [ADP-forming] subunit 
beta, mitochondrial 
139 
1386 gi|27819614 N/A actin, alpha skeletal muscle 662 
1386 gi|296482731 N/A actin, gamma-enteric smooth muscle  681 
1432 gi|21038992 0.13 troponin T fast skeletal muscle type  844 
1495 gi|115497482 0.097 prostaglandin reductase 2 175 
1591 gi|164420789 0.2 pyruvate dehydrogenase E1 component 
subunit beta, mitochondrial precursor 
876 
1591 gi|77735405 0.2 four and a half LIM domains protein 3 72 
1597 gi|41386697 0.1 troponin T, slow skeletal muscle 410 
1600 gi|164420789 0.13 pyruvate dehydrogenase E1 component 
subunit beta, mitochondrial precursor 
335 
1635 gi|41386697 N/A troponin T, slow skeletal muscle  2020 
1648 gi|528940817 0.28 F-actin-capping protein subunit beta isoform 
X1  
2106 
1756 gi|296482731 N/A actin, gamma-enteric smooth muscle 1255 
1756 gi|71037405 N/A heat shock protein beta-1 2463 
1791 gi|529007450 0.045 heat shock protein beta-1 isoform X1 268 
1888 gi|115496556 0.072 myosin light chain 6B 469 
1897 gi|115496556 0.027 myosin light chain 6B 416 
1911 gi|115496724 0.024 heat shock protein beta-6 324 
2012 gi|27819614 N/A actin, alpha skeletal muscle 111 
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Figure 3-2. Proteins of interest identified through 2DE experiments in beef tissue. 
Mascot database search resulted in the following identifications: a – heat shock protein beta 6, b – troponin T, c – myosin 7, d – actin, e - heat shock 
protein beta 1, f – actin, g – myosin light chain 6B, h – pyruvate dehydrogenase E1, i – desmin. The x-axis represents PMI, T0, T3, T7 and T11 correspond to 
0, 3, 7 and 11 days PM, respectively. Y-axis shows the log standardised pixel volume of the protein spots (only spots which were included in the statistical 
evaluations were included in the graph). The dots represent the volume of each protein spot. The dashed lines connect the spots compared on 1 gel. The + 
sign shows the mean value between samples from the same time point, which are connected with a line to show the trend across the time course.
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The proteins displayed in Figure 3-2 provide a good example of the purpose of 
using an untargeted proteomics approach to look for protein markers for time 
since death. A number of proteins were separated and identified in this 
experiment. Different proteins show different trends with increasing time since 
death and this way we can look for proteins which show steadily increasing or 
decreasing patterns. Of particular interest, heat shock protein ß6 and actin 
(Figure 3-2 a and d respectively) show nearly linear decrease and increase, 
respectively, over the PMI studied. Heat shock protein and troponin T were also 
identified in the trial experiment. 
Figure 3-3 shows gel images for each of the samples included in the experiment. 
They appear distorted as Decyder software warps the images to improve 
matching. The proteins of interest were selected from various parts of the gel; 
however, none of the gels contained all of the 25 protein spots of interest. The 
gels look very similar; however, differences can be seen between them in the 
intensity and resolution of the spots. The longer the PMI, the more ‘messy’ the 
image looks. Poorly resolved regions of the gel appear in the later PMIs, which 
are absent or a lot smaller at earlier PMIs. More apparent and abundant protein 
spots could indicate a build-up of protein fragments. These would accumulate as 
the proteins break down with tissue degradation over time. 
The results of the experiments carried out using beef tissue were very promising. 
However, the decomposition process in an intact cadaver would proceed in a 
different way than in an isolated tissue fragment. Therefore, subsequent studies 
were directed to intact cadavers. 
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Figure 3-3. Comparison of images obtained for all of the investigated beef samples. 
Images correspond to the following samples: a – T0 (0 days PM), b – T3 (3 days PM), c – T7 (7 days PM), d – T11 (11 days PM). All of the gels were run 
together under the same conditions; all above images represent samples labelled with Cy5 and scanned with red laser (633nm). The images look ‘messier’ 
with increasing time since death. Tissue in more advanced stages of decomposition seems to be poorly resolved using 2DE separation technique. 
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3.3.2 Rat muscle 
The rat was selected as an appropriate animal model in which to discover 
potential markers of PMI. Rats were euthanized and allowed to decompose 
intact. Biceps femoris samples were collected from different rats at different 
post-mortem intervals (0, 24, 48 and 72 h). In this case the post-mortem period 
under investigation was much shorter than in the case of beef, due to the 
limited number of rats used and practicalities of storing cadavers at room 
temperature.  
The multiplex 2DE experimental design that had proved effective in the trial 
study with beef was applied to rat tissue. This time, an automated spot picker 
was used to pick the spots, allowing for more accurate matching and picking of 
the selected spots, as well as the identification of a larger number of potential 
biomarker candidates. Forty-six gel spots were selected for picking (see Figure 
3-4) and 40 were successfully picked. Table 3-3 shows a list of proteins that 
were identified in the 40 spots that were picked. Additional information about 
them can be found in Appendix III. They were selected on the basis of how the 
protein levels changed over time, irrespective of their proximity to each other 
on the gel. Therefore, some of the spots were picked from the same area of the 
gel and were subsequently identified as the same protein. Twenty-two unique 
proteins were identified, though their appearance at different positions on the 
2D gels is consistent with the presence of multiple isoforms. These may arise 
through different post-translational modification events, which might have 
occurred during life or post-mortem, as the result of dysregulation of the 
pathways for protein synthesis, modification or degradation. The biological 
relevance of post-translational modification may be to alter the structure, 
function or localisation of proteins, through the regulated addition of 
phosphates, sugars, lipids etc., or through proteolytic cleavage (Brooker et al. 
2014, p.431). Post-translational modification is a major source of complexity in a 
proteome, as there is the potential for each gene product to be present as many 
proteoforms. In post-mortem tissue, modifications may occur in an unregulated 
manner, and proteolysis will accumulate over time. Most different proteoforms 
will have chemical features that alter mass or charge, and these may thus be 
evident in 2DE separation. This can be observed in Figure 3-4 – protein spots 
with numbers 1256, 1274, 1279, 1284, 1287 and 1290 were all identified as 
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myosin-binding protein C, slow type (Table 3-3). These spots are aligned 
horizontally across the gel, as they all have a similar MW but different pI value. 
This reinforces the correct identification of the protein and, although it reduces 
the number of gene products that are candidate markers of PMI, it highlights 
specific pathways that show modifications after death. Furthermore, even 
though the properties of the modified proteins differ, all of them behave in a 
similar way post-mortem. All of the proteins identified as myosin-binding protein 
C gradually increase with time since death (see Figure 3-5), however at various 
rates. For example, protein in spot 1274 increased nearly 15-fold but protein in 
spot 1256 only 3-fold. However, this is not the case for two other proteins 
identified in multiple gel spots in this experiment. Different proteoforms of 
myosin-4 and alpha-actinin-3 show both decreasing and increasing trends (see 
Figure 3-6). 
The change in levels of the proteins can also be seen by direct comparison of the 
gel images. Figure 3-7 shows how three selected spots can be seen appearing or 
disappearing with increasing time since death. The images of the gels containing 
each of the different samples (labelled with the same dye - Cy3) were aligned 
with increasing time since death. The samples were taken at 24 h intervals, 
therefore there is not much difference in the general appearance of the gels. 
However, certain spots show clear differences in intensity between the images.  
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Figure 3-4. Image of a DiGE gel showing all of the 46 proteins of interest and their spot numbers (rat tissue). 
One of four DiGE gels included in this experiment. This particular image represents the pooled standard (contains equal amounts of all 4 samples included 
in the experiment), labelled with Cy2 and scanned with blue laser (488nm). Spots with the following numbers, 1108, 1291, 1387, 1610, 1776 and 1974 were 
not successfully picked. Proteins were separated using pH gradient 4-7 (from left to right)
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Table 3-3. List of proteins identified using a single multiplex 2DE experiment in rat muscle 
tissue. 
Spot numbers correspond to Figure 3-4. NCBI database was used for Mascot search. 
Accession number given in the NCBI database. T-test indicates the significance of the 
change observed. Fold change for each protein across the time course, minus sign 
indicates a decreasing trend. Mascot search result shows the ID assigned by Mascot search 
engine and its corresponding MOWSE probability score. A score of 35 or higher indicates a 
significant match, with the significance threshold of p<0.05. N/A – data not available.  
Spot 
no 
Accession no T-test Fold 
change 
Mascot search result MOWSE 
score 
656 gi|106879208 0.087 -1.44 myosin-4  826 
752 gi|300797519 0.029 -1.61 myomesin-1  443 
761 gi|300797519 N/A -1.48 myomesin-1  292 
762 gi|300797519 0.045 -1.63 myomesin-1  455 
808 gi|281306803 0.26 -1.18 myomesin 2  1155 
811 gi|564319841 N/A 1.34 histone H3.3-like 38 
819 gi|281306803 0.019 -1.65 myomesin 2  1550 
904 gi|106879208 0.0056 3.33 myosin-4  51 
908 gi|149043182 N/A 1.19 actin, alpha 1, isoform CRA_a 64 
1080 gi|157823379 0.13 -1.63 myosin-binding protein C, fast-type  857 
1086 gi|157821545 N/A -1.55 uncharacterized protein LOC362455  37 
1112 gi|157823379 0.005 -2.99 myosin-binding protein C, fast-type 333 
1168 gi|157823379 N/A -2.29 myosin-binding protein C, fast-type 497 
1182 gi|157823379 N/A -2.87 myosin-binding protein C, fast-type  621 
1233 gi|40849900 0.0033 3.91 plectin 8  88 
1256 gi|281604187 N/A 3.18 myosin-binding protein C, slow-type 355 
1274 gi|281604187 0.002 14.81 myosin-binding protein C, slow-type  1100 
1279 gi|281604187 N/A 6.39 myosin-binding protein C, slow-type 363 
1284 gi|281604187 N/A 6.38 myosin-binding protein C, slow-type  249 
1287 gi|281604187 N/A 8.84 myosin-binding protein C, slow-type  306 
1290 gi|281604187 N/A 2.07 myosin-binding protein C, slow-type  110 
1360 gi|19071449 N/A 1.31 organic anion transporter K8 37 
1386 gi|19173800 N/A -1.25 alpha-actinin-3  177 
1392 gi|19173800  N/A -1.38 alpha-actinin-3  318 
1399 gi|564323684  N/A 2.07 girdin-like isoform X1 38 
1467 gi|564332022 N/A 2.77 glycogen phosphorylase, isoform X1  851 
1536 gi|51859516 N/A -2.79 heat shock protein 90kDa alpha 1091 
1568 gi|19173800 N/A 2.05 alpha-actinin-3  385 
1721 gi|347019 0.28 1.42 dnaK-type molecular chaperone 
hsp72-ps1 
107 
1755 gi|347019 0.0075 4.14 dnaK-type molecular chaperone 
hsp72-ps1 
290 
1767 gi|149047633 0.11 1.22 rCG35722, isoform CRA_b  63 
1804 gi|38303941 0.11 -1.85 myosin binding protein H  94 
1806 gi|77917546 0.14 2.26 mitochondrial membrane protein  66 
1973 gi|40018568 0.2 -1.48 tubulin beta-4B chain  74 
2161 gi|58865384 0.026 1.19 NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 2 
347 
2269 gi|4501881 0.14 -1.13 actin, alpha skeletal muscle 1166 
2404 gi|149041699 0.023 1.22 isocitrate dehydrogenase 3 (NAD+) 
alpha, isoform CRA_a  
290 
2537 gi|20304123 0.13 1.3 3-mercaptopyruvate sulfurtransferase 142 
2607 gi|538426 0.049 1.28 triosephosphate isomerase  46 
2639 gi|51948506 0.025 1.38 adenylate kinase 8  38 
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Figure 3-5. Graphs representing changes in proteins identified as myosin-binding protein C. 
The graphs show spots with the following numbers: a – 1256, b – 1274, c – 1279, d – 1284,   
e – 1287 and f – 1290. All of the proteins show similar trends, however their rates of increase 
differ. The x-axis represents PMI, T0, T1, T2 and T3 correspond to 0, 1, 2 and 3 days PM, 
respectively. Y-axis shows the log standardised pixel volume of the protein spots. The dots 
represent the volume of each protein spot. The dashed lines connect samples from same 
gel. The + sign is the mean value between samples from the same time point. 
 
Figure 3-6. Graphs illustrating differences in trends between same proteins. 
Proteins excised from separate gel spots and identified as the same protein. Graphs a and b 
show myosin-4 and c and d show alpha-actinin-3. The x-axis represents PMI, T0, T1, T2 and 
T3 correspond to 0, 1, 2 and 3 days PM, respectively. Y-axis shows the log standardised 
pixel volume of the protein spots. The dots represent the volume of each protein spot. The 
dashed lines connect samples from same gel. The + sign is the mean value between 
samples from the same time point. 
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Figure 3-7. Representation of the change in spot abundance in gels with different PMI. 
Images correspond to the following samples: A – T0 (day 0), B – T1 (1 day PM), C – T2 (2 
days PM), D – T3 (3 days PM). All samples in the above images were labelled with Cy3 and 
scanned with green laser (532nm). Selected protein spots were identified as a – Heat shock 
protein 90kDa alpha (spot 1536), b – dnaK-type molecular chaperone hsp72 (spot 1755) and 
c – myosin-binding protein C (spot 1274). The graphs show the change in log standardised 
protein volume (y-axis) over time in days (x-axis, T0 – T3 as above). 
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Of the 22 identified proteins, 9 were selected as potential PMI markers. These 
are shown in Figure 3-8. These proteins were selected based on two criteria. 
First, they showed a clear, steady increasing or decreasing trend, and secondly, 
the levels of these proteins were comparable between replicate samples. The 
graph is based on the mean of the values obtained between two different gels 
(each sample was separated in duplicate - on two different gels). If the 
discrepacy between the protein levels was large, the graphical representation of 
how the protein levels changed was not accurate. An example of this can be 
seen in graphs a and b in Figure 3-6. Since both aliquots come from the same 
sample extract and they are matched at the same position in both gels, it can be 
assumed that it is the same protein. Therefore, they should be present in similar 
levels on both gels. However, this is assesed based on the intensity of the spot 
measured in the gel image, which can be affected by the efficiency of the dye 
labelling. 
The proteins of interest differ in the case of rat and beef tissue. An untargeted 
approach was applied in both studies and the best candidates were selected in 
each case. There are however, some similarities: members of actin, myosin and 
heat shock protein families were identified in both cases.  
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Figure 3-8. Proteins of interest identified through 2DE experiment in rat tissue. 
Mascot database search resulted in the following identifications: A – myomesin-1, B – 
myosin-binding protein C (fast-type), C – myosin-binding protein C (slow-type), D – girdin-
like isoform X1, E – glycogen phosphorylase, F – organic anion transporter K8, G – heat 
shock protein 90kDa alpha,  H – alpha-actinin-3, I – dnaK-type molecular chaperone hsp72-
ps1. The x-axis represents PMI, T0, T1, T2 and T3 correspond to 0, 1, 2 and 3 days PM, 
respectively. Y-axis shows the log standardised pixel volume of the protein spots (only 
spots which were included in the statistical evaluations were included in the graph). The 
dots represent the volume of each protein spot. The dashed lines connect the spots 
compared on 1 gel. The + sign shows the mean value between samples from the same time 
point, which are connected with a line to show the trend across the time course. 
3.3.3 Human tissue 
The experiments carried out using animal tissue demonstrated that proteomic 
methodology can be used to monitor changes in protein levels post-mortem. 
Additionally, these experiments showed that some protein changes are 
reproducible and could potentially be used as PMI markers. However, it was of 
interest to verify the relevance of this approach in human cadavers. Therefore, 
further experiments were carried out using human tissue. Human biceps femoris 
tissue, the same muscle that was investigated in rats, was collected at various 
times PM. This muscle was chosen for consistency and because it is convenient 
to sample, with limited disruption to the cadaver. Due to limited facilities where 
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the sampling took place, four of the cadavers were stored in refrigerated 
conditions and two of them were placed outdoors. It was not possible to control 
the PMI of the cadavers included in this study, but the time of death was known 
in each case. Basic information about the subjects including PMI, age, sex and 
cause of death are detailed in chapter 2.  
3.3.3.1 Subject selection 
Tissue samples from six different people were collected, but it would be very 
impractical to try to compare all of them using a single 2DE experiment, as it 
would involve running a very large number of gels at once. Therefore, initially, 
only tissue collected from subject 2 was tested. This particular subject was 
selected, for three main reasons: first of all, the body was stored in refrigerated 
conditions (constant temp). Secondly, this individual’s legs were still intact, 
contrary to subjects 1 and 3 (also refrigerated). Subject 1 was a tissue donor, so 
the bone and tissue from his legs were removed, leaving just the muscle 
wrapped in bandages. Additionally, there was an incision made along the back of 
the legs of subject 3. This would significantly influence the rate of 
decomposition of the tissue, as it was exposed to the surrounding environment. 
In the case of subject number 5, the wrong portion of muscle was mistakenly 
sampled for the first two days. Finally, the metabolomics analysis (explained in 
detail in chapter 4) of the human tissue was carried out before the proteomics 
investigations and the results obtained for subject 2 were the most promising 
out of all of the subjects. 
3.3.3.2 Subject 2 
Four samples were collected for this individual at PMIs of 11, 12, 13 and 14 days 
and all of these were included in the 2DE experiment. Forty-five proteins of 
interest were selected. Figure 3-9 shows a gel image with the selected spots and 
their corresponding spot numbers. Mass spectrometry analysis failed to generate 
a confident identification for 14 of these 45. A list of confident protein IDs 
obtained for the remaining 31 spots is displayed in Table 3-4. The confidence 
was assigned based on a MOWSE score equal or higher than the confidence 
threshold, in this case 38 (associated with a match probability of p<0.05). A full 
list of the analysed spots, including Mascot links, is attached in Appendix IV. 
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Figure 3-9. Image of a DiGE gel showing all of the 45 proteins of interest and their spot numbers (human tissue, subject 2). 
One of four DiGE gels included in this experiment. This particular image represents the pooled standard (contains equal amounts of all 4 samples included 
in the experiment), labelled with Cy2 and scanned with blue laser (488nm). Proteins were separated using pH gradient 4-7 (from left to right). 
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Table 3-4. List of confidently identified proteins using a single multiplex 2DE experiment in 
human muscle tissue. 
Spot numbers correspond to Figure 3-9. NCBI database was used for Mascot search. 
Accession number given in the NCBI database. T-test indicates the significance of the 
change observed. Fold change for each protein across the time course, minus sign 
indicates a decreasing trend. Mascot search result shows the ID assigned by Mascot search 
engine and its corresponding MOWSE probability score. A score of 38 or higher indicates a 
significant match, with the significance threshold of p<0.05. N/A – data not available. 
Spot 
no 
Accession no T-test Fold 
change 
Mascot search result  MOWSE 
score 
237 gi|29727 0.11 1.46 cardiac beta myosin heavy 
chain  
100 
262 gi|179508 0.29 1.15 beta-myosin heavy chain  124 
498 gi|115496169 0.51 -1.06 myosin-7  908 
1052 gi|189209 0.013 1.34 nidogen  42 
1063 gi|4501893 0.0071 -1.17 alpha-actinin-2 isoform 1  418 
1064 gi|4501893 0.029 -1.18 alpha-actinin-2 isoform 1  113 
1076 gi|4501893 0.03 -1.21 alpha-actinin-2 isoform 1  393 
1077 gi|4501893 0.035 -1.2 alpha-actinin-2 isoform 1  375 
1106 gi|4501893 0.045 1.58 alpha-actinin-2 isoform 1  128 
1107 gi|4501893 0.028 1.98 alpha-actinin-2 isoform 1  97 
1240 gi|17066105 0.013 1.61 Titin  99 
1271 gi|4504165 0.089 -1.15 gelsolin isoform a precursor  48 
1275 gi|38044288 0.042 -1.21 gelsolin isoform b  57 
1516 gi|395759492  0.034 -1.33 Chain A, Crystal Structure Of A 
Heat Shock 70kda Protein 2 
(Hspa2)  
380 
1550 gi|190613719 0.033 -1.2 Chain B, Crystal Structure Of A 
Complex Of Sse1p And Hsp70 
728 
1551 gi|23307793 0.081 1.58 serum albumin  92 
1797 gi|23506465 0.0014 -1.49 mutant desmin 434 
1974 gi|4502111 0.16 -1.15 annexin A7 isoform 1  52 
2019 gi|499719 0.02 -1.33 mitochondrial dihydrolipoamide 
succinyl transferase  
235 
2392 gi|426252759 0.017 1.18 alpha-actin  154 
2396 gi|178027  0.15 1.11 alpha-actin  260 
2605 gi|6841302 0.088 -1.66 HSPC326  64 
2723 gi|119626083 0.026 1.19 albumin, isoform CRA_t  50 
2743 gi|4505773 0.022 1.15 prohibitin isoform 1  291 
2752 gi|178027 0.0027 1.93 alpha-actin  97 
2859 gi|178027 0.35 1.05 alpha-actin  282 
2890 gi|4507949 0.25 -1.08 14-3-3 protein beta/alpha  96 
2960 gi|4504517 N/A 1.25 heat shock protein beta-1  184 
3142 gi|5453559 0.036 1.1 ATP synthase subunit d, 
mitochondrial isoform a  
208 
3333 gi|34846 0.0035 2.18 cardiac ventricular myosin light 
chain-2  
59 
3417 gi|49259004 0.0048 2.08 Chain A, Crystal Structure Of 
The Paz Domain Of Human 
Eif2c1 In Complex With A 9-Mer 
Sirna-Like Duplex 
40 
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Among the 31 identified proteins, 24 unique proteins were found, with alpha-
actin and alpha-actinin identified in a number of spots. Different types of the 
myosin and heat shock proteins were identified (Table 3-4). Nine proteins were 
selected as possible biomarker candidates and the graphs of how their levels 
change with increasing time since death can be seen in Figure 3-10. 
 
 
Figure 3-10. Proteins of interest identified through 2DE experiment in human tissue (subject 
2). 
Mascot database search resulted in the following identifications: A – alpha-actinin-2 isoform 
1, B – gelsolin isoform b, C – Chain A, Crystal Structure Of A Heat Shock 70kda Protein 2, D 
– Chain B, Crystal Structure Of A Complex Of Sse1p And Hsp70, E – serum albumin, F – 
mutant desmin, G – alpha-actin, H – heat shock protein beta 1, I – ATP synthase subunit d, 
mitochondrial isoform a. The x-axis represents PMI, PMI_11, PMI_12, PMI_13 and PMI_14 
correspond to 11, 12, 13 and 14 days PM, respectively. Y-axis shows the log standardised 
pixel volume of the protein spots (only spots which were included in the statistical 
evaluations were included in the graph). The dots represent the volume of each protein 
spot. The dashed lines connect the spots compared on 1 gel. The + sign shows the mean 
value between samples from the same time point, which are connected with a line to show 
the trend across the time course. 
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Figure 3-11 shows two proteins, which were identified in all three investigated 
species, alpha actin and myosin. Alpha actin seems to be a promising candidate. 
The changes in the levels of this protein follow similar increasing patterns over 
time in all of the mammals (see Figure 3-11). However, according to the Mascot 
search, it is not exactly the same protein – as mentioned previously, different 
forms of the same protein occur, especially when it comes to different species. 
Both alpha actins identified in the beef and human tissue have 377 residues and 
very similar, yet not identical protein sequence. The rat alpha actin, on the 
other hand, has been identified as isoform CRA_a of alpha actin with 465 
residues. The peptide sequence is very similar to the other two, but is longer 
(see Figure 3-12). However, considering that none of the peptides unique to the 
CRA_a isoform were detected and matched in the protein sequence, it cannot be 
said for certain that this is a different isoform. The peptides matched can also 
be matched to other actin proteins with similar sequences. Moreover, this should 
not make much difference to the end result, given that in all cases it is alpha 
actin and it behaves in a similar manner in all three cases. Myosin does not show 
the same trends between all species, but it shows a similar trend between rat 
and human samples. Heat shock proteins have also been identified in all three 
species, but their sequences vary to a much larger extent, therefore they are 
not considered to be similar and were not included in the comparison in Figure 
3-11. The similarities between the sequences of the actin and myosin proteins 
identified gave rise to this comparison. 
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Figure 3-11. Overview of the two types of protein found in all of the investigated species. 
Each row represents different protein type – alpha actin (top row) and myosin (bottom row). 
The graphs are also separated into three columns according to their species (indicated on 
top of each column – beef, rat, human from left to right). PMI and letter T followed by a 
number on the x-axis indicate PMI in days. Y-axis shows the log standardised pixel volume 
of the protein spots. The dots represent the volume of each protein spot. The dashed lines 
connect the spots compared on 1 gel. The + sign shows the mean value between samples 
from the same time point.
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Figure 3-12. Protein sequence alignment of alpha-actin identified in three different species. 
The sequences were aligned using an online UniProt sequence alignment tool. The column on the left hand side shows accession numbers of the aligned 
sequences: gi│149043182 (rat, 465 residues), gi│27819614 (beef, 377 residues) and gi│178027 (human, 377 residues), followed by UniProt protein ID’s 
(partial). Sequences are presented in groups of 60 residues (horizontal rows), the numbers immediately to right and left indicate the sequence position of 
terminal residues – N-terminus (left), C-terminus (right). The similarity of each residue is indicated by a symbol below it: an * indicates positions which 
have a single, fully conserved residue; a : indicates conservation between groups of strongly similar properties; a . indicates conservation between groups 
with weakly similar properties; no sign indicates no similarity.
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3.3.3.3 Subject 5 
The proteomics approach was successfully applied to human tissue from Subject 
2 and revealed more possible biomarker candidates. However, this was only 
tested in a single human subject, which of course needs further confirmation. It 
seemed most logical to test another human cadaver, which had been 
decomposing for a similar amount of time. Two other subjects fulfilled that 
criteria, subject 3 (female) and 5 (male). The PMI overlap was better with the 
female, however, it was the only female cadaver included in the study as well as 
the only subject who did not die of natural causes (suicide). As a potential 
‘outlier’ it would be difficult to interpret any collected data, as the effect of 
the cause of death on the decomposition process and any changes in the 
proteome is unknown. Therefore, the male subject was selected for the second 
analysis and comparison.  
Four out of the five collected tissue samples for this individual were included in 
the analysis (PMI of 12, 13, 14 and 15 days). In the previous experiments, two 
replicate samples from each time point were analysed. In this case, in order to 
obtain a more reliable statistical representation of the results, three replicates 
of each sample were used, increasing the number of gels used in this experiment 
to 7 gels (six DiGE + one prep gel). Additionally, the proteins identified in beef 
and rat tissue were often repeating in different spots, as the proximity of the 
selected spots was not considered while selecting ones to pick. Therefore, in this 
analysis the positioning of the spots was taken into account, in order to include 
various proteins from different parts of the gel. Finally, a full advantage was 
taken of the use of an automated spot picker – not limiting the number of 
protein spots picked. As a result, seventy eight protein spots of interest were 
selected and picked. Figure 3-13 shows an image of one of the gels from this 
experiment highlighting the selected protein spots (including their spot 
numbers). All of the selected proteins showed increasing or decreasing trends 
over the investigated time period, very often nearly linear. Figure 3-14 shows 
nine graphs of proteins which were considered to be the most promising 
candidates out of the 78 selected spots. 
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Figure 3-13. Image of a DiGE gel showing all of the 78 proteins of interest and their spot numbers (human tissue, subject 5). 
One of six DiGE gels included in this experiment. This image represents sample PMI 13 (13 days PM) labelled with Cy5 and scanned with red laser (633nm). 
All of the spots were successfully picked, but only two spots were identified through mass spectrometry (2256 and 2725) due to contamination issue. 
These spots of high volume were identified as actin and tropomyosin, respectively. Proteins were separated using pH gradient 4-7 (from left to right). 
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Figure 3-14. Proteins of interest identified through 2DE experiment in human tissue (subject 
5). 
Corresponding spot numbers: A – 338, B – 686, C –919, D – 956, E – 1963, F – 2366, G –2395, 
H –3007, I – 3296. The x-axis represents PMI, PMI_12, PMI_13, PMI_14 and PMI_15 
correspond to 12, 13, 14 and 15 days PM, respectively. Y-axis shows the log standardised 
pixel volume of the protein spots (only spots which were included in the statistical 
evaluations were included in the graph). The dots represent the volume of each protein 
spot. The + sign shows the mean value between samples from the same time point, which 
are connected with a line to show the trend across the time course. 
The selected protein spots of interest were analysed using LC-MS, in order to 
identify them. However, the result of the analysis was very puzzling as the 
majority of the 78 picked spots were identified as one protein – vimentin. This 
could not be a correct result since by definition, the proteins in the gel were 
separated out based on their weight and pI, and therefore it is highly unlikely to 
have the same protein in so many different parts of the gel. This indicates that 
the gel pieces were contaminated in some way with vimentin. The samples were 
re-analysed and finally, re-extracted again from the gel spots which were kept 
after initial extraction to test these results. Unfortunately, results of both of 
these analyses confirmed the contamination, which led to the conclusion that 
the contamination came from the gel itself, even before the LC-MS analysis. 
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Due to the sample contamination issue, it was impossible to identify the proteins 
of interest from this experiment. However, there were two very abundant spots, 
which were identified as actin and tropomyosin (spot no 2256 and 2725 in Figure 
3-13, respectively) in all of the three tests. The contamination is still present in 
these spots; however, contrary to all of the other 76 results, in this case the 
proteins were much more abundant than vimentin. Additionally, their match 
scores and sequence coverage were quite high (see Figure 3-15), which 
suggested they were definitely present in these spots. Finally, they were picked 
from areas of the gel where the presence of these proteins could be expected. 
On the other hand, these areas contained a large pool of poorly resolved 
proteins, therefore, it is possible that more than one protein would be present 
and it would be very difficult to state which protein caused the observed change 
in abundance over PM time (Figure 3-15). 
 
Figure 3-15. Graphs representing change in protein abundance of spots identified as actin 
and tropomyosin in human tissue (subject 5). 
Graph a – alpha actin (spot no: 2256, accession no: gi|4501881, T-test: 0.2, fold change: -
1.19, mascot score: 633, sequence coverage: 46%), graph b – tropomyosin alpha (spot no: 
2725, accession no: gi|49660014, T-test: 0.12, fold change: -1.32, mascot score: 608, 
sequence coverage: 53%). The x-axis represents PMI: PMI_12, PMI_13, PMI_14 and PMI_15 
correspond to 12, 13, 14 and 15 days PM, respectively. Y-axis shows the log standardised 
pixel volume of the protein spots (only spots which were included in the statistical 
evaluations were included in the graph). The dots represent the volume of each protein 
spot. The + sign shows the mean value between samples from the same time point, which 
are connected with a line to show the trend across the time course. 
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3.4 Discussion 
The aim of this experiment was to identify possible protein biomarkers in muscle 
tissue, which could help to estimate PMI. The hypothesis was that certain 
proteins would show a predictable change in abundance with increasing PMI. 
Upon death, homeostasis ceases. Tissues that are no longer supplied with oxygen 
and nutrients are unable to maintain the intra and intercellular 
compartmentalisation that is required for controlled metabolism. However, 
many enzymes remain active and biochemical pathways will proceed, albeit in 
an increasingly chaotic manner. The proteome will be modified by the activity of 
the many enzymes that can modify proteins, by cleaving or modifying the 
polypeptide chain, and these changes may be evident in 2DE analysis through 
changes in the protein spot map that is observed. Thus, a protein that is cleaved 
by a protease activity will show decreased abundance as the amount of 
unmodified protein remaining is reduced. The products of this cleavage may 
show increased abundance, providing they are sufficiently large to be resolved 
on the gel, and sufficiently stable to accumulate. Alternatively, a protein may 
be rapidly degraded so that none of the intermediate products of degradation 
accumulate to detectable levels. Thus, an untargeted proteomics approach may 
allow identification of a number of polypeptides that show a steady increasing or 
decreasing trend over time post-mortem. Characterisation of these proteins by 
mass spectrometry may identify the gene product from which they originated, 
potentially highlighting a marker for time since death. 
Three different tissue types were tested, beef steak, rat and human muscle 
tissue (biceps femoris). Proteins of interest were successfully identified in all 
three species. However, the proteins of interest varied between them. The 
protein spots in the case of beef tissue were hand-picked, which limited the 
number of identified proteins (25 out of 105). Nine proteins were selected as 
possible biomarker candidates, based on the graphical representation of how 
their levels change with time (Figure 3-2). These included heat shock protein 
beta 6, troponin T, myosin 7, actin, heat shock protein beta 1, myosin light 
chain 6B, pyruvate dehydrogenase E1 and desmin. Out of these, heat shock 
protein beta 6, troponin T and actin showed nearly linear relationships with PMI. 
The former two showed a decreasing trend and the latter increasing. In the case 
of rat tissue the PMI range was a lot shorter than in the other tissue types; 
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however, the experiment used intact cadavers, which were more likely to 
resemble an authentic decomposition process than an isolated piece of meat. In 
this case 40 spots of interest were picked using an automated spot picker, which 
yielded 22 different protein IDs. Again, the 9 best candidates were selected as 
shown in Figure 3-8, including myomesin-1, myosin-binding protein C (fast-type), 
myosin-binding protein C (slow-type), girdin-like isoform X1, glycogen 
phosphorylase, organic anion transporter K8, heat shock protein 90kDa alpha, 
alpha-actinin-3 and dnaK-type molecular chaperone hsp72-ps1. None of these 
matched the top 9 proteins identified in beef tissue, although actin and myosin 
were both identified in the two types of tissue. Finally, human muscle was also 
tested, 44 spots of interest were picked and 31 out of the 44 spots were 
identified. These 31 spots contained 24 unique proteins as alpha-actin and 
alpha-actinin were identified in a number of spots. The top 9 proteins selected 
were alpha-actinin-2 isoform 1, gelsolin isoform b, Chain A - Crystal Structure Of 
A Heat Shock 70kda Protein 2, Chain B - Crystal Structure Of A Complex Of Sse1p 
And Hsp70, serum albumin, mutant desmin, alpha-actin, heat shock protein beta 
1, ATP synthase subunit d (mitochondrial isoform a). Again, these were very 
different results, with the exception of actin and heat shock protein. Myosin-7 
was also identified, as in the case of beef tissue, but was not included in the top 
9 choices (Figure 3-10). Tissue collected from a second human test subject was 
also tested, however, this analysis failed due to contamination. 
Similarities were observed among all three species. Actin and myosin proteins 
were identified as proteins of interest in all three mammals (Figure 3-11). Actin 
and myosin serve as building blocks for the muscle structure and are also 
involved in muscle contraction, as well as in the formation of rigor mortis post-
mortem. Actin seems the most likely candidate for a PMI biomarker. It was not 
only identified in all three tissue types, but more importantly, a similar pattern 
of increase was seen in all three mammals. The fact that it is one of the most 
abundant proteins in muscle makes it fairly easy to detect and a good biomarker 
candidate. Myosin is also a strong candidate, although it showed similar trends in 
only two out of three tissue types (rat and human), but nonetheless, it was 
selected as possible marker in all three. Heat shock proteins could also be good 
candidates as PMI biomarkers. Different members were identified from this class 
of proteins in different tissue types (with the exception of heat shock protein 
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beta 1 which was identified in both human and beef samples). However, they 
share similarities in their function. They are called stress-induced proteins, 
which help to maintain regular cellular conditions in times of stress (Campbell & 
Reece 2005). Cellular death would initiate a stress management response in 
tissues. They were previously identified as possible markers for post-mortem 
myofibrillar changes (Jia, Hildrum, et al. 2006) and degradation (Balan et al. 
2014) in muscle tissue.  
The 2DE proteomics approach, used in this study, is a gel based separation 
technique, which allows comparison of the proteome changes between two 
samples. It separates intact proteins as well as protein fragments, and is very 
sensitive to modifications that might result in changes in SDS-binding (apparent 
molecular weight) or native charge. For example, post-translational modification 
may result in a change in the charge of a protein. This is evident in the case of 
Troponin T (beef) and alpha-actinin (human, e.g. see Figure 9, spot numbers 
1063, 1064, 1076, 1077, 1106 and 1107, with the last two showing an increase). 
The spots identified as these proteins are aligned horizontally along the gel, 
which suggests the same MW, but different pI. The collected data also shows 
evidence of proteolysis, which results in protein fragments with different 
molecular weights. As large proteins break down, smaller protein fragments will 
appear, for example, alpha-actinin identified in rat tissue (see Figure 3-4; spot 
numbers 1386, 1392 levels decreasing and 1568 increasing). The protein spot 
showing an increasing trend is situated slightly lower in the gel than the spots 
showing decreasing trends. This indicates that they have different MWs and the 
fragments which are lower down are smaller as the smaller proteins move easier 
and faster down the gel. A general idea of how the charge and molecular weight 
are separated/positioned within a 2DE gel can be obtained from Figure 3-16. 
Other, commonly used techniques like western blots or enzyme assays employ a 
targeted approach and are less sensitive to the complex changes in the 
proteome. They use protein-specific antibodies, which bind selectively to the 
protein of interest. In the case of western blots, the proteins are only separated 
based on their molecular weight (Mahmood & Yang 2012). However, the 2DE 
approach does have its limitations. For example, only two samples can be 
compared on one gel. This can be adapted to compare more samples at once 
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through the use of multiple gels and standards. However, this significantly 
increases the complexity and the costs of such experiments. 
 
Figure 3-16. General representation of how molecular weight and pH are distributed in a 
standard 2DE gel.  
The pH ranges from 4 to 7 from the left hand side of the gel to the right. The weight 
distribution occurs from top to bottom of the gel with the larger proteins on top, getting 
smaller towards the bottom of the gel. The numbers on the left indicate a rough scale of 
molecular weight in kDa. 
Another limitation of this untargeted approach stems from the complexity of the 
sample, which causes problems with the reproducibility of the results. The 
proteome is very complex, consisting of thousands of large molecules which can 
also be easily transformed and modified to fulfil various roles in the organism, 
adding uncounted possibilities and protein combinations. Unless the proteins are 
somehow fractionated to look at a subset of the proteome, it is very difficult to 
obtain reproducible results between different experiments. 
Protein fragmentation seen in this experiment may be caused by a process called 
proteolysis – various changes occurring post-mortem, which lead to loss of 
structural integrity of muscle tissue. After death, the blood flow ceases, which 
means there is no more oxygen delivered to the cells. The cells attempting to 
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carry on normal function, switch to anaerobic energy metabolism, i.e. glycolysis. 
This leads to build up of lactic acid in muscle tissue and in turn, lowers the pH 
(Koohmaraie 1992). This, combined with the gradually decreasing temperature 
of the body, initiates the decomposition process including proteolysis. The 
process of post-mortem proteolysis has been researched in the past, however, 
mainly with respect to muscle tenderisation in meat production. Nonetheless, 
this process would undoubtedly be occurring in skeletal tissue of any mammal, 
with differences in the extent and the rate of the process, which depends on the 
post-mortem conditions (e.g. temperature). Three proteolytic systems have 
been investigated with respect to post-mortem proteolysis: the calpain system, 
the lysosomal cathepsins and the multicatalytic proteinase complex (MCP) 
(Koohmaraie & Geesink 2006; Nowak 2011; Lian et al. 2013). However, it is 
believed that it is the calpain system which is mainly, if not solely, responsible 
for proteolytic degradation of skeletal muscle. The calpain system is activated 
by high levels of free calcium (Ca2+) in tissue. During life, the Ca2+ levels are 
low, which ensures the system is inactive. However, after death the levels of 
free calcium increase as it is released from mitochondria and sarcoplasmic 
reticulum (due to changes in pH and temperature conditions). At the same time, 
low pH inhibits the activity of calpastatin, which is a natural calpain inhibitor. 
Calpains cleave proteins titin, nebulin, filamin, desmin and Troponin-T (Huff-
lonergan & Beekman 1996). Actin and myosin are cleaved by lysosomal proteases 
(cathepsins) (Goll et al. 1983). Once the muscle filaments are degraded into 
smaller peptide fragments, they can then be further degraded to amino acids by 
the lysosomes or by the MCP system (Goll et al. 1992). There are two main 
modes of protease action, which separates them into exo- or endoproteases. 
Exopeptidases (e.g. some lysosomes) attack the N- or C-terminus of the peptide 
chain and cleave it one amino acid at a time. Endopeptidases (e.g. calpains) 
cleave the peptide chain in the middle, therefore creating smaller peptides.  
Proteomic analysis of post-mortem muscle is most often carried out in order to 
establish how different factors affect meat tenderisation (Yates et al. 1983; 
Anderson et al. 2012; Picard et al. 2014) and how to improve the quality of aged 
meat (Frylinck et al. 2013). However, a few researchers tried to find a link 
between the post-mortem changes in muscle and PMI. A few studies, by 
Sabucedo et al. (Sabucedo & Furton 2003), Pittner et al. (Pittner et al. 2015) 
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and two by Kumar et. al. (Kumar, Ali, Singh, et al. 2015; Kumar, Ali, 
Bhattacharya, et al. 2015) pointed towards troponin as a possible PMI biomarker. 
The former study investigated cardiac Troponin I (cTnI) and the other three, 
cardiac troponin T (cTnT) in porcine (Pittner et al. 2015) and human tissue. All 
studies reported degradation of troponin with a linear relationship over time. 
Geesink and Koohmaraie also reported degradation of troponin T (TnT), while 
investigating the proteolysis process in post-mortem lamb tissue (Geesink & 
Koohmaraie 1999) and Lametsch et al. identified two different fragments of TnT 
in aged pig meat (Lametsch et al. 2002). The fragments were of slightly 
different sizes, 43 and 38 kDa, where the larger fragment decreased in 
abundance over time and the smaller one increased. This is similar to the 
present study, as TnT was identified in three different spots and showed both 
increasing and decreasing trends. However, contrary to Lametsch’s results, the 
size of the protein fragments was the same, but the pI differed slightly. This 
would indicate proteins with different post-translational modifications, which 
can behave differently. In this study, troponin was only detected in beef tissue 
and was not selected in the results for rat or human tissue. Nevertheless, it is a 
very strong candidate for a PMI biomarker. It is already a known marker of 
myocardial damage (Osuna et al. 1998; Ellingsen & Hetland 2004; Zhu, Ishikawa, 
Michiue, Li, Zhao, Oritani, et al. 2006; Zhu, Ishikawa, Michiue, Li, Zhao, 
Kamikodai, et al. 2006; Everett et al. 2015).  
Another two studies by Xiao and Chen (Xiao & Chen 2005) and Liu et al. (Y. Liu 
et al. 2008) looked at the degradation of actin post-mortem. The former used 
the western blotting technique to test the presence of actin and tubulin in rat 
liver, up to 18 days post-mortem. They reported that they were able to detect 
actin up to 8 days PM and that it was not detectable from 10 days onwards. 
Additionally, they detected beta-tubulin up to 2 days PM and stated it was not 
visible 4 days after death. The second group looked at actin in various organs 
and tissues up to 72 h PM. They concluded that actin was gradually degrading 
with time at various rates, depending on the tissue. They suggested actin could 
be used for time since death estimation. These results disagree with the data 
obtained in this study. Actin was identified in all three species investigated in 
this experiment in multiple protein spots for each, and all but one actin spot 
(beef tissue) showed actin increasing in abundance after death. Additionally, the 
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human tissue from subject 2 was collected between 11 and 14 days PM and actin 
was still detectable. These findings agree with the study of Lametsch et al. 
where an increase in actin levels was also observed (Lametsch et al. 2002). 
These differences could arise from the different tissue types used. Hepatic 
tissue used in the study by Xiao and Chen is very enzymatically rich; therefore, it 
degrades more rapidly than muscle tissue. Additionally, both of these studies 
used western blot technique, whereas 2DE was used in this and Lametsch’s 
study. 
Two other proteins, myosin and heat shock protein were identified in the 
present study as proteins of interest. To the best of the author’s knowledge, 
neither of them has previously been suggested as a potential PMI biomarker. 
However, their degradation, or the lack thereof, has been looked at as a part of 
the investigation of the post-mortem proteolysis process. According to Geesink 
and Koohmaraie, myosin heavy chain shows very little degradation from 0 to 56 
days post-mortem while myosin light chain remains unchanged in this time 
period in lamb muscle (Geesink & Koohmaraie 1999). Tuttle et al. also reported 
that the levels of myosin heavy chain remain unaffected over the period of up to 
7 days PM in rabbit tissue (Tuttle et al. 2014). On the other hand, Lametsch et 
al. reported an increase in the abundance of this protein post-mortem in pig 
meat (Lametsch et al. 2002). The results of the present study agree with the 
last-mentioned publication. Myosin heavy chain was detected in human tissue 
and an increase was observed over time and the same was seen for myosin light 
chain identified in beef. Myosin binding protein C (both fast and slow type) was 
identified in rat tissue and it was seen that the slow type accumulates over time 
while the fast type degrades. This is contrary to the findings of Di Luca et al. 
where the authors reported that the fast type of myosin binding protein C 
increases in abundance in porcine muscle over time since death (Di Luca et al. 
2013). 
Various types of heat shock proteins (HSPs) were identified previously in aged 
meat, for example pork (Di Luca et al. 2013) and beef (Jia, Hollung, et al. 2006). 
Additionally, one study by Tavichakorntrakool et al. looked at PM changes in 
human muscle tissue and heat shock protein 27 kDa (otherwise known as heat 
shock protein beta 1) was among the proteins which were reported to be altered 
after 48 h PM (Tavichakorntrakool et al. 2008). All of these studies showed that 
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HSPs degrade with increasing time since death. This is in agreement with the 
results obtained for beef and rat tissue in this study. However, in human tissue, 
heat shock protein beta-1 was identified and appeared to be increasing in level 
over time. 
3.5 Conclusion 
The untargeted proteomics approach successfully allowed the detection and 
identification of a number of proteins which change in abundance post-mortem. 
Skeletal muscle tissue from three different species, cow, rat and human, was 
tested. Proteins from the myosin, actin and heat shock families were identified 
as proteins of interest in all three cases. However, only actin showed similar 
increasing trends in all three, which makes it the strongest candidate as a PMI 
biomarker. Additionally, evidence of post-mortem proteolysis and protein 
fragmentation was observed. Due to the complexity of the proteome and the 
limitations of the methodology used it was not possible to fully develop this 
method for PMI estimation. However, this study created a great starting point 
for further research. The next step would require using one of the targeted 
approaches to test the above candidates in larger cohorts of test subjects. 
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4 METABOLOMICS (LC-MS) 
4.1 Introduction 
“Omics” approaches, such as proteomics and metabolomics, have led to the 
identification of biomarkers that are diagnostic or prognostic for disease states 
(Pena et al. 2015; LeWitt et al. 2013; Fedele et al. 2013; González-Domínguez et 
al. 2014; Blasco et al. 2014; Manna et al. 2015). This chapter deals with 
metabolomics (for proteomics see Chapter 3). Untargeted metabolomics can 
report on the relative abundance of a broad range of small molecules (such as 
amino acids, oligopeptides, sugars, bile acids and fatty acids) in any biological 
system of interest (Clarke & Haselden 2008). In the present study, an untargeted 
comparative metabolomics analysis was applied to search for molecular markers 
that evolve with predictable kinetics over time since death. The analytical 
methods most commonly employed for metabolomics are liquid chromatography-
mass spectrometry (LC-MS), nuclear magnetic resonance (NMR) and gas 
chromatography-mass spectrometry (GC-MS). These techniques allow 
identification and quantitation of low molecular weight metabolites (up to ~1000 
Da) (Clarke & Haselden 2008).  
Various metabolites have previously been investigated for utility in PMI 
estimation. Harada et al. investigated the changes in levels of specific 
metabolites (lactate, alanine, pyruvate and glucose) in animal organs and tissues 
(liver, kidney, spleen, brain, heart and dorsal muscle) and found a correlation 
between PMI and levels of lactate and pyruvate in heart and muscle tissue 
(Harada et al. 1984). Sparks et al. presented a linear relationship between 3-
methoxytyramine (3-MT) and PMI in the dorsal putamen (Sparks et al. 1986). The 
authors also concluded that this relationship varies with the cause of death. In 
cases where the cause of death was attributed to a heart disease, 3-MT was 
negatively correlated with PMI, while being positively correlated in cases with 
other causes of death. Three other studies reported metabolites that evolve 
over time in post-mortem sheep brain (Ith et al. 2002; Scheurer et al. 2005; 
Musshoff et al. 2011). Free trimethylammonium (fTMA), propionate and butyrate 
were found in all three investigations, among other compounds emerging post-
mortem. Ith et al. also included human brain in the study and found similarities 
between the decomposition of human and sheep brain (Ith et al. 2002). 
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Banaschak et al. investigated the post-mortem changes in pig brain (Banaschak 
et al. 2005), and also identified fTMA in their study, as well as creatinine, 
lactate, acetate, alanine and succinate. More recently, Mao et al. showed a 
correlation between PMI and the breakdown products of ATP in rat brain, kidney 
and spleen (Mao et al. 2013). Meanwhile, Donaldson et al. discussed increasing 
concentrations of hypoxanthine, ammonia, NADH and formic acid in rat, pig and 
human blood post-mortem (Donaldson & Lamont 2013). Kang et al. was one of 
the first groups to utilise a global mass-spectrometry based metabolomics 
approach (as opposed to metabolite assays) in time since death estimation (Kang 
et al. 2012). Metabolites extracted from rat livers over the first 48 hours post-
mortem were analysed by UPLC/Q-TOF MS. Statistical analysis of the data 
yielded 15 potential biomarker candidates, including various polysaccharides, 
steroids, nucleosides, amino acids and more. 
This section shows the development of an LC-MS metabolomics approach to 
address PMI in beef and rat models, and the application of this approach to 
human cadavers with known PMI. 
 
4.2 Methodology 
Sample collection, preparation and analysis were as described in Chapter 2. 
 
 
4.3 Results 
Metabolites of interest were selected primarily because they showed a 
predictable and steady rate of change with PMI, as well as the confidence in the 
metabolite identification. Furthermore, selected metabolites showed similar 
trends between the tested human subjects as well as the animal (beef, rat) 
tissue and reinforced the confidence in selected compounds as markers. 
Metabolites of interest identified in rat and human tissue included skatole (3-
methylindole), xanthine, n-acetylneuraminate, 1-methylinicotinamide, choline 
phosphate, uracil and a number of amino acids (see Table 4-1) with tyrosine, 
threonine and lysine being the most promising candidates. 
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Table 4-1. List of all identified metabolites of interest in rat and human tissue.  
KEGG ID – number corresponding to a given metabolite in Kyoto Encyclopedia of Genes 
and Genomes (Kanehisa 1995), RT – retention time, Metabolite ID code – suggested coding 
system for reporting confidence of metabolite identification (Sumner et al. 2014). HRMS – 
high resolution mass spectrometry; superscript ‘1’ means a normal full scan mass 
spectrum; subscript ‘a’ indicates the spectrum was matched to an authentic standard; 
subscript ‘lib’ indicates a spectral match to a reference library; Rta signifies retention time 
matched identifications (high confidence); the remaining ones are putatively identified. 
Metabolite name Elemental 
formula 
KEGG 
ID 
Detected 
Mass 
RT 
(min) 
Metabolite 
ID code 
L-Arginine C6H14N4O2 C00062 174.1116 25.79 HRMS
1
a, Rta 
L-Histidine C6H9N3O2 C00135 155.0696 14.59 HRMS
1
a, Rta 
L-Leucine C6H13NO2 C00123 131.0946 10.12 HRMS
1
a, Rta 
L-Lysine C6H14N2O2 C00047 146.1055 24.39 HRMS
1
a, Rta 
L-Methionine C5H11NO2S C00073 149.0511 10.83 HRMS
1
a, Rta 
L-Phenylalanine C9H11NO2 C00079 165.079 9.54 HRMS
1
a, Rta 
L-Proline C5H9NO2 C00148   115.0633 11.96 HRMS
1
a, Rta 
L-Threonine C4H9NO3 C00188 119.0583 13.52 HRMS
1
a, Rta 
L-Tryptophan C11H12N2O2 C00078 204.09 10.94 HRMS
1
a, Rta 
L-Tyrosine C9H11NO3 C00082 181.0739 12.2 HRMS
1
a, Rta 
L-Valine C5H11NO2 C00183 117.079 11.68 HRMS
1
a, Rta 
Putrescine C4H12N2 C00134 88.1001 21.97 HRMS
1
a, Rta 
Xanthine C5H4N4O2 C00385 152.0334 9.03 HRMS
1
a, Rta 
Choline Phosphate C5H14NO4P C00588 183.0662 17.52 HRMS
1
a, Rta 
Uracil C4H4N2O2 C00106 112.0273 7.985 HRMS
1
a, Rta 
L-Asparagine C4H8N2O3 C00152 132.0535 14.48 HRMS
1
a 
L-Aspartate C4H7NO4 C00049 133.0375 14.0 HRMS
1
a 
L-Cysteine C3H7NO2S C00097 121.0198 13.09 HRMS
1
lib 
L-Glutamate C5H9NO4 C00025 147.0532 9.59 HRMS
1
a 
L-Serine C3H7NO3 C00065 105.0426 14.97 HRMS
1
a 
Cadaverine C5H14N2 C01672 102.1157 22.08 HRMS
1
lib 
Indole C8H7N C00463 117.0579 10.59 HRMS
1
lib 
Skatole C9H9N C08313 131.0735 10.94 HRMS
1
lib 
N-acetylneuraminate C11H19NO9 C00270 309.1061 12.23 HRMS
1
a 
1-methylnicotinamide C7H8N2O C02918 136.0637 24.5 HRMS
1
lib 
 
4.3.1 Beef tissue 
The preliminary investigation using a beef steak sample resulted in putative 
identification of 2068 metabolites using the pHILIC method and 2309 using the 
HILIC method (for spreadsheets including all of the collected data see 
Appendices V and VI, pHILIC and HILIC respectively). Both columns are used for 
separation of polar and hydrophilic compounds (Loukas & Dotsikas 2011). 
However, the former column is more appropriate for basic conditions and the 
second for acidic conditions, so that some chemical classes are better separated 
in one system compared with the other. For example, organic acids will be 
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better separated by pHILIC chromatography, and biogenic amines (e.g. 
decomposition products) using HILIC chromatography. pHILIC and HILIC 
chromatography are thus complementary separation methods in LC-MS 
metabolomics. 
A variety of compounds showed either increasing or decreasing patterns of 
change. Figure 4-1 shows an example of four different metabolites with 
interesting patterns of change over the investigated period.  
 
Figure 4-1. Examples of metabolites identified in trial beef study. 
The graphs show as follows: a – n-acetyl-beta-alanine, b – purine, c – glutathione, d – 
choline. Muscle sample was aged over thirteen days: y-axis represents average instrument 
response (arbitrary units), the analysis included three technical replicates (three sections 
taken from one piece of tissue) of each sample, x-axis represents PMI (days). Error bars 
indicate standard deviation calculated from average instrument response.  
4.3.1.1 Decomposition products 
This untargeted metabolomics approach resulted in a large amount of data, 
necessitating a methodical strategy of analysis. Therefore, based on information 
gained from the literature, certain classes of compounds were selected as 
possible PMI biomarkers. In the first instance, commonly known decomposition 
products like putrescine, cadaverine, indole and skatole were investigated (Vass 
2001). They are formed by bacterial breakdown of amino acids after death, 
however, they are also present in living tissue (Wishart et al. 2013). Cadaverine 
is a product of lysine metabolism, putrescine of arginine and proline metabolism 
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and both indole and skatole are produced from tryptophan. The above 
compounds, as they are biogenic amines, were expected to be identified using 
the HILIC method of separation. However, only indole was detected this way. It 
was also detected using the pHILIC method along with putrescine and 
cadaverine. Neither of the decomposition products detected using the pHILIC 
method showed any obvious trend of change (see Figure 4-2a, b and c). On the 
other hand, indole detected using the HILIC method showed a steadily increasing 
pattern starting from the 3rd day post-mortem (see Figure 4-2d). This is a more 
reliable result since the HILIC column is more suitable for the separation of 
biogenic amines.  
 
Figure 4-2. Decomposition products identified in beef tissue. 
The graphs represent: a – putrescine, b – cadaverine, c – indole (pHilic), d – indole (Hilic). Y-
axis are showing average instrument response (N=3), x-axis are showing PMI (days). Error 
bars indicate standard deviation calculated from average instrument response. The analysis 
included three technical replicates of each sample. 
4.3.1.2 Amino acids 
Since the decomposition products did not yield a clear pattern, other compounds 
were investigated. Proteogenic amino acids were among the metabolites which 
were identified with the highest confidence; therefore, they were also looked at 
as potential candidates. All 20 of these amino acids were detected in beef 
tissue. In general, most of them showed increasing trends, however, not 
consistently over the whole investigated period. Two of the amino acids, 
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glutamine and alanine, showed decreasing trends contrary to the others. Figure 
4-3 shows 14 out of the 20 detected amino acids which were identified with high 
confidence. Tryptophan, threonine, methionine, leucine and phenylalanine 
started to increase after the 5th day PM. Aspartate showed a general increasing 
trend throughout the investigated period. Glycine, glutamate, proline, serine 
and cysteine increased until the 9th or 10th day post-mortem and then started 
to decrease. Valine increased until the 3rd day PM and showed a fairly constant 
level from day 6 onwards. Arginine did not show a clear pattern of change (not 
shown). From the presented amino acids, serine, cysteine, threonine, 
methionine and alanine showed very clear and consistent changes over time. 
 
Figure 4-3. Patterns of change observed in the identified amino acids (beef tissue). 
The graphs represent: a – glycine, b – glutamate, c – proline, d – serine, e – cysteine and f – 
valine. Amino acids shown in graphs a-e show an increase until 9th or 10th day PM and then 
decrease. Valine increases for the first 3 days PM. Y-axes signify the average instrument 
response (arbitrary unit) and x-axes PMI (days). Error bars were calculated from standard 
deviation based on three technical replicates used for each time point. 
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Figure 4-3. Continued from previous page. 
The graphs represent: g – tryptophan, h – threonine, i – methionine, j – leucine, k – 
phenylalanine, l – aspartate, m – glutamine, n – alanine. Amino acids in graphs g-k show an 
increase from about day 5 onwards. Aspartate shows a general increasing trend throughout 
the investigated PMI. Glutamine and alanine show a decreasing trend. Y-axes signify the 
average instrument response (arbitrary unit) and x-axes PMI (days). Error bars were 
calculated from standard deviation based on three technical replicates used for each time 
point. 
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The amino acids showed promising results and could potentially serve as PMI 
biomarkers. In general, most of them showed increasing patterns with PMI. 
However, an isolated piece of tissue cannot fully represent the complexity of the 
decomposition process occurring in an intact cadaver. Therefore, after 
completing method development using a beef steak sample, the study was 
extended to include rat cadavers as an animal model. The methodology was 
shown to be well suited for the intended purpose. Hence it was followed by a 
more controlled study with intact cadavers, in order to give more insight into 
the reproducibility and reliability of amino acids as potential markers. 
4.3.2 Rat tissue 
Muscle samples were obtained from 8 rats at 0, 24, 48 and 72 h PM (two rats 
dissected at each time point). Metabolites were extracted and analysed using an 
untargeted LC-MS approach. Both pHILIC and HILIC methods of separation were 
used. This approach allowed the detection and putative identification of 1753 
metabolites in pHILIC and 1080 in HILIC (Appendices VII and VIII contain IDEOM 
spreadsheets with all of the detected metabolites using pHILIC and HILIC, 
respectively). The majority of the detected molecules were classified as 
peptides (separated into peptides, di-, tri- and tetra-peptides) and lipids 
(including fatty acyls, glycerolipids, glycerophospholipids, polyketides, prenols, 
sphingolipids, sterol lipids and gangliosides). Smaller groups included 
metabolites involved in amino acid, carbohydrate and nucleotide metabolism. 
Additionally, large numbers of identified metabolites remained unclassified as 
members of any particular metabolisms or pathways (479 in pHILIC and 270 in 
HILIC method). Figure 4-4 and Figure 4-5 show the percentage of the metabolites 
which were successfully classified. 
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Figure 4-4. Graph representing the classes of compounds identified through the pHILIC 
method in rat tissue. 
1753 metabolites were detected using the pHILIC method, out of which 1274 were classified 
into above groups by IDEOM (Creek et al. 2012). Values presented show the percentage of 
the total of classified compounds. Metabolites labelled as ‘other’ were classified as 
xenobiotics and medium components. Peptides group includes single, di-, tri- and tetra- 
peptides. Lipids group includes fatty acyls, glycerolipids, glycerophospholipids, 
polyketides, prenols, sphingolipids and sterol lipids. 
 
Figure 4-5. Graph representing the classes of compounds identified through the HILIC 
method in rat tissue. 
1080 metabolites were detected using the pHILIC method, out of which 810 were classified 
into the above groups by IDEOM (Creek et al. 2012). Values presented show the percentage 
of the total of classified compounds. Metabolites labelled as ‘other’ were classified as 
xenobiotics and medium components. Peptides group includes single, di-, tri- and tetra- 
peptides. Lipids group includes fatty acyls, glycerolipids, glycerophospholipids, 
polyketides, prenols, sphingolipids and sterol lipids and gangliosides. 
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4.3.2.1 Amino acids 
Nineteen out of 20 of the proteogenic amino acids were detected in the rat 
muscle. Iso-leucine was indistinguishable from leucine, as these two compounds 
are isomers and eluted together. Similar to the data obtained from beef tissue, 
sixteen of them showed steadily increasing patterns over time since death. The 
remaining three (glycine, alanine and glutamine) showed less change over the 
investigated time period. Figure 4-6 shows the changes observed in eleven of 
those amino acids, which were identified with high confidence.  
Among all of the detected amino acids, cysteine showed the highest rate of 
increase, nearly 22-fold by the third day post-mortem. However, it is not shown 
in Figure 4-6 as a potential biomarker candidate as the calculated error at one of 
the time points was very high. Leucine and aspartate increased 13-fold in that 
time, followed by valine with a 10-fold increase. Most of the other amino acids 
increased between 4 and 8-fold with proline increasing at the slowest rate of 2-
fold change over the same time period and arginine and lysine 3-fold. 
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Figure 4-6. Change in levels of eleven amino acids with increasing time since death in rat 
tissue.  
Graph a shows changes in levels of methionine, leucine, phenylalanine, tryptophan, 
aspartate and valine. Graph b shows lysine, tyrosine, histidine, threonine and arginine. 
Average instrument response (arbitrary unit) was normalised to time 0 and plotted against 
time. Error bars indicate standard deviation calculated from average instrument response. 
Two rats were analysed per time point, both right and left leg being sampled for each rat 
(N=4). 
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Additionally, since two rat cadavers were sampled at each time point, their 
metabolite levels were compared to each other. The absolute levels of the 
metabolites differed; however, the rates of increase of four amino acids 
(histidine, lysine, proline and asparagine) showed similarities between different 
rats (see Figure 4-7). 
 
Figure 4-7. Amino acids which show similar instrument response for two rats sampled at the 
same PMI. 
Graphs show the following amino acids: a – histidine, b – lysine, c – proline and d – 
asparagine. Two rats were dissected at each time point, the average response for both was 
normalised to time 0 at each PMI and compared. Error bars indicate standard deviation 
calculated from average instrument response. Left and right biceps femoris samples were 
treated as technical replicates for each rat (N=4). 
 
4.3.2.2 Decomposition products 
Biogenic amines such as cadaverine, putrescine, indole and skatole, are well 
known decomposition products (Vass 2001). Contrary to the results obtained 
using beef tissue, all of these compounds were detected using the HILIC method, 
with the exception of skatole (pHILIC). Additionally, the compounds showed a 
clear trend which was not the case with beef. Putrescine, skatole and indole 
were found to be increasing with time since death while cadaverine, 
unexpectedly, decreased (Figure 4-8). The first three aforementioned 
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compounds increased approximately 4-, 7- and 8-fold, respectively. Cadaverine 
decreased by about 3-fold. 
 
Figure 4-8. Patterns of change of identified decomposition products with increasing time 
since death in rat tissue. 
Graphs show a mean instrument response (N = 4) with error bars to indicate the standard 
deviation: a – putrescine, b – cadaverine, c – indole and d – skatole. Y-axes represent 
instrument response, x-axes show days since death. 
4.3.2.3 Other metabolites 
Five new compounds of interest were selected in rat tissue, based on their 
steady increasing changes over time as well as on the confidence in the 
compound identification: xanthine (purine metabolism), n-acetylneuraminate 
(derivative of neuraminic acid), uracil (pyrimidine metabolism), choline 
phosphate (glycerophospholipid metabolism) and 1-methylnicotinamide 
(metabolite of nicotinamide) (Wishart et al. 2013). Xanthine displayed the most 
significant increase of approx. 58-fold over three days post-mortem. N-
acetylneuraminate and uracil showed a slower, but still significant, rate of 
increase – approximately 24- and 15-fold, respectively. Choline phosphate and 1-
methylnicotinamide also increased consistently over the investigated period (see 
Figure 4-9). 
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Figure 4-9. Metabolites that increase in rat tissue with increasing PMI. 
Graphs represent: a – xanthine (approx. 58-fold increase), n-acetylneuraminate (approx. 24-
fold), uracil (approx. 15-fold) and b – choline phosphate (approx. 2-fold), 1-
methylnicotinamide (approx. 1.4-fold). Means and standard deviations (shown by the error 
bars) were calculated from data collected from muscle of both right and left legs of two 
individual rats. The metabolites above, with the exception of 1-methylnicotinamide, were 
identified by matching to a reference standard.   
4.3.3 Human tissue 
The end goal of this research was to devise a PMI estimation method that could 
be used by forensic scientists in the investigation of fatalities. Therefore, the 
results obtained using the animal models were tested in human muscle in the 
final stages of the project. The human tissue was prepared and analysed in the 
same way as the rat tissue, with the exception of data processing. In the case of 
rat tissue, the data for all cadavers was analysed collectively and rats dissected 
at the same time point were treated as biological replicates in single analysis. 
Whereas, due to the high variability of the individual human cadavers (cause of 
death, age, sex, diet, environmental exposure since death, etc.), the data 
collected for each individual was processed as an individual time course to 
demonstrate changes in the metabolome in comparison to baseline. On average, 
for each human subject, 998 metabolites were detected and putatively 
identified using the pHILIC and 991 using the HILIC separation methods. 
Appendices IX, XI, XIII, XV, XVII and XIX show metabolites detected using pHILIC 
separation for subjects 1, 2, 3, 4, 5 and 6, respectively. Appendices X, XII, XIV, 
XVI, XVIII and XX show metabolites analysed using the HILIC method for subjects 
1, 2, 3, 4, 5 and 6, respectively. 
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4.3.3.1 Amino acids 
As was the case for rat tissue, generally increasing patterns were observed for 
most of the amino acids, for all of the tested human cadavers, with the 
exception of subject 1. Figure 4-10 shows an example of how the levels of one of 
the amino acids of interest (leucine) change over time for all of the subjects.  
 
Figure 4-10. An example of how the levels of a single metabolite (leucine) change over time 
for all of the investigated subjects. 
The graphs represent: a – subject 1, b – 2, c – 3, d – 4, e – 5 and f – 6. A steady increasing 
pattern can be seen for all of the subjects, with exception of subject 1. The levels of this 
amino acid go up irrespective of the temperature that the body was stored at (subjects 4 
and 6 were stored outdoors). Y-axes represent instrument response and X-axes show time 
since death (days). Error bars indicate standard deviation calculated from average 
instrument response. The analysis included three technical replicates of each sample. 
Similar trends were observed for nearly all of the proteogenic amino acids with 
the exception of glutamine and alanine, which did not show much change. Not 
every metabolite shared the same pattern in every single test subject, however, 
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leucine (Figure 4-10), tryptophan, tyrosine, threonine, lysine, phenylalanine and 
aspartate showed steady increases for all. The quantitative changes in amino 
acid levels were more variable between human individuals than between rats (as 
shown in Figure 4-6).  
Although similar trends were observed in all subjects, it was difficult to draw 
conclusions based on this particular set of subjects, due to differences in storage 
conditions of the cadavers as well as their different PMIs. The measured levels of 
amino acids for subjects 2, 3 and 5 (who were of similar age and PMI) were 
normalised to PMI 12 in each subject (the first common time point for all of the 
three subjects). Four amino acids (glutamate, histidine, methionine and 
threonine) show similar rates of increase for the two male subjects, while lysine 
and tyrosine show an overlap for subjects 3 and 5 – female and male respectively 
(see Figure 4-11). Cysteine and serine show an overlap for all three subjects (see 
Figure 4-12). This finding is in agreement with data collected from rat cadavers, 
especially for histidine and lysine which showed similar rates of increase 
between different rat subjects. 
Among the amino acids, tyrosine, threonine and lysine showed the most 
consistent increase over time between different individuals. Additionally, as 
mentioned above, they show similar rates of change for subjects around the 
same age and PMI, suggesting they are promising candidates for time since death 
biomarkers. 
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Figure 4-11. Amino acids which show similar trend of increase over time for different 
subjects at the same PMI. 
Metabolites shown above: a – glutamate, b – histidine, c – methionine, d – threonine (two 
male subjects) e – lysine and f – tyrosine (male and a female). The average response for 
each subject was normalised to PMI 12 (first mutual time point for all subjects). Error bars 
indicate standard deviation calculated from average instrument response. The analysis 
included three technical replicates of each sample. 
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Figure 4-12. Amino acids which show similar trend of increase over time for three different 
subjects at the same PMI. 
The graphs represent: a – cysteine, b – serine. The results for each amino acid were 
normalised to PMI 12 (first mutual time point for all subjects). Error bars indicate standard 
deviation calculated from average instrument response. The analysis included three 
technical replicates of each sample. 
4.3.3.2 Phenylalanine assay 
Amino acids are among the most promising candidates for time since death 
biomarkers. Ideally, the method of quantification of these metabolites should be 
quick and easy, in order to facilitate its routine use. Therefore, the use of 
commercially available amino acid enzymatic assay kits was tested, to see if 
similar results can be achieved as by means of mass spectrometry. Five specific 
amino acid assay kits were available from a regular supplier (Sigma-Aldrich, UK): 
alanine, aspartate, glutamate, glutamine and phenylalanine. Alanine and 
glutamine were not included in the list of the metabolites of interest, therefore 
these were excluded. Aspartate, glutamate and phenylalanine show consistent 
trends with PMI in rat tissue, and phenylalanine also showed a similar trend in 
human tissue, so a phenylalanine assay kit was selected for initial testing. 
Two assays were carried out to test what volume and dilution of the tissue 
extract should be used, so that it would fit within the calibration range 
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(described in detail in the methods section). After these tests there was only 
enough reagent left to carry out one test, including two of the human subjects – 
2 and 5. Those two subjects were selected due to coincidental similarities 
between them – both male and around the same age. The levels of different 
metabolites were compared between them in the previous section and showed 
similarities. The enzymatic assay readings obtained from these two subjects are 
shown in Table 4-2. 
Table 4-2. Phenylalanine assay reading of samples obtained from human subjects 2 and 5. 
Row A includes the readings of the phenylalanine standard (in duplicate) at concentrations 
ranging from 0 to 1nmole. Columns 1 and 5 contain sample blanks of each sample. Rows 
B1-3, C1-3, D1-3 and E1-3 contain samples collected from subject 2: PMI 11, 12, 13 and 14, 
respectively. Rows F1-3, G1-3, H1-3, B5-7 and C5-7 contain samples collected from subject 
5: PMI 12, 13, 14, 15 and 16, respectively. All samples were pipetted in duplicate with 
exception of sample blanks (not enough reagents left). 
<> 1 2 3 4 5 6 7 8 9 10 11 12 
A 5351 4976 11926 9392 18545 14294 21927 23675 21806 27154 28953 32448 
B 29195 42039 38272  23915 25093 32080      
C 25166 43777 38778  11842 18639 15635      
D 34948 38277 35156          
E 27204 30862 42859          
F 15865 21999 28001          
G 22602 27337 32765          
H 16139 27188 27449          
 
The duplicate readings obtained for the phenylalanine standard were averaged 
and plotted against the expected concentration. This graph is shown in Figure 
4-13. 
 
Figure 4-13. Graph representing the standard curve for the phenylalanine enzymatic assay. 
Y axis represent the average instrument reading (based on duplicate measurements), x axis 
shows the expected amount of phenylalanine (nmole). Best fit line was created based on the 
plotted points. The equation for this line and the R
2
 value are also displayed. R
2
 represents 
how well the trend line is matched with the points – the closer to 1, the better the match. 
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The equation shown in Figure 4-13 was used to calculate the amount of 
phenylalanine present in each sample. The results of these calculations are 
presented in Table 4-3.  
Table 4-3. The amount of phenylalanine present in the samples (subjects 2 and 5), 
calculated using the standard curve. 
Average reading – mean result of two readings per each sample, reading minus blank – the 
number obtained by taking away the blank from average reading for every sample, 
phenylalanine – the amount of phenylalanine calculated with the curve equation. 
 PMI Average 
reading 
Reading 
minus blank 
Phenylalanine  
(nmole) 
Subject 2 11 40156 34992 1.4 
12 41278 36114 1.4 
13 36717 31553 1.2 
14 36861 31697 1.2 
Subject 5 12 25000 19837 0.76 
13 30051 24888 0.97 
14 27319 22155 0.86 
15 28587 23423 0.91 
16 17137 11974 0.45 
 
 
As the protocol stated, the average result obtained for the blank in the standard 
curve was taken away from the readings for all of the standards and samples. 
The results of this calculation for all of the samples are shown in Table 4-3. The 
protocol also suggested that a sample blank may be used to correct for 
background interference. Since it was not crucial to include the sample blank in 
the assay this step was omitted from the calculations. Unfortunately, the 
reading for subject 2 took the amount of phenylalanine higher than the top 
standard in the curve, which meant it could not be accurately quantified.  
The concentration of phenylalanine present in the sample could be calculated 
using the amount of phenylalanine measured by the assay. This was done using a 
simple formula presented in Equation 4-1.  
𝐶 =  
𝑆𝑎
𝑆𝑣
 
Equation 4-1. Formula used to calculate the concentration of phenylalanine in the sample. 
Where Sa = Amount of phenylalanine in unknown sample (nmole) from standard curve, Sv = 
sample volume (µl) added to the wells, C = concentration of phenylalanine in the sample. 
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Since the amount of phenylalanine in the samples collected from subject 2 was 
too high to be measured by the standard curve, only the concentrations of 
phenylalanine in samples collected from subject 5 were calculated. The results 
of this calculation are presented in Table 4-4. 
Table 4-4. The concentration of phenylalanine present in samples collected from subject 5. 
Concentration calculated using the amount of phenylalanine measured experimentally by 
the phenylalanine assay. PMI – post-mortem interval. 
Subject 5 
PMI Phenylalanine (nmole/µl) 
12 0.015 
13 0.019 
14 0.017 
15 0.018 
16 0.0090 
  
The above concentrations were then plotted on a graph to see how the 
concentration changed with increasing time since death. This is shown in Figure 
4-14a. Figure 4-14b shows the levels of phenylalanine measured using the 
standard metabolomics pipeline (LC-MS). The trends represented in those two 
graphs should be similar as they show the same metabolite measured in the 
same tissue samples. However, this is not the case. The levels of phenylalanine 
measured by the enzymatic assay show no particular trend with increasing time 
since death, while the ones measured by liquid-chromatography show an 
increasing trend. 
 
Figure 4-14. Comparison of phenylalanine levels measured using two different methods 
(subject 5). 
Figure a – phenylalanine concentrations measured in all samples using the enzymatic 
assay, b – levels obtained through LC-MS analysis (average instrument response 
normalised to the first time point in the series). Error bars indicate standard deviation 
calculated from: a – duplicate reading, b – three technical replicates used for each sample. 
METABOLOMICS (LC-MS), 147 
 
The concentration of phenylalanine for subject 2 could not be calculated as the 
amount of the metabolite was not within the range of the standard curve. 
However, the average readings for this subject were also plotted on a graph in 
order to get an illustration of what the trend looked like and how it compared to 
what was measured using the LC-MS method. This is displayed in Figure 4-15. 
 
Figure 4-15. Comparison of phenylalanine levels measured using two different methods 
(subject 2). 
Figure a – average phenylalanine enzymatic assay reading for all of the samples (measured 
in duplicate), b – levels obtained through LC-MS analysis (average instrument response 
normalised to the first time point in the series). Error bars – standard deviation calculated 
from: a – duplicate reading, b – three technical replicates used for each sample. 
As in the case of subject 5, the trend emerging from phenylalanine levels 
measured using the assay is different than one seen from the LC-MS data (Figure 
4-15). The latter displays a clear and steady increasing pattern, while the former 
does not seem to change at all. However, the phenylalanine responses for all of 
the samples tested for this subject are too saturated to measure its 
concentration and draw any valid conclusions. 
4.3.3.3 Other metabolites 
The known decomposition products cadaverine, putrescine and indole, which 
showed promising changes in rat tissue did not show such changes in human 
tissue. In some cases they were not even detected at all. However, another 
decomposition product (skatole), was consistently identified in five out of the six 
tested subjects. Furthermore, it showed increasing patterns in 4 of them (with 
the exception of subject 1).  
As in the case of rat tissue, a number of metabolites showed steady increasing 
patterns between the tested subjects (xanthine, choline phosphate, uracil, n-
acetylneuraminate and 1-methylnicotinamide). General increasing patterns were 
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observed for all of the forementioned metabolites, for all of the tested 
cadavers, with the exception of subject 4. In the case of subject 4 only xanthine 
and skatole showed a slowly increasing pattern. However, in this case tissue 
collection was only possible at three time points and the cadaver was stored 
outdoors. N-acetylneuraminate showed the highest rate of increase over time for 
5 out of the 6 subjects (with the exception of subject 3). Figure 4-16 shows the 
changes observed in the levels of these metabolites for all of the subjects. 
Additionally, since the PMIs of the investigated cadavers varied and were 
scattered from as little as 3 days post-mortem to 19 days after death, a general 
idea can be obtained of how these metabolites changed in levels throughout this 
period. They increased in all cases but subject 4, suggesting that these 
metabolites increase in level later in the post-mortem period (between 7 and 19 
days post-mortem). 
METABOLOMICS (LC-MS), 149 
 
 
 
Figure 4-16. Graphs showing PMI changes in human cadavers of levels of metabolites of interest (n-acetylneuraminate, 1-methylnicotinamde, choline 
phosphate, xanthine and uracil). 
Data shown for all of the human cadavers tested: a – subject 1, b – subject 2, c – subject 3, d – subject 4, e – subject 5 and f – subject 6. Skatole was not 
detected in data collected for subject 6. Cadavers 4 and 6 were kept outdoors. Error bars indicate standard deviation calculated from average instrument 
response. The analysis included three technical replicates of each sample.
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4.3.4 PMI calculations 
Post-mortem interval is most often reported as the amount of time which has 
passed since death. However, the ambient temperature at which the cadaver 
decomposes has a significant effect on the rate of decomposition. Therefore, the 
PMI calculation is sometimes corrected to include the temperature 
measurement. For example, Vass et al. reported PMI values in Cumulative 
Degree Hours (CDH) (Vass et al. 2002). To allow for comparison of the results 
presented in this thesis with existing literature, the PMIs of the subjects 
included in this study were also presented in CDH (see Table 4-5). CDH was 
calculated according to Vass et al. by using a 12 h temperature cycle to describe 
the advancement of the decomposition process. The temperature (°C) at 12 h 
intervals is averaged and cumulatively added to obtain CDH. For example, if the 
temp reached 25°C at 12 in the afternoon and 15°C at 12 at night, then the CDH 
for that 24 h period would equal to (25 + 15)/2 = 20 for the first 12 h and then 
(15 + 25)/2 = 20 for the following 12 h. This summarised (20 + 20) gives a CDH of 
40. For human cadavers, calculations were based on the assumption that storage 
was at 4°C at the medical examiner’s office prior to receipt at FACTS. At FACTS 
the temperature for the refrigerated cadavers was constant (45°F ≈ 7.2°C) and 
for the outdoor subjects the weather data was recorded. CDH for rats was 
included for the purpose of comparison with shorter PMIs. For the rodent model 
the temperature was controlled (20°C). 
  
METABOLOMICS (LC-MS), 151 
 
Table 4-5. Sampling times for rat and human subjects included in this study as Post-Mortem 
Interval (PMI) and Cumulative Degree Hours (CDH).  
PMIs in days and their corresponding CDH values for all time points (calculated according 
to Vass et al. (Vass et al. 2002)). Subjects 1-6 refer to human individuals. Rats were stored at 
ambient temperature (20°C), human subjects 4 and 6 outdoors and others were refrigerated 
during the sampling period. X indicates that there were no more data points collected for 
this particular subject. 
 Unit Time 
point 1 
Time 
point 2 
Time 
point 3 
Time 
point 4 
Time 
point 5 
Rats PMI  0 1 2 3 X 
CDH 0 40.0 80.0 120.0 X 
Subject 1 PMI 7 8 9 10 X 
CDH 81.6 96.0 110.4 124.8 X 
Subject 2 PMI 11 12 13 14 X 
CDH 88.0 102.4 116.8 131.2 X 
Subject 3 PMI 11 12 13 14 15 
CDH 107.2 121.6 136.0 150.4 164.8 
Subject 4 PMI 3 4 5 X X 
CDH 137.4 178.9 222.4 X X 
Subject 5 PMI 12 13 14 15 16 
CDH 108.8 123.2 137.6 152.0 166.4 
Subject 6 PMI 18 19 X X X 
CDH 144.0 186.0 X X X 
 
4.4 Discussion 
This experiment aimed to discover potential metabolite biomarkers for PMI 
estimation. Beef steak was used as test sample to develop and optimise the 
methodology, followed by testing in rat and human cadavers. An untargeted 
metabolomics approach allowed the identification of a number of metabolites 
which showed potential as PMI biomarkers. Testing carried out using rat 
cadavers resulted in a number of putative markers, mainly proteogenic amino 
acids. Nearly all of the identified amino acids showed a steady rate of increase 
during the first 72 h after death. Protein degradation may explain many of the 
changes observed in this study. Since protein synthesis will cease in dead tissue, 
the pool of free amino acids does not deplete. The loss of homeostasis that 
accompanies death will rapidly compromise membrane functions that are 
actively maintained, leading to breakdown of cellular and subcellular 
compartmentalisation. The many proteases that are sequestered in living tissue 
will gain unregulated access to protein substrates and the resulting proteolysis 
will break down proteins into peptides and, ultimately, amino acids.  
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Well known decomposition products, cadaverine, putrescine, skatole and indole 
also showed promising patterns of change. The latter three compounds increased 
over time but cadaverine, surprisingly, decreased. It is possible that the 
decomposition was not sufficiently advanced for this particular polyamine to 
increase in level. Additionally, it is a metabolite of lysine, which showed one of 
the slowest rates of increase among the amino acids observed.  
Five other metabolites were also identified as possible biomarkers: xanthine 
(purine base), uracil (pyrimidine found in RNA), choline phosphate (precursor of 
choline in glycerophospholipid metabolism), n-acetylneuraminate (otherwise 
known sialic acid, derivative of amino sugar neuraminic acid) and 1-
methylnicotinamide (metabolite of nicotinamide) (Wishart et al. 2013). Levels of 
these compounds increased with time since death. Xanthine is formed from 
hypoxanthine, which in turn in can be formed from inosine. The level of inosine 
increased rapidly from a low level, within the first 24 hours post-mortem in rat 
tissue and started to fall after that. This coincided with a rapid increase in 
hypoxanthine and xanthine within the same time period, which might suggest 
that this pathway is still active for some time after death and that inosine is 
converted to hypoxanthine and xanthine. This was also observed in two other 
studies in porcine and avian vitreous humour (Gardiner et al. 1989) and rat and 
human brain (Kovács et al. 2005). Xanthine can also be formed through DNA 
degradation, i.e. guanine deamination (Lindahl 1993). However, this is a less 
likely scenario as guanine levels also show an increase in the collected data. DNA 
degradation can also be responsible for an increase in uracil levels, through 
cytosine deamination (Lindahl 1993). However, this reaction is alkali catalysed 
and the pH of a decaying body is more likely to be acidic. Additionally, the 
levels of cytosine also show an increase post-mortem; therefore, uracil 
formation is likely to be a result of a different pathway. For example, uridine 
monophosphate (UMP) leads to formation of uridine and uridine is converted to 
uracil, which could explain the uracil increase, as UMP levels decreased and 
uridine remained fairly constant.  
The increase in levels of the three remaining compounds is a bit more difficult to 
explain. Choline phosphate is a precursor of choline, but it can also be formed 
from choline, through a reverse reaction catalysed by choline phosphokinase 
(Dawson 1955). However, this reaction requires ATP to proceed, which is absent 
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in dead tissue. Another pathway leading to the formation of choline phosphate is 
from phoshodimethyl ethanolamine, which was not detected in this study, so 
cannot be commented upon. N-acetylneuraminate (sialic acid) was suggested as 
an indicator of muscle damage (Iwata et al. 2013). Sialic acid is present in the 
sarcolemma of skeletal muscle (for a muscle composition diagram see chapter 1) 
and it was proposed that as a result of muscle damage cytosolic enzymes are 
released into the extracellular space. One of these enzymes, sialidase, removes 
sialic acid from the sarcolemma. It is possible that this process could occur post-
mortem as enzymes are released from the decomposing muscle tissue. Finally, it 
was shown that 1-methylnicotinamide is involved in the regulation of NAD 
content in cells and at the same time, recovery of ATP (Hoshino et al. 1984). As 
ATP is being used up in dying cells, the 1-methylnicotinamide could be 
synthesised from nicotinamide as a compensation mechanism. 
These findings were also tested using human tissue at various stages of 
decomposition, where subject selection, cause of death and ante- and post-
mortem environment could not be controlled. Nonetheless, the data collected 
using human subjects broadly agrees with the data obtained from rats. The same 
compounds were identified in most of the cadavers, showing similar trends. The 
only exceptions were decomposition products – cadaverine, putrescine and 
indole did not show significant changes in human tissue, perhaps because 
microbial colonisation of the larger human skeletal muscles is delayed compared 
with rats. On the other hand, skatole, showed increasing trends in human tissue. 
Additionally, certain amino acids (especially histidine and lysine) showed 
comparable rates of increase between different rat and human subjects. The 
absolute levels of these molecules may vary, but given the same conditions (i.e. 
temperature at which the decomposition occurs), they follow similar 
decomposition trends. The cadavers were stored at the same temperature at the 
time of sampling. This provided a controlled environment which resulted in 
similarities in the decomposition rates of these individuals. Lysine, tyrosine and 
threonine show the most potential for becoming biomarkers among the three 
species. 
Furthermore, since amino acids are among the candidates for biomarkers of PMI, 
the use of a commercial amino acid enzymatic assay for this purpose was put to 
the test. The optimisation of the sample preparation for the assay was slightly 
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problematic, as the levels of phenylalanine in muscle tissue were unknown, and 
they had to fit within a small range (0 – 1 nmole) of the standard curve. An 
appropriate sample dilution was experimentally tested; however, when two 
different subjects were tested the levels of only one of them were within the 
calibration range. Metabolite levels vary from person to person, which might 
make this approach impractical as these differences can be large and require the 
optimisation of the extraction protocol for each of the tested subjects. This 
hinders the ease and speed of use of the assay as a test method. Additionally, 
the trends resulting from the enzymatic assay measurements did not agree with 
the trends seen in the LC-MS data. The LC-MS data was not quantitative; 
however, a similar trend of increase should be expected. The mass spectrometry 
approach offers higher sensitivity and reproducibility than the enzymatic assay, 
hence more reliable results. However, it would be impractical to use MS as a 
method of PMI estimation. It was used for biomarker discovery, with the aim of 
finding a marker which can then be tested with a high throughput assay. Finally, 
the homogeneity of the sample could be an issue. It is very difficult to say if the 
same amount of phenylalanine is present in every part of the muscle. This 
cannot be controlled; however, in this case sample size would make a 
difference. The weight of tissue sample used for the assay is very small 20mg, as 
opposed to 0.5g used for the extraction for LC-MS analysis. To summarise, at this 
stage of the investigation, the commercially available amino acid assays do not 
seem suitable for the purpose of PMI estimation. Amino acids show a great 
potential as PMI markers, however, more time is required to develop this test 
using available assays or analysers. 
Amino acids have previously been suggested as possible markers in PMI 
estimation. In agreement with this study, increasing levels of amino acids were 
reported in various post-mortem specimens: vitreous humour (Patrick & Logan 
1988a; Girela et al. 2008), cerebrospinal fluid (Kärkelä & Scheinin 1992; Girela 
et al. 2008), blood (Donaldson & Lamont 2014; Sato et al. 2015) and brain (Ith et 
al. 2011). Perry et al. presented a post-mortem increase in levels of various 
amino acids in rat and human brain samples (up to 48 h after death) (Perry et al. 
1981). The investigators described a rapid increase in levels of most of the 
proteogenic amino acids within 24-48 h post-mortem, with the exception of 
glutamate. The levels of this amino acid remained unchanged over the 
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investigated PMI, which is contrary to our findings, that glutamate levels 
increase post-mortem. This difference could be explained by the involvement of 
glutamate in metabolic synthesis of GABA (gamma-aminobutyric acid) in brain, 
which would cause its depletion. On the other hand, the hydrolysis of proteins 
and GSH (glutathione) would contribute to increasing levels which added 
together might leave the levels of glutamate unchanged overall. It is possible 
that the first pathway does not occur in muscle tissue, or at least not to the 
same extent as in brain, so protein hydrolysis would be the primary contributor 
to increasing glutamate levels measured in this study.  
Vass et al. investigated various compounds in different post-mortem organs and 
tissues, including muscle tissue (Vass et al. 2002). Similar to our findings in 
human tissue, this group found the most commonly known decomposition 
products (cadaverine and putrescine) not to be suitable for time since death 
determination due to their variability. The authors describe various amino acids 
as good biomarker candidates. However, according to their findings, muscle 
tissue can only be used to determine PMI longer than 300CDH. To put this into 
context, subject 2 was sampled between 88 and 131.2 CDH (11-14days PM) and 
subject 3 107.2 and 164.8 CDH (11-15 days PM). This is contrary to our findings, 
as we found amino acids to be useful biomarkers at earlier PMIs. Additionally, 
we found lysine to be one of the most promising biomarker candidates, while 
Vass et al. did not find it a consistent indicator of time since death, in any of the 
analysed types of tissue. 
To our knowledge, xanthine, uracil, choline phosphate, n-acetylneuraminate and 
1-methylnicotinamide have not previously been suggested as possible PMI 
markers. Lendoiro et al. presented an LC-MS/MS method of PMI estimation based 
on the measurement of hypoxanthine levels in vitreous humour (Lendoiro et al. 
2012). The method was also validated to quantify levels of xanthine, however, 
not as a potential marker. Another study by Kovacs et al. showed increasing 
levels of both xanthine and uracil during first 24 h post-mortem in rat and 
human brains (Kovács et al. 2005). These findings are in agreement with the 
data presented in this thesis. However, PMI determination was not the scope of 
their investigation.  
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Muscle tissue has rarely been the focus in PMI research; however, it has great 
potential as a forensic specimen. Superficial muscle tissue is very easy to collect 
and is less emotive than sampling of internal organs for the next of kin. 
Additionally, it is more stable post-mortem than other organs or body fluids. As 
demonstrated in this study, it can be easily applied in PMI investigations. Various 
compounds show a steady increase over time, with threonine, tyrosine and lysine 
showing the most potential. However, more work is required to validate these 
results. The next step would be to apply targeted analysis in a larger cohort of 
subjects to test the selected metabolites. Quantification of the levels of these 
compounds would allow for a thorough statistical evaluation of the data and 
possibly a mathematical model for the estimation of PMI in muscle tissue. 
Importantly, instrumentation and workflows for the quantification of amino 
acids in samples are well developed and are ubiquitous in clinical biochemistry 
laboratories.  
4.5 Conclusion 
The complexity of the decomposition process makes the PMI estimation difficult. 
This study demonstrates how the newly emerging field of metabolomics can 
advance this area of forensic research. In agreement with previous studies, we 
found a positive correlation between the levels of proteogenic amino acids and 
increasing time since death. Additionally, we discovered six new metabolites of 
interest in PMI investigation. Lysine, threonine and tyrosine show the most 
potential to become PMI markers in muscle tissue, however, more time and 
testing is required to develop these markers further. 
  
METABOLOMICS (GC-MS), 157 
 
5 METABOLOMICS (GC-MS) 
5.1 Introduction 
Gas-chromatography (GC) coupled with mass spectrometry is a tool growing 
increasingly popular in the field of metabolomics. It might not be chosen as 
often as LC-MS, as it is limited to the detection of volatile compounds and non-
volatile metabolites must thus be derivatised prior to GC analysis. However, 
when analysing low molecular weight compounds, GC-MS is highly sensitive, 
efficient, reproducible and quantitative. Additionally, it is capable of obtaining 
highly reproducible compound fragmentation patterns which allows building 
comprehensive reference libraries for compound identification, that can be used 
by different laboratories (Garcia & Barbas 2011).  
The objective of an untargeted metabolomics approach is to create a detailed 
metabolic profile of an organism, as well as giving the opportunity to find any 
changes and differences on a molecular level, when the state of that organism 
changes for any reason (i.e. disease state). The versatility of this approach can 
be used in various areas of research - food, nutrition, systems biology, drug 
discovery and mode of action (Lee et al. 2016; Petersson et al. 2015; Zhang et 
al. 2015), but most frequently it is used to discover new biomarkers, both 
diagnostic and prognostic (Surowiec et al. 2015; Yi et al. 2006; Jiye et al. 2005; 
Kloet et al. 2012; Kenny et al. 2005; Wu et al. 2011). GC-MS is a perfect tool for 
this task, however, best results are obtained when orthogonal approaches are 
used to complement each other (Fanos et al. 2014). Therefore, this chapter 
describes how the GC-MS metabolic profiling approach has been successfully 
applied in PMI biomarker research and how two different approaches (LC-MS and 
GC-MS) can be used together to get a better insight into biological processes 
occurring after death. 
Metabolic markers of PMI previously presented in the literature have been 
discussed in the previous chapter (chapter 4). The most relevant publications 
will be presented in the discussion section of this chapter. 
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5.2 Methodology 
Sample derivatisation and analysis using GC-MS was carried out by Stefan Weidt, 
mass spectrometry technologist at Glasgow Polyomics - rat tissue at the Thermo 
facility in Runcorn, UK and human tissue at Glasgow Polyomics. In both cases the 
Trace 1310 gas chromatograph coupled with a QExactive-GC mass spectrometer 
(Thermo Scientific) was used. Sample preparation, analysis and instrumentation 
used were described in Chapter 2. Sample collection, extraction and the 
processing of the collected GC-MS data was carried out by the author of this 
thesis. 
5.2.1 Peak identification, average response calculation and 
presentation for relative quantification 
Raw MS-data was processed using Trace Finder 4.0 software (Thermo Fisher). 
The software compiled a list of detected peaks for each of the study groups (rat, 
human – each subject separately) and also matched the detected peaks against 
compounds present in the reference library (NIST - The National Institute of 
Standards and Technology). Peaks of interest were selected based on the 
graphical representation of the change in the level of the compound over time. 
Unidentified compounds or those with an unlikely library match were not 
considered. As the software did not calculate the error associated with these 
levels, a list of response areas for all samples for each peak of interest was 
obtained from the software. Samples collected at each time point were analysed 
in three technical replicates. Therefore the mean and standard deviation of the 
area response were calculated for each time point. Finally, the average values 
for all time points were normalised to time point 0, to compare how much each 
of the samples differ from time 0 and each other (fold change). All of these 
calculations were carried out in Microsoft Excel, where the graphs representing 
the data were also created. These were obtained by plotting the average 
response (either normalised or not, as required) against time, including the 
associated error with each sample (± standard deviation). The spreadsheets with 
the above calculations are attached in Appendices XXI and XXII for rat and 
human samples, respectively. 
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5.3 Results 
Gas chromatography-mass spectrometry was used to test two out of three 
species included in this study, rat and human. Beef tissue, used for method 
development in case of LC-MS analysis, was not subjected to GC-MS analysis, in 
order to focus the remaining period of the project on sample sets which showed 
promising results in the LC-MS analysis. A number of metabolites of interest 
were detected in both cases, however, unlike LC-MS results, the list of selected 
compounds differed slightly between species. Certain compounds, i.e. 
proteogenic amino acids were highlighted in both the LC and GC-MS parts of the 
study. Also, the GC-MS analysis revealed a few additional compounds of interest, 
including non-proteogenic amino acids as well as compounds involved in the 
purine and pyrimidine pathways. 
5.3.1 Rat tissue 
Biceps femoris muscle was collected from 8 rats, two at a time, over a period of 
4 days (time 0 - right after death, 24 h, 48 h and 72 h after death). Muscle tissue 
was extracted, derivatised and analysed using an untargeted GC-MS approach. 
The data collected yielded 22 metabolites of interest, which are presented in 
Table 5-1. 901 peaks were detected in total, across 4 time points and 148 of 
these peaks were putatively identified. However, these included ambiguous 
identifications, where the matched compound was not silylated. Given that the 
samples were derivatised before analysis, the detected compounds of interest 
should occur in a silylated form (addition of one or more Si(CH3)3 groups). This 
reduced the number of possible compounds of interest further. The final 
criterion for a metabolite of interest was increasing or decreasing abundance 
over the investigated PMI. Based on this, 22 compounds were selected as 
possible biomarker candidates. These included 17 amino acids, 13 proteogenic 
and 4 non-proteogenic, and hexanoic acid (carboxylic acid), uracil (pyrimidine 
metabolism), hypoxanthine, adenine (purine metabolism) and glucosamine 
(carbohydrate metabolism). 
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Table 5-1. List of metabolites of interest as PMI biomarkers selected in rat tissue. 
Peak ID – identifier given to each peak by the software, RT – retention time, Monoisotopic 
mass – fragment masses used to identify the compound, NIST (The National Institute of 
Standards and Technology) – mass spectral reference library used to identify the peaks. 
The compounds present in the sample were silylated prior to analysis, which is represented 
in the elemental composition, although omitted from the compound name.  
Peak ID RT 
(min) 
Monoisotopic 
Mass 
NIST Elemental 
Composition 
peak @ 6.22 173.10 6.22 173.099289 Hexanoic acid C9H20O2Si 
peak @ 8.35 218.10 8.35 218.10289 L-Tryptophan C17H28N2O2Si2 
peak @ 9.16 158.14 9.16 158.136017 L-Leucine C12H29NO2Si2 
peak @ 9.46 158.14 9.46 158.136017 L-Isoleucine C12H29NO2Si2 
peak @ 10.03 241.08 10.03 241.08226 Uracil C10H20N2O2Si2 
peak @ 10.36 204.12 10.36 204.123459 Serine C12H31NO3Si3 
peak @ 10.70 218.14 10.70 218.138794 Cystathionine C19H46N2O4SSi4 
peak @ 11.20 160.08 11.20 160.078812 L-Aspartate C10H23NO4Si2 
peak @ 11.26 248.13 11.26 248.13182 Alanine C12H31NO2Si3 
peak @ 12.40 176.09 12.40 176.092484 L-Methionine C11H27NO2SSi2 
peak @ 12.85 220.10 12.85 220.100769 L-Cysteine C12H31NO2SSi3 
peak @ 13.61 246.13 13.61 246.134262 L-Glutamate C10H24O2NSi2 
peak @ 13.69 218.10 13.69 218.103378 L-Phenylalanine C15H27NO2Si2 
peak @ 14.11 234.12 14.11 234.116287 Homocysteine C13H33NO2SSi3 
peak @ 14.17 188.09 14.17 188.092194 Asparagine C13H32N2O3Si3 
peak @ 15.65 265.09 15.65 265.093567 Hypoxanthine C11H20N4OSi2 
peak @ 16.17 174.11 16.17 174.11293 N-Acetyl-L-Lysine C17H40N2O3Si3 
peak @ 16.23 218.10 16.23 218.102722 L-3-Methylhistidine C13H27N3O2Si2 
peak @ 16.31 264.11 16.31 264.109619 Adenine C11H21N5Si2 
peak @ 16.83 203.12 16.83 203.115646 Glucosamine C24H61NO5Si6 
peak @ 16.88 156.12 16.88 156.120346 L-Lysine C18H46N2O2Si4 
peak @ 17.04 218.10 17.04 218.103378 L-Tyrosine C18H35NO3Si3 
 
The samples were collected at early PMIs, at relatively short intervals of 24 h 
apart. However, the post-mortem changes occurring in the tissue samples could 
be seen simply by the comparison of total ion chromatograms (TICs) of samples 
collected at different time points. The TIC is a chromatogram which contains of 
all of the GC peaks detected in the sample. Figure 5-1 displays four TICs, each 
from one of the samples collected at each of the four time points, arranged with 
increasing PMI for the purpose of comparison.  
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Figure 5-1. Comparison of TICs obtained from analysis of rat tissue samples collected at 
each time point. 
TIC – total ion chromatogram. Starting from the top of the image, first chromatogram 
corresponds to sample collected at time 0, second chromatogram corresponds to sample 
collected at day 1, third and fourth correspond to days 2 and 3, respectively. Sections 
between 10 to 28 min of the chromatograms are shown, with the highest abundance of 
peaks. Total run time was 36 min. Four samples were collected and analysed for each time 
point, chromatograms for only one out of four are displayed. Samples were analysed in full 
scan mode. Top chromatogram is greyed out as it was selected at the time when the screen 
shot was taken. This image was created using Xcalibur Qual Browser (Thermo). 
Clear differences can be seen between the chromatograms in Figure 5-1. Certain 
peaks became more intense with increasing PMI and others became less intense 
or even disappeared. This is highlighted further, using a shorter run time interval 
to make the differences clearer, in Figure 5-2. The abundances between the 
replicates of each sample differed slightly, with varying degrees of variation 
between time points. The coefficient of variation (%CV), which is a measure of 
the degree of variability with respect to the average of the data set, varied from 
0.06 to 0.53 for the relative abundance of the peaks. However, even considering 
the variance between the replicates, still a general increase was observed across 
the time points. The peaks of interest presented in Figure 5-2 were submitted to 
the NIST mass spectral reference library for identification. The compounds were 
matched to glycine, serine, threonine, thiourea, oxo-proline, glutamate and 
lysine, with most of the peaks increasing in intensity over time. 
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Figure 5-2. Comparison of selected peaks in the TIC’s of samples collected at each time 
point (rat tissue). 
TIC – total ion chromatogram. Chromatograms were labelled with their corresponding time 
points on the right-hand side of each chromatogram. Sections between 9.5 and 20 min of 
the chromatograms are shown to highlight peaks of interest. Total run time was 36 min. The 
highlighted peaks correspond to the following compounds (matched in the NIST database): 
a – glycine, b – serine, c – cystathionine, d – thiourea, e – methionine, f – glutamate, g – 
lysine. Four samples were collected and analysed for each time point, chromatograms for 
only one out of four are displayed. Samples were analysed in full scan mode. Top 
chromatogram is greyed out as it was selected at the time when the screen shot was taken. 
This image was created using Xcalibur Qual Browser (Thermo). 
Some of the peaks highlighted in Figure 5-2 were later included in the list of 
compounds of interest in Table 5-1. Not all of the peaks discussed above were 
included in this list as the final list was created based on the results obtained 
from the data processed with the TraceFinder software. Glycine (RT 9.63) and 
thiourea (RT 12.01) were not incorporated in the final list. 
5.3.1.1 Amino acids 
Amino acids comprised the majority (17 out of 22) of the metabolites of interest. 
Thirteen of them were proteogenic amino acids, which were highlighted as 
compounds of interest through LC-MS analysis (Chapter 4). Figure 5-3 shows the 
detected changes of these thirteen compounds with increasing PMI. Apart from 
the listed compounds, glutamine was also detected, but did not show a clear 
trend with PMI. The remaining 6 proteogenic amino acids were not detected, 
however, the GC analysis allowed separation of two isomers, leucine and 
isoleucine, which was not possible with the LC-MS method used. 
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Figure 5-3. Change in levels of thirteen proteogenic amino acids with increasing time since 
death in rat tissue.  
Graph a shows changes in levels of leucine, methionine and cysteine. Graph b shows 
tryptophan, isoleucine, aspartate, phenylalanine, asparagine and tyrosine. Graph c shows 
serine, glutamate, lysine and alanine. Average instrument response (arbitrary units) was 
normalised to time 0 and plotted against time. Error bars indicate standard deviation 
calculated from average instrument response. Two rats were analysed per time point, both 
right and left leg being sampled for each rat (N=4). 
Cysteine displayed the highest rate of increase of about 36-fold, followed by 
leucine at 20-fold. The majority of the amino acids (methionine, tryptophan, 
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isoleucine, aspartate, phenylalanine, asparagine and tyrosine) increased 
between 10- and 15-fold. Serine, glutamate and lysine all increased by about 5-
fold, with alanine showing the smallest increase of around 3-fold. 
Most of the amino acids listed above were already highlighted as compounds of 
interest through the LC-MS experiment, with two exceptions. First, isoleucine 
and leucine were not discriminated by liquid chromatography. Second, alanine 
did not show a clear pattern of change with PMI in LC-MS analysis. Surprisingly, it 
showed a clear increasing pattern over time in the results of this experiment. 
The changes observed for this compound using the two different chromatography 
methods are compared in Figure 5-4. 
 
Figure 5-4. Change in levels of Alanine detected using two different methods, GC-MS (a) and 
LC-MS (b). 
Alanine was one of the metabolites of interest detected in rat tissue via GC-MS. Here, 
results of GC-MS analysis are compared with those obtained by LC-MS analysis of the same 
tissue extracts. Y-axes represent average instrument response (N=4), x-axes show time 
since death (days). Error bars indicate standard deviation calculated from average 
instrument response. 
Additionally, four other, non-proteogenic amino acids were selected as 
metabolites of interest, cystathionine, homocysteine, n-acetyl-L-lysine and L-3-
methylhistidine. Cystathionine and homocysteine are involved in cysteine 
synthesis from serine (Kanehisa 1995). N-acetyl-lysine is an acetylated form of 
lysine and is a common post-translational modification of intact proteins. 3-
Methylhistidine is produced as a result of methylation of actin and myosin, two 
of the main building blocks of muscle tissue (Wishart et al. 2013). The trends of 
change observed for these compounds are presented in Figure 5-5. All of their 
levels increase over time by approximately 5-fold. The LC-MS results for these 
compounds can be seen in Figure 5-6. 
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Figure 5-5. Change in levels of non-proteogenic amino acids of interest with increasing time 
since death in rat tissue. 
Graphs show the mean instrument response (N = 4) with error bars to indicate the standard 
deviation: a – cystathionine, b – homocysteine, c – N-acetyl-L-lysine and d – L-3-
methylhistidine, detected using GC-MS. Y-axes represent instrument response, x-axes show 
days since death. 
 
Figure 5-6. Non-proteogenic amino acids of interest compared with LC-MS results. 
Compounds detected in the GC-MS analysis were also found in the LC-MS analysis and 
presented here for comparison. The above graphs represent: a – cystathionine, b – 
homocysteine, c – N-acetyl-L-lysine, d – L-3-methylhistidine detected using LC-MS. Y-axes 
represent average instrument response (N=4), x-axes show time since death (days). Error 
bars indicate standard deviation calculated from average instrument response. 
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Unlike the proteogenic amino acids, the compounds shown in Figure 5-5 did not 
present themselves as metabolites of interest in the LC-MS analysis. For the 
purpose of comparison, the list of metabolites detected in the LC-MS analysis 
was searched for these compounds. They were also detected using the other 
method, however the results differed slightly. In the LC-MS data cystathionine 
and 3-methylhistidine also show steadily increasing trends. However, 
homocysteine and N-acetyl-lysine do not show much change over the 
investigated period, which disagrees with the GC-MS data.  
 
5.3.1.2 Other metabolites 
The GC-MS approach not only confirmed that amino acids are strong PMI 
biomarker candidates, but also allowed the identification of several additional 
prospective markers. Five other metabolites, hexanoic acid (carboxylic acid, 
otherwise known as caproic acid (Wishart et al. 2013)), uracil (pyrimidine 
metabolism), glucosamine (carbohydrate metabolism), hypoxanthine and 
adenine (purine metabolism), also showed promising changes with increasing 
PMI. The first four of the aforementioned compounds showed an increasing trend 
over time (see Figure 5-7), while adenine decreased (see Figure 5-8). This 
compound also showed the smallest rate of change, as its level only decreased 
by about half over the investigated time period. Glucosamine showed the 
highest rate of increase of about 43-fold. The level of uracil increased about 18-
fold, followed by hypoxanthine with about 12-fold increase. Hexanoic acid 
showed the slowest rate of increase among all of the metabolites of interest of 
about 2.5 fold. Uracil was also highlighted as a possible marker in the LC-MS 
data. 
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Figure 5-7. Metabolites that increased in rat tissue with increasing PMI. 
Graphs represent: a – hexanoic acid, b – uracil, c – glucosamine, d – hypoxanthine. Y-axes 
represent average instrument response (N=4), x-axes show time since death (days). Error 
bars indicate standard deviation calculated from average instrument response. 
 
Figure 5-8. Adenine showed a decreasing trend in rat tissue with increasing PMI. 
Graph shows a mean instrument response (N = 4) with error bars to indicate the standard 
deviation. Data collected using GC-MS. Y-axes represent instrument response, x-axes show 
days since death. 
Again, the data obtained through the GC-MS approach was compared with the 
LC-MS as all but one of the compounds (uracil) were not previously highlighted 
as possible markers. Figure 5-9 shows a comparison between the trends of 
change of uracil, hexanoic acid, hypoxanthine and adenine through both 
approaches. Glucosamine was not included as the LC-MS results for this 
compound were inconclusive, both increasing and decreasing trends were 
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observed. The other four compounds of interest, presented in Figure 5-9 show 
very similar, if not identical trends. 
 
Figure 5-9. Comparison of changes in metabolites of interest based on GC-MS and LC-MS 
results. 
Compounds detected in the GC-MS analysis (indicated by .1) were also found in the LC-MS 
analysis and presented here for comparison (indicated by .2). The above graphs represent: 
a – uracil, b – hexanoic acid, c – hypoxanthine, d – adenine. Y-axes represent average 
instrument response (N=4), x-axes show time since death (days). Error bars indicate 
standard deviation calculated from average instrument response. 
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5.3.2 Human tissue 
Aliquots of human tissue samples, previously extracted for LC-MS analysis 
(Chapter 4), were derivatised and analysed at Glasgow Polyomics. However, 
human samples were analysed using a newly set up GC-MS instrument (Q 
Exactive GC system, Thermo Scientific). Initially, samples collected from 
subjects 2, 3 and 5 were analysed as a test (referred to as batch 1). These 
subjects were selected as the cadavers were kept at the same temperature and 
their PMIs were overlapping. Samples collected from subjects 4 and 6 (stored 
outdoors, referred to as batch 2) were run separately on a different occasion, 
after further method improvements. Samples collected from subject 1 were not 
analysed in this study. Additionally, apart from the tissue extracts, a mixture of 
various amino acids (see Chapter 2) at different concentrations was analysed 
within the two batches. This was carried out in order to create a calibration 
curve, which would enable absolute quantification of the amino acids detected 
in the test samples. An internal standard was added to all of the samples and 
calibrators to make this possible (the method is described in detail in Chapter 
2). However, when the internal standard is not considered, relative 
quantification can also be carried out. Both relative and absolute quantifications 
of this data will be discussed in separate sections below. 
5.3.2.1 Relative quantification 
Data was collected for 5 out of 6 human subjects included in this study. Data 
collected for each individual was processed separately. The average response, 
fold changes across the time courses and standard deviations were calculated as 
described in section 5.2.1 of this chapter. The selection criteria applied to 
choose metabolites of interest were the same as in the case of rat tissue 
(compounds showing a clear trend of change over time, which were matched 
though the NIST library search to a likely match in a silylated form). A separate 
list of compounds of interest was created for each of the subjects. The list for 
subject 2 was created first and contained 19 metabolites of interest. The 
subsequent lists for the other subjects contained smaller numbers of possible 
markers, but also highlighted some additional markers not observed in subject 2. 
Selected compounds did not always show the same trends between subjects and 
in some cases, the peaks detected in one subject were not detected in the 
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others. To obtain a clearer view of any changes that were consistent across all of 
the tested subjects, the lists were combined into a colour coded chart in Table 
5-2. Twenty four metabolites were selected and are presented in Table 5-2. 
Among them, there are 16 amino acids, of which 13 are proteogenic. The 
remaining seven compounds are pipecolic acid (metabolite of lysine), 
diethanolamine (otherwise DEA, organic chemical compound), uracil (pyrimidine 
metabolism), malic acid (TCA cycle intermediate), glycerate-3-phosphate 
(glycolysis intermediate), benzoic acid (carboxylic acid), hypoxanthine and 
inosine (purine metabolism) (Wishart et al. 2013). Table 5-2 shows how each of 
the compounds behaved for each of the subjects. Compounds which increased 
with PMI were labelled with blue and those which decreased with green. Darker 
shades of these two colours were used if the peak ID did not match the listed 
compound in the subject. A purple colour was used if the metabolite level 
remained constant. A yellow colour indicates that the peak did not show any 
particular trend with time and red if the peak was not detected in a subject. 
Ideally, it is desirable to see compunds which increased or decreased in all of 
the tested subjects (i.e. blue or green colour all across the table). This can be 
observed for one of the selected compounds, diethanolamine. Another four 
compounds were very close to this result, showing similar trends for 4 out of 5 
tested subjects. These were pipecolic acid, isoleucine, uracil and aspartate. 
Another compound worth pointing out is inosine, the only metabolite that 
showed a decreasing trend in 3 out of 5 subjects. These top 6 metabolites of 
interest are displayed in Figure 5-10, which shows their change over time for 
subjects 2, 3, 5 and 6. Subject 4 was not included in this figure, as only two out 
of the top 6 compounds (diethanolamine and aspartate) showed a steadily 
increasing trend in this subject. These two compounds can be seen in Figure 
5-11. Additionally, only 4 out of the 24 metabolites of interest detected in 
human tissue showed any consistent trend for subject 4 (diethanolamine, 
aspartate, 5-oxo-proline and glycerate-3-phosphate). On the other hand, in the 
case of subjects 2 and 6, promising patterns of change were shown by 19 and 20 
out of the 24 selected biomarker candidates, respectively  (see Table 5-2).  
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Table 5-2. Metabolites of interest selected in human tissue. 
Table shows a list of selected metabolites and how their levels change over time in all of the tested subjects. Colours indicate the type of change observed, 
darker shades of colours indicate that the peak ID did not match the listed compound i.e. light and dark blue colour indicate an increasing pattern, but ID 
differs for dark blue. Same applies to green, indicating a decrease. Yellow – no clear pattern was observed, purple – level did not change and red – peak 
was not detected. Peak ID – identifier assigned by the software, RT – retention time, NIST – mass spectral library used to identify peaks. The compounds 
present in the sample were silylated prior to analysis, which is represented in the elemental composition, although omitted from the compound name. 
Peak ID RT 
(min) 
Monoisotopic 
Mass 
NIST Elemental 
Composition 
Subject 2 Subject 3 Subject 4 Subject 5 Subject 6 
peak @ 6.90 158.14 6.90 158.135788 L-Leucine C12H29NO2Si2      
peak @ 7.34 156.08 7.34 156.083969 Pipecolic acid C12H27NO2Si2      
peak @ 7.75 218.10 7.75 218.102631 3-Hydroxy-tyrosine C21H43NO4Si4      
peak @ 8.53 218.10 8.53 218.102921 Diethanolamine C13H35NO2Si3      
peak @ 9.16 158.14 9.16 158.135895 L-Isoleucine C12H29NO2Si2      
peak @ 9.28 174.11 9.28 174.11261 Glycine C11H29NO2Si3      
peak @ 9.50 241.08 9.50 241.082321 Uracil C10H20N2O2Si2      
peak @ 9.64 204.12 9.64 204.123459 Serine C12H31NO3Si3      
peak @ 9.83 219.11 9.83 219.110336 L-threonine C12H33NO3Si3      
peak @ 10.15 248.13 10.15 248.13176 Alanine C12H31NO2Si3      
peak @ 10.51 189.11 10.51 189.112579 Malic acid  C13H30O5Si3      
peak @ 10.72 232.12 10.72 232.118301 L-Aspartate C13H31NO4Si3      
peak @ 10.75 176.09 10.75 176.092422 L-Methionine C11H27NO2SSi2      
peak @ 10.77 156.08 10.77 156.083969 5-Oxo-L-Proline C11H23NO3Si2      
peak @ 10.97 220.10 10.97 220.100235 Cysteine C12H31NO2SSi3      
peak @ 11.33 246.13 11.33 246.134048 Glutamate C14H33NO4Si3      
peak @ 11.43 218.10 11.43 218.102631 L-Phenylalanine C15H27NO2Si2      
peak @ 12.38 357.11 12.38 357.113159 Glycerate-3-phosphate C15H39O7PSi4      
peak @ 12.45 265.09 12.45 265.093872 Hypoxanthine C11H20N4OSi2      
peak @ 12.70 174.11 12.70 174.11261 N-Acetyl-L-Lysine C17H40N2O3Si3      
peak @ 12.89 179.09 12.89 179.088638 Benzoic Acid C10H15O2Si      
peak @ 13.03 156.12 13.03 156.120209 L-Lysine C18H46N2O2Si4      
peak @ 13.12 218.10 13.12 218.102631 L-Tyrosine C18H35NO3Si3      
peak @ 15.93 217.11 15.93 217.107498 Inosine C22H44N4O5Si4      
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Figure 5-10. Trends of change of the six metabolites of interest for subjects 2, 3, 5 and 6. 
The above graphs represent the change in levels of pipecolic acid, diethanolamine, 
isoleucine, uracil, aspartate and inosine for a – subject 2, b – subject 3, c – subject 5 and d – 
subject 6. Levels of inosine and aspartate for subjects 2 and 3, respectively, are not 
included as they did not show the same pattern and obscured the rest of the graph. Error 
bars indicate standard deviation calculated from average instrument response. The analysis 
included three technical replicates of each sample. 
 
Figure 5-11. Metabolites showing increasing trend with PMI for subject 4. 
Graphs show the change in levels of a – diethanolamine and b – aspartate for subject 4, 
detected using GC-MS. Y-axes represent average instrument response, calculated from 
three technical replicates of each sample, x-axes show time since death (days). Error bars 
indicate standard deviation calculated from average instrument response. 
The data described above were compared with data collected using the LC-MS 
approach. Diethanolamine was not detected by LC-MS and, as was the case for 
rat tissue, isoleucine was not separated from its isomer leucine. Pipecolic acid 
showed an increasing trend for only 2 out of 5 subjects, while uracil, aspartate 
and inosine showed very similar trends, increasing for the former two compunds 
and decreasing for the latter. 
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A few other compounds presented in Table 5-2 seem to be likely biomarker 
candidates. The amino acids alanine, methionine, phenylalanine, lysine, tyrosine 
and N-acetyl-lysine, as well as as benzoic acid, showed increasing trends for 
three out of the five tested subjects. Slightly less likely candidates are 
glutamate, glycine, serine, threonine and 5-oxo-proline, which showed promising 
trends only for two out of five tested subjects. Four of the remaining 
metabolites, glycerate-3-phosphate, malic acid, 3-hydroxy-tyrosine and cysteine 
showed conflicting trends among the tested subjects, while hypoxanthine was 
listed as a metabolite of interest only for subject 2. This result is suprising in 
comparison with the LC-MS results, in which tryptophan, tyrosine, threonine, 
lysine and phenylalanine showed steady increases for all tested individuals. On 
the other hand, aside from the proteogenic amino acids, neither of the selected 
compunds of interest showed any particular changes with PMI when separated 
using the pHILIC LC column. Additionally, benzoic acid and 3-hydroxytyrosine 
were not detected. However, benzoic acid was detected using the HILIC column 
and showed a general increasing trend for subjects 2, 5 and 6. N-acetyl-lysine 
also showed increasing trends for subjects 2 and 5 in the HILIC data. 
Leucine, which showed the second highest rate of increase in rat tissue, 
remained virtually unchanged for all of the tested subjects (see Figure 5-12 for 
subjects 2, 3, 5 and 6). The levels oscillated around the value of the initial time 
point, with the other values only slightly exceeding 1-fold. This disagrees with 
the data collected through the LC-MS approach, where levels of leucine 
increased steadily over time for the same subjects (see Figure 5-13). For subject 
2, levels of this metabolite increased just over 2-fold, for subject 3 nearly 3-
fold, for subjects 4 and 5 slightly under 2-fold (graph not shown for subject 4) 
and 2-fold for subject 6. This is a moderately slow increase over time in 
comparison to other metabolites. Overall, a clear increasing trend can be seen 
in the LC-MS data, but this is not mirrored in the GC-MS set. 
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Figure 5-12. Levels of leucine detected in human tissue by GC-MS. 
Graphs represent levels of leucine detected over time for a – subject 2, b – subject 3, c – 
subject 5 and d – subject 6 using GC-MS. Y-axes represent average instrument response, 
calculated from three technical replicates of each sample, x-axes show time since death 
(days). Error bars indicate standard deviation calculated from average instrument response. 
 
Figure 5-13. Levels of leucine detected in human tissue by LC-MS. 
Graphs represent levels of leucine detected over time for a – subject 2, b – subject 3, c – 
subject 5 and d – subject 6 using LC-MS. Y-axes represent average instrument response, 
calculated from three technical replicates of each sample, x-axes show time since death 
(days). Error bars indicate standard deviation calculated from average instrument response. 
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The data collected from human cadavers is very variable; however, it was 
possible to pinpoint certain compounds with the potential to become PMI 
biomarkers. Pipecolic acid, diethanolamine, isoleucine, uracil, aspartate and 
inosine showed the most potential out of the 24 compounds of interest. 
Additionally, aspartate and uracil were also among the compounds of interest 
selected in the rat study. Amino acids showed the most consistent changes 
among all of the different species tested using both LC and GC approaches; 
therefore, they were selected for absolute quantification in the final part of this 
study.  
5.3.2.2 Absolute quantification 
The GC-MS approach was used to try to accurately quantify the amount of the 
amino acids present in PM samples, since they had been shown to have the 
highest potential to become PMI markers in this study so far. A mixture of amino 
acids at known concentrations was analysed along with the samples to provide a 
calibration curve. Twenty four different amino acids were included in the mix, 
mainly proteogenic amino acids with the addition of cystine, ornithine, 
hydroxyproline and homoserine. Figure 5-14 shows chromatograms of 14 out of 
the 24 amino acids included in the mix. The amino acids displayed in Figure 5-14 
are the ones detected in the untargeted analysis described in section 5.3.2.1 of 
this chapter. Running these standards served not only as the basis for a 
calibration curve, but also the retention times of the peaks in the standards 
could be compared with those in the samples to confirm the identities of the 
compounds. Provided that the standard is analysed under the same conditions as 
the sample, the RT of each compound should remain the same and permit 
unambiguous compound identification. Two batches of samples were analysed on 
different days and the RTs of the compounds did not differ by more than 
0.01min from batch to batch. Chromatograms in Figure 5-14 are shown to 
confirm the identities of the amino acids presented in Table 5-2 (section 
5.3.2.1). RT comparison confirmed the identities of all but three of the 14 amino 
acids detected which had a reference standard. Leucine was identified at RT 
6.90, while the standard eluted at 8.99 min and alanine was detected at 10.15 
while the reference standard eluted at 7.25 min. The retention times of 
compounds might differ between different instruments as well as from batch to 
batch on the same instrument. The discrepancy in the retention times of the 
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aforementioned compounds might have been caused by running the human 
samples in two separate batches. Hydroxyproline eluted at the same time as the 
compound identified as 5-oxo-proline, which suggests it is more likely that it is 
hydroxyproline. However, these two compounds have very similar mass spectra 
(in the derivatised form). Amino acids have common fragments, which give raise 
to the same masses in their spectra. Usually, a few unique fragments can be 
identified, but this is not always the case. Manual comparison of the detected 
masses with the library records indicates 5-oxo-proline is a correct match. 
 
Figure 5-14. Extracted ion chromatograms of selected amino acid standards. 
The graphs above show the peaks and retention times of six amino acids: a – alanine, b – 
aspartate, c – cysteine, d – glutamate, which were included in the standards mix and run 
together with the human samples in batch 1. Y-axis shows the relative intensity, the most 
abundant peak visible in the window is assigned as 100 and the other peaks are scaled 
accordingly to that peak. RT – retention time in min (x-axis), AA – peak area, AH – absolute 
height of the peak. 
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Figure 5-14. Continued from previous page. 
The graphs above show the peaks and retention times of six amino acids: e – glycine, f – 
hydroxyproline, g – isoleucine, h – leucine, i – lysine, j – methionine, which were included in 
the standards mix and run together with the human samples in batch 1. Y-axis shows the 
relative intensity, the most abundant peak visible in the window is assigned as 100 and the 
other peaks are scaled accordingly to that peak. RT – retention time in min (x-axis), AA – 
peak area, AH – absolute height of the peak. 
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Figure 5-14. Continued from page 18. 
The graphs above show the peaks and retention times of six amino acids: k – 
phenylalanine, l – serine, m – threonine and n – tyrosine, which were included in the 
standards mix and run together with the human samples in batch 1. Y-axis shows the 
relative intensity, the most abundant peak visible in the window is assigned as 100 and the 
other peaks are scaled accordingly to that peak. RT – retention time in min (x-axis), AA – 
peak area, AH – absolute height of the peak. 
A pooled standard, an aliquot of each of the samples mixed together, is 
commonly included in analysis of large batches of metabolomics samples. This 
sample mix is injected a few times at the beginning of the run, to condition the 
system before analysis of the samples of interest, as well as at regular intervals 
throughout the batch as a check for reproducibility of the analysis. For this 
reason, a pooled standard was included in the analysis described in this chapter. 
The pooled standard was injected every 5 samples. The first six pooled standards 
were injected to condition the system at the start of the batch. The pooled 
standard was analysed 16 times in batch 1 and 11 times in batch 2. The 
instrument responses of the pooled standard were plotted on a graph to check 
for reproducibility across the batch (see Figure 5-15). The pooled standards were 
labelled in order of injection. In batch 1 the first standard shows much higher 
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response than the subsequent pooled standards. The remaining 5 conditioning 
pooled standards varied in response, showing a decreasing trend, however, they 
showed much less variation than the samples injected later on throughout the 
batch. In batch 1 the pooled standard was injected multiple times from a single 
aliquot. In order to address the issue of the high variation in the response of the 
control sample, separate aliquots were prepared for each injection in batch 2. 
This improved the pooled standard response across the batch; however, 
reproducibility issues are still apparent in the second batch. 
 
Figure 5-15. Graph representing the pooled standard response across the batch. 
The response obtained for each pooled standard was plotted in the order of injection, for 
batch 1 (graph a) and batch 2 (graph b). Y-axis represents the response of each sample and 
x-axis contains the label given to each pooled standard with the numbers indicating the 
order in which these samples were injected. First 6 samples were injected at the beginning 
of the batch to condition the column. 
Additionally, internal standards were added to all of the samples, calibrators 
and quality control samples (QC), to increase precision and accuracy of the 
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collected data (described in detail in chapter 2). Ideally, the internal standard 
used should be an isotopically labelled version of the target compound (Dunn et 
al. 2011). However, that complicates and significantly increases the cost of the 
analysis in the case of multiple target analytes (as in this case). Isotopically 
labelled compounds might not be available for each of the analytes. Therefore, 
three internal standards were used: 13C6-glucose, D27-myristic acid and scyllo-
inositol. Both glucose and myristic acid were in a labelled form and scyllo-
inositol, an isomer of inositol, does not naturally occur in mammalian tissue 
(MacRae & Ferguson 2005). This ensured that the detected levels of each 
internal standard would not be confused with levels of any of the compounds 
naturally occurring in the samples. In principle, the response of these three 
compounds should be the same in all of the samples, calibrators and quality 
control samples. Figure 5-16 and Figure 5-17 show the levels of response 
obtained for these compounds within the two batches run (subjects 2, 3 and 5 in 
batch 1 and subjects 4 and 6 in batch 2). Of course, small variation in the 
response between the samples was to be expected. However, in these analyses 
all three of the internal standards in both batches showed a very large variation 
of response across the samples.  
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Figure 5-16. The responses of internal standards shown across the whole batch (batch 1). 
The graphs show the peak areas (y-axis) for each particular calibrator, QC, samples and 
pooled standards (x-axis) for three ISs: a – 
13
C6-glucose, b – D27-myristic acid and c – scyllo-
inositol. The labels in the y-axis indicate cal – calibrators (1-10), PS – pooled standards (1-
17), QC – quality control samples (1-2) and SnDn – samples, where S stands for subject and 
D stands for the day (time point), n – number in the sample name. Due to high number of 
samples every third sample name is displayed in y-axis. Batch 1 included subjects 2, 3 and 
5. 
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Figure 5-17. The responses of internal standards shown across the whole batch (batch 2). 
The graphs show the peak areas (y-axis) for each particular calibrator, QC, samples and 
pooled standards (x-axis) for three ISs: a – 
13
C6-glucose, b – D27-myristic acid and c – scyllo-
inositol. The labels in the y-axis indicate cal – calibrators (1-10), PS – pooled standards (1-
11), QC – quality control samples (1-2) and SnDn – samples, where S stands for subject and 
D stands for the day (time point), n – number in the sample name. Due to high number of 
samples every second sample name is displayed in y-axis. Batch 2 included subjects 4 and 
6. 
The calibration curve consisted of 10 different concentrations ranging from 4.6 
nmole to 23 pmole. Table 5-3 shows the expected concentrations at which the 
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calibrators were prepared. Calibrators 6-10 were 1 in 10 dilutions of calibrators 
1-5. This was done in order to expand the range of the calibration curve. As a 
result, calibrators 4 and 6 and 5 and 7 have the same concentration. Table 5-3 
also shows the apparent concentrations of the calibrators calculated from the 
experimental data obtained. This was achieved by plotting the areas of the 
calibrators on a graph and describing the trend obtained with a mathematical 
(quadratic) equation. This equation was then used to calculate the apparent 
concentrations of the calibrators as well as the concentrations of the unknowns 
(amino acids in the human tissue samples). This data processing was carried out 
by Stefan Weidt using Xcalibur software. 
Table 5-3. Actual vs calculated concentrations of the calibrators. 
The table shows the actual concentrations at which the calibrators were prepared and the 
calculated concentrations obtained from the calibration curve (. % difference shows how 
close the calculated value is to the expected value in percentage, minus sign indicates the 
calculated value is smaller than the expected one. This data was collected for isoleucine, 
chosen as an example. 
Sample ID Concentration (nmole) Calculated 
Concentration (nmole) 
%Difference 
Calibrator 1 4.545 4.556 0% 
Calibrator 2 2.273 2.192 -4% 
Calibrator 3 0.909 0.985 8% 
Calibrator 4 0.455 0.607 33% 
Calibrator 5 0.227 0.149 -34% 
Calibrator 6 0.455 0.621 36% 
Calibrator 7 0.227 0.098 -57% 
Calibrator 8 0.091 0.030 -67% 
Calibrator 9 0.045 0.006 -86% 
Calibrator 10 0.023 -0.023 -202% 
 
As can be seen in Table 5-3, large errors appear in the resulting calculated 
concentrations, even though the R2 value of the calibration curve was 0.998. A 
separate calibration curve was prepared for each of the amino acids included in 
the standard mix. A similar trend was observed in each case. Calibrators 1-5 
(higher concentrations) were not far off the expected concentration of the 
standard, however, the calibrators on the lower end of the curve were very 
variable and with a large error. This was also observed in the case of the quality 
control samples. Two QC samples were run in each batch at two concentrations 
1.591 and 0.159 nmole. These were mid-range concentrations between 
calibrators 1-5 and a 1 in 10 dilution of this value. The QC with the lower 
concentration failed for most of the amino acids included in the mix, while the 
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other QC passed. A threshold of 20% variation from the actual concentration was 
used as a cut-off value to determine if a QC passed or failed.  
The reproducibility issue seen in the responses of internal and pooled standards 
as well as the error associated with the calibrators and QC samples puts the 
validity of the quantification into question. Nevertheless, the trends of change 
of detected metabolites were compared between the absolute and relative 
quantification results. An example comparison for leucine and glutamate is 
shown in Figure 5-18. The levels of leucine were quantitated within the lower 
range of the calibration and the trends seen differ from the trend obtained 
through relative quantitation. In the case of glutamate both graphs show an 
increasing pattern, however, slightly different. The levels of glutamate were 
quantitated within the higher range of the calibration which had a smaller error 
associated with it. 
 
Figure 5-18. Comparison of results obtained with absolute and relative quantification. 
The above graphs show the trends of change detected for leucine (graphs a.1 and a.2) and 
glutamate (graphs b.1 and b.2). Graphs labelled with 1 (absolute quantification) represent 
the average calculated amount of the amino acids in nmole (y-axis in a.1 and b.1). Graphs 
labelled with 2 (relative quantification) show the average response detected for these 
compounds (y-axis in a.2 and b.2). In all four graphs the x-axis show PMI (days). Error bars 
show the standard deviation calculated from the average amount of the metabolites shown 
in the graphs (N=3). Three aliquots of each sample were used for analysis. Metabolite 
concentration was calculated using a calibration curve prepared with amino acid standards. 
Results shown were collected for subject 2. 
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The absolute quantification method needs improvement. However, the relative 
quantitation allowed the detection and identification of possible biomarker 
candidates. A number of amino acids, as well as uracil, hypoxanthine and n-
acetyl-lysine were listed as metabolites of interest in both rat and human tissue. 
5.4 Discussion 
This part of the study aimed to apply a state-of-the-art GC-MS instrument in PMI 
biomarker research. Furthermore, a new method for absolute quantification of 
multiple amino acids was developed and tested. Two types of tissue were 
tested, rat and human. Relative quantification was carried out on the first and 
both relative and absolute quantification on the human data. Similar to the LC-
MS approach described in chapter 4, an untargeted approach was also applied in 
this case. The results of this study confirmed that amino acids are the most 
likely candidates for PMI biomarkers. However, a few new metabolites were also 
added to the list of possible compounds, which were not considered before. 
Confirming the results of the LC-MS analysis, 11 proteogenic amino acids were 
detected and showed an increase with PMI in rat tissue: tryptophan, leucine, 
serine, aspartate, methionine, cysteine, glutamate, phenylalanine, asparagine, 
lysine and tyrosine. Additionally, alanine also showed an increasing trend, which 
was not apparent in the LC data, and isoleucine and leucine were successfully 
discriminated, as the GC approach allowed separating these isomers. The 
differences observed between leucine trends by GC-MS and LC-MS are most 
probably the result of its co-elution with isoleucine in the LC data. Furthermore, 
a few other, non-proteogenic amino acids were detected - homocysteine, 
cystathionine, n-acetyl-lysine and 3-methylhistidine. Interestingly, homocysteine 
and cystathionine are both involved in the cysteine synthesis pathway. 
Homocysteine reacts with acetyl-serine to give cystathionine and then 
cystathionine can be deaminated to form cysteine (see Figure 5-19). Cysteine 
showed the highest rate of increase among all of the amino acids, which could 
suggest that the two abovementioned reactions continue post-mortem. Of 
course, there are many other metabolic pathways which lead to cysteine 
formation, however, without detecting the compounds involved, it is impossible 
to say which could have any impact on cysteine accumulation post-mortem. On 
the other hand, both homocysteine and cystathionine also increase over time, 
although at a much lower rate. The rates of increase of these compounds are 
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comparable, about 5-fold, (see Figure 5-5), while cysteine increased about 35-
fold.  The large increase in cysteine level can be most probably attributed to a 
combination of a few different factors (protein degradation, compound 
decompartmentalization etc. as discussed in chapters 3 and 4), rather than 
simply metabolic synthesis. All three of these compounds act as intermediates in 
a few metabolic reactions, both synthesising them and using them for synthesis 
of other compounds. Cysteine, being one of the proteogenic amino acids would 
be probably more abundant in general. 
 
Figure 5-19. Scheme showing two reactions involved in cysteine synthesis (Kanehisa 1995). 
The figure shows the synthesis of cystathionine from homocysteine and acetyl-serine (a) 
and the synthesis of cysteine from cystathionine (b). The names of the compounds are 
placed below them. The number preceded by C under each compound, indicates its Kyoto 
Encyclopaedia of Genes and Genomes (KEGG) identification number (). The reactions 
included in the cysteine pathway are found in KEGG (Kanehisa 1995). 
Interestingly, another amino acid of interest, 3-methylhistidine, is formed by 
methylation of actin and myosin (Wishart et al. 2013), which comprise muscle 
tissue and were selected as proteins of interest in the proteomic part of this 
study. Additionally, this compound is a known indicator of muscle degradation 
(Wang et al. 1998; Elia et al. 1981; Rathmacher et al. 1995). When muscle tissue 
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degrades, histidine present in the peptide chains of actin and myosin is 
methylated and excreted in urine (Elia et al. 1981). After the methylation occurs 
the compound is no longer used for protein synthesis. It is possible that after 
death, when bodily functions cease and the compound is not removed from the 
organism, it builds up in muscle tissue. This would make this compound a perfect 
candidate for PMI estimation, however, under carefully controlled dietary 
conditions, as meat intake can influence the amount of 3-methylhistidine 
present. 
Five other compounds were selected as metabolites of interest in rat tissue: 
caproic acid (carboxylic acid (Wishart et al. 2013)), uracil (pyrimidine 
metabolism), glucosamine (carbohydrate metabolism), hypoxanthine and 
adenine (purine metabolism). All but one of these compounds, adenine, showed 
an increasing trend with PMI. Adenine decreased with time.  
Human tissue was also tested for possible biomarkers with varying results from 
subject to subject. However, in general, various proteogenic amino acids showed 
the most promising changes, as was observed for rat tissue. Additionally, n-
acetyl-lysine, uracil and hypoxanthine were also selected in both tissue types. 
On top of that, a few new compounds were added to the list: pipecolic acid, 3-
hydroxy-tyrosine, diethanolamine, malic acid, 5-oxo-proline, glycerate-3-
phosphate, benzoic acid and inosine. Out of all of the detected compounds of 
interest, the top six were picked, because they showed promising changes in 
most, if not all, of the tested subjects. These included pipecolic acid, 
diethanolamine, uracil, aspartate, isoleucine and inosine. A compound identified 
as diethanolamine showed a promising pattern of change, but this is likely a 
spurious identification as diethanolamine is not thought to be endogenous to the 
human body. In one of the subjects (subject 6) the diethanolamine peak was 
identified as indole-2-carboxylic acid. This is a more likely endogenous 
identification, however, less possible according to the database match. Further 
enquiry into the identity of this compound is required to present it as a possible 
biomarker. Uracil, aspartate and isoleucine are therefore the three most robust 
candidates based on the results from both human and rat tissue. 
The results obtained through the GC-MS approach were compared with the 
results obtained using the LC-MS approach. In general the same trends of change 
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were observed when comparing results, with a few exceptions. For example, 
alanine (rat) and leucine (human) showed an increasing trend by GC-MS but by 
LC-MS the levels remain fairly constant over time. The differences seen between 
results could depend on the sensitivity of the instruments used, as well as on the 
correct identification of the compound. Many of the compounds presented here 
were putatively identified, especially in the case of GC rat data, where no 
standards were run within the batch. Additionally, LC chromatography suffers 
from ion suppression in which co-elution of different molecules or isomers 
affects the signal of the detected compound. In the case of LC analysis many 
compounds were identified with a few possible isomers. The resolution power of 
GC is better therefore; ion suppression is not an issue in this case. Furthermore, 
in the LC approach, many more compounds were detected and putatively 
identified in comparison with the GC data. This is most likely due to the fact 
that gas chromatography, as the name suggests analyses compounds in the 
gaseous state. Compounds which are not naturally volatile have to be derivatised 
before the analysis. However, a different range of compounds can be detected 
using this method, as the LC columns used in this study were specified to 
separate polar compounds. Derivatisation adds more steps into sample 
preparation, which can potentially bias quantitation to handling errors or sample 
loss. Also derivatisation efficiency comes into play. Compounds which have not 
derivatised efficiently will not be separated and detected. Furthermore, 
multiple derivatisation products can occur (i.e. Aspartate-2TMS and Aspartate-
3TMS), which results in smaller numbers of different compounds detected. 
Therefore, sample preparation is crucial in GC experiments; reagents must be 
carefully selected and preparation method optimised. In the case of this 
experiment, especially in batch 1, there was not enough time to fully optimise 
the sample preparation. Certain stages of the preparation were carried out by a 
robot, which added appropriate aliquots of reagents to the samples. In theory, 
that should increase the reproducibility between the samples, however, that was 
not the case. The use of the robot was discontinued for this purpose. Smaller 
numbers of detected compounds means smaller numbers of possible biomarker 
candidates, but makes data analysis more straightforward. GC-MS proved an 
orthogonal approach that resulted in new biomarker candidates being added to 
the list. However, it must be kept in mind that there was limited time to carry 
out this analysis and the methods used require further optimisation. Even though 
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the analysis did not perform as well as it could, it was worth trying to carry out 
absolute quantification of the amino acids. The GC approach is better suited for 
this purpose as it does not suffer from ion suppression. Additionally, the 
fragmentation patterns obtained using an electron ionisation method give very 
reproducible fragmentation patterns, allowing compound identification through 
an established database. However, the molecular ion is often lost in the 
fragmentation. Knowing the molecular weight of a compound helps to limit the 
number of possible matches, which in this case is hindered. In LC fragmentation 
spectra the molecular ion is always present; however less structural information 
is obtained. Both approaches have their strengths and weaknesses, however, 
when combined, they can help to characterise a large part of the metabolome. 
As mentioned above, the GC-MS approach gives the opportunity of absolute 
quantification of the metabolites present in the sample. Amino acids were 
selected for this part of the study as they seemed the most likely biomarker 
candidates, as seen in this and the previous chapter. This was the final part of 
the project, with not much time left for instrument and method optimisation, 
therefore the quantification was not successful. Reproducibility between the 
samples was an issue, which made the normalisation of the data very difficult. 
The internal standard used for this purpose was added to the samples post-
extraction (ideally it should be added pre-extraction). As a result, it did not 
correct for the extraction efficiency, but it would have corrected for the 
derivatisation and injection efficiency. The sample was injected in a split mode 
with a small split ratio of 1:10. Split ratio is the ratio between the carrier gas 
flow rate and the split vent flow rate. This ratio should be carefully selected 
based on the capacity of the inlet liner, temperature of the liner and type of the 
solvent used. Any issues in the ratio of these factors can cause an issue with the 
sample flow and in turn with reproducibility. It was later observed (outside the 
scope of this study) that a higher split flow improved the reproducibility 
between the samples analysed using this instrument. The amino acid 
quantification was unsuccessful; however, considering the aim of this project, 
the absolute amount of the biomarker might not be necessarily required. 
Knowing the exact amount of the analyte in question would help to produce an 
accurate mathematical equation describing the change of this analyte with PMI. 
However, the levels of metabolites vary from person to person and therefore 
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this absolute amount will differ in each case. But if it was possible to find a 
metabolite for which the rate of change over time is similar between different 
people, this would prove more useful in PMI estimation, irrespective of the 
absolute amount of the analyte present.  
As described in the previous chapter, various metabolites, including amino acids 
were previously suggested as potential markers for PMI (Vass et al. 2002; Patrick 
& Logan 1988a; Girela et al. 2008; Kärkelä & Scheinin 1992; Kang et al. 2012), 
however very few studies used a global metabolomics approach for this purpose 
(Hirakawa et al. 2009; Schmidt et al. 2014). The field of metabolomics is 
growing fast and GC-MS is becoming increasingly popular for this purpose. 
Similarly, more and more researchers show interest in PMI estimation and with 
the advancements and developments in the metabolomics field, they are trying 
new ways of approaching this issue. Donaldson and Lamont used a GC-MS based 
metabolomics approach to identify biomarkers in post-mortem blood (Donaldson 
& Lamont 2014). As a result they mainly listed proteogenic amino acids as 
possible candidates.  
Sato et al. (Sato et al. 2015) and Kaszynski et al. (Kaszynski et al. 2016) both 
used very similar approaches to GC-MS metabolic profiling as that described 
here. The only difference is that both groups created mathematical PMI 
prediction models and here, an absolute quantification of various metabolites 
was attempted. Due to the limited amount of test subjects in the case of rat 
tissue, and the varying PMI scattered along a large time frame of 19 days in the 
case of human tissue, it was not possible to create an accurate prediction model 
from the data presented here. Sato et al. tested post-mortem rat plasma, while 
Kaszynski et al. muscle and serum of mice. Similar to the results presented here, 
both studies listed amino acids as metabolites of interest. Kaszynski et al. also 
listed hypoxanthine as a possible biomarker in muscle tissue. Hypoxanthine 
levels were previously correlated with PMI, however, measured in vitreous 
humour (Camba et al. 2014; Passos et al. 2009; Muñoz-Barús et al. 2010; 
Lendoiro et al. 2012; Muñoz Barús et al. 2002; Rognum et al. 1991) or blood 
(Donaldson & Lamont 2013). The previously mentioned study by Sato et al. also 
lists another metabolite of interest highlighted in this study, namely uracil (Sato 
et al. 2015). They list it as one of the metabolites detected, but they do not 
include it as one of the components of the PMI prediction model. To the best of 
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the author’s knowledge, n-acetyl-lysine, the final metabolite of interest, has not 
been previously suggested as a potential marker for PMI. 
5.5 Conclusion 
This chapter demonstrated how state-of-the-art GC-MS technology can be 
successfully applied in PMI research. The absolute quantification method 
requires optimisation and validation but relative quantification was successfully 
applied. The approach further confirmed the results of the LC-MS analysis, 
pointing towards amino acids as the best candidates for PMI biomarkers, 
especially isoleucine, aspartate and n-acetyl-lysine. Additionally, a few new 
possible candidates were discovered: adenosine in rat, inosine in human and 
hypoxanthine in both tissue types. GC-MS is not without its challenges, but it has 
potential as a tool for metabolic profiling. Used in complement with the LC-MS 
approach (Chapter 4), GC-MS augments the process of biomarker discovery. 
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6 GENERAL DISCUSSION 
Estimation of the post-mortem interval in the case of an unwitnessed or a hidden 
death is an extremely difficult task. The currently used methods present a 
rather short window of time (24-48 h) when this can be accurately assessed 
(Fatteh 1973). Throughout the years, many researchers have attempted to solve 
this issue, both by trying to improve already known methods, as well as by 
applying new and advanced techniques (Nelson 2000; Usumoto et al. 2010; 
Young et al. 2013; Vass et al. 2002), but with limited success. The 
decomposition of the human body is a very complicated process, which can be 
influenced by many different factors. The environment in which the body is 
decomposing (including temperature, humidity, substrate, local fauna and flora) 
and whether the body is clothed or buried, will affect how fast and in what way 
decomposition proceeds. However, it is not just the surroundings of the dead 
body that matter in the decomposition process. Many studies have evaluated the 
chemical and biological processes occurring after death (Sabucedo & Furton 
2003; Zapico et al. 2014; Jia, Hildrum, et al. 2006), but interindividual 
differences in body composition, metabolism etc. are influenced by our 
genotype and lifestyle (diet, weight or possible disease state). All of these 
factors, which are important during life, may have a bearing on the processes 
occurring post-mortem and may thus influence estimation of time since death. 
Trying to quantify or assess post-mortem changes in some way would require 
extensive studies, involving many test subjects, from various backgrounds, 
representing different groups of age, body shape, cause of death etc. Basically, 
it would require a large clinical study on dead bodies. However, each large 
clinical study also requires a negative control group. What kind of control group 
could be used in this case? Subjects where the samples were collected seconds 
after death, or from a living healthy individual? This is a very unique field of 
research which is limited by not only logistical but also ethical issues. Not many 
laboratories are equipped to store dead bodies or would be able to source any 
samples from them. This was one of the issues encountered at the very 
beginning of this project. Initially, it was possible to obtain neither animal nor 
human cadavers, which could be stored and sampled at various intervals. In the 
UK, pathologists examining the bodies of deceased only sample what is required 
to determine the cause of death. Cadavers which are donated to science usually 
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go to a university anatomy department and due to their ethical commitments, 
they do not allow any specimens to leave their laboratory. It would only be 
possible after the tissue was formalin fixed, which limits any further testing. A 
similar scenario was encountered at the animal unit, where potentially, rat 
cadavers could be sourced for the study. We were advised against storing the 
cadavers at our laboratory facilities and it was not possible to keep them for a 
prolonged length of time at the animal unit. Therefore, the initial testing was 
carried out using a piece of beef steak obtained from an abattoir. However, in 
the later stages of the project, thanks to co-operation with Dr Mark McLaughlin 
from the veterinary school at the University of Glasgow and Dr Daniel Wescott 
from Texas State University, we were able to source rat and human post-mortem 
tissue for testing. 
Despite the initial problems with sourcing appropriate test subjects for sampling, 
the project was very successful. As hypothesized, a number of biological 
compounds were shown to increase or decrease post-mortem. This was 
demonstrated using established proteomics and metabolomics methodologies. 
These techniques allow detection and quantification of biomolecules in any 
given organism. Moreover, these techniques provide a snapshot of the proteome 
and metabolome of an organism in a given state. In this particular case, the 
project involved looking at changes occurring over time in post-mortem muscle 
tissue (biceps femoris).  
Muscle tissue is not a commonly used specimen in forensic research. Blood, 
vitreous humour, urine or liver are more often used. Depending on the cause or 
circumstances of death, blood or urine might not always be available for 
sampling. Also, blood coagulates and settles down in lower parts of the body, 
therefore, it might not always be practical to obtain a representative blood 
sample. However, muscle is much easier to sample as it is situated just beneath 
the surface of the skin. It is highly unlikely that a muscle tissue sample will not 
be available. Additionally, muscle tissue is more stable post-mortem, i.e. it does 
not degrade as fast as, for example, liver, which is rich in enzymes that can 
accelerate  decomposition (Vass 2001).  
The proteomics approach was an obvious choice for the task. Muscle tissue 
sampled in this study is very protein rich. Protein degradation is known to be one 
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of the processes occurring in decaying tissue (Vass 2001). It has been thoroughly 
researched in the past, mainly in studies investigating meat tenderisation 
processes, aiming to improve its quality as food (Koohmaraie & Geesink 2006; 
Kemp & Parr 2012; Nowak 2011; Lametsch et al. 2002). However, this proteolysis 
process was later recognised as a possible key to PMI estimation (Poloz & O’Day 
2009; Pittner et al. 2015). The study described in this thesis also showed clear 
evidence of protein degradation, as both small and large fragments of the same 
proteins were detected. The proteins most often suggested as possible PMI 
markers are troponin (Sabucedo & Furton 2003; Kumar, Ali, Singh, et al. 2015; 
Pittner et al. 2015) and actin (Lametsch et al. 2002; Y. Liu et al. 2008; Xiao & 
Chen 2005). The results of this study also point towards these two proteins as 
possible markers. However, troponin was only detected in beef tissue. Actin on 
the other hand was detected in all three species and showed similar trends for 
all. Out of all of the detected proteins, it is the strongest biomarker candidate. 
Two other proteins also appeared as very strong candidates: myosin and heat 
shock protein. All three of these proteins were detected in all three species, 
however, a few different types of heat shock protein were found. Apart from 
these three proteins, the results between the species varied considerably. The 
protein spots on electrophoresis gels picked for analysis were selected on the 
basis of the measured change in the protein level. However, this was limited by 
a number of factors in the 2DE approach, mainly the efficiency of the protein 
precipitation and separation, the quality and efficiency of the reagents used as 
well as the quality of the gel images. These and other factors can influence how 
the gel looks and how many protein spots can be detected by the software and 
successfully matched between the gels. This, as well as the nature of the 
untargeted approach, means that there is no guarantee that the results will be 
reproducible, which of course does not mean that for example troponin, does 
not behave in similar way in rat and beef tissue. It just has not been detected. 
In order to fully investigate the potential candidates discovered in this study, it 
should be followed by more experiments employing a targeted approach. This 
way the samples could be tested for particular proteins and any common trends 
could be investigated further. 
The proteomics approach was very successful. The initial hypothesis was proven 
and potential protein PMI biomarkers were found. However, the 2DE approach 
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used is a very time consuming and expensive technique. A single 2DE experiment 
can take up to two weeks to complete from start to finish; therefore, it would 
be impractical to employ it as a routine tool of PMI estimation. Of course, this 
approach could be just the initial step of the biomarker discovery and once 
validated, other methods of detection could be used routinely, for example 
assays targeting specific proteins. This would require further testing to pinpoint 
a specific protein as a marker. Due to the complexity of the proteome, involving 
large numbers of potential protein types and modifications, this might be a 
challenging task. Additionally, proteins can be quite unstable and are 
susceptible to further degradation during the extraction process if 
inappropriately handled. Undoubtedly, when using muscle tissue as a test 
specimen, protein extraction will be required.  
The extraction protocol for the LC-MS metabolomics approach was much shorter 
and did not involve as many steps as the protein extraction protocol. In the case 
of the GC-MS approach, sample derivatisation is required which adds more steps 
to the sample preparation. Metabolomics profiling aims to detect small 
molecules present in the sample, which is easier to carry out than detection and 
identification of large proteins. Hundreds or even thousands of compounds can 
be detected simultaneously in a single experiment and putatively identified 
through a search in a reference database. The identity of many of these 
compounds can also be verified through the inclusion of appropriate standards in 
the experiment, multiple compounds at a time. As a result, the metabolomics 
approach is perhaps better equipped to develop high throughput assays for 
biomarker detection.  
As expected, the metabolomics study resulted in a number of possible biomarker 
candidates, mainly proteogenic amino acids, but also other products of amino 
acid metabolism, decomposition products, and metabolites involved in purine, 
pyrimidine and other pathways. Two different approaches were used in this 
case, liquid and gas chromatography, both coupled to mass spectrometry. The 
first approach yielded higher numbers of detected metabolites, most probably 
because the LC-MS protocol is a well-established and routinely used at Glasgow 
Polyomics, whereas, the GC-MS protocol was somewhat a trial run. Both methods 
pointed towards proteogenic amino acids as the best biomarker candidates and 
the results were very similar, yet not for all compounds. The similarities 
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between results from the two methods were quite reassuring and put more 
confidence into the obtained results. The GC-MS approach was slightly more 
problematic in terms of the sample preparation and method optimisation; 
however, it has a potential to offer high sensitivity and reproducibility. 
Additionally, fragmentation patterns are highly reproducible between different 
instruments, which gives the possibility to create public libraries (Garcia & 
Barbas 2011). These two approaches, where possible, are best used as 
complementary techniques. They can detect different classes of compounds 
which increases the experimental coverage of the metabolome. This was 
apparent in this study. The LC-MS approach yielded a large amount of data and 
many possible biomarker candidates, yet the GC-MS approach still managed to 
add to the list and certain compounds detected in the GC dataset were not 
present in the LC dataset. 
Liquid and gas chromatography are both widely used in forensic laboratories for 
various purposes (e.g. toxicological analysis). Therefore, it would be quite 
feasible to implement a PMI estimation method based on one or both of these 
techniques. Ideally, however, it would be best to translate the developed 
method into a smaller, easy to use assay, for example ELISA (enzyme-linked 
immunosorbent assay), which could detect the levels of specific proteins or 
other markers. A quick assay would save a lot of time and significantly reduce 
the cost of the testing. Therefore, a commercially available amino acid assay 
(phenylalanine) was tested to see if it could be implemented as a new method of 
PMI estimation. Tissue from two human subjects was tested with this assay and 
even though tests were carried out to find an appropriate dilution of the 
extracted samples, levels for one of the subjects were outwith the calibration. 
Also the trends of change measured with the assay differed significantly from 
those measured with the LC-MS method. This could be due to cross-reactivity of 
tyrosine present in the sample.  More work is required to further optimise the 
sample preparation and validate the method in order to improve the results of 
the assay. There was not enough time and reagents left in the kit to test all of 
the possible pre-treatment steps. Nevertheless, commercially available amino 
acid assays may well be suitable for this kind of testing. 
Despite the initial difficulties with sourcing appropriate samples, the project 
progressed well. As intended, possible biomarker candidates were discovered, 
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through both proteomic and metabolomics approaches. The data collected 
confirmed some of the previous findings in the field and added a few new 
possible biomarker candidates. To the best of the author’s knowledge, xanthine, 
uracil, choline phosphate, n-acetylneuraminate and n-acetyl-lysine, have not 
been previously suggested as PMI markers. 
This project is the first step towards a new method of PMI estimation. To take 
this project further, more testing including more test subjects would be required 
to validate the results. However, it would be more useful to monitor the changes 
in bodies decaying at room temperature. Here, the facilities were limited; 
therefore, the bodies were kept in the fridge during testing. The decomposition 
process was still apparent, but it is unlikely that corpses being the subject of 
forensic investigation would be kept in refrigerated conditions until discovery. 
Additionally, if some of the cadavers would be kept outdoors, it would be best to 
find a better way of closing up the incision point or sample different sites of the 
muscle. Over 3 days, insects enter the incision, which made further sampling 
very difficult, if not impossible. Moreover, the activity of insect larvae present 
would influence the way the tissue decomposes. As a result, it might not be 
comparable to tissue decomposing under the skin. The same could be said about 
leaving the incision site opened over the few days of sampling as contact with 
oxygen will definitely influence the processes occurring in the tissue. Maybe 
various smaller sampling sites could be made on different days to avoid this or a 
needle muscle biopsy approach could be used. In this type of study it is of 
utmost importance to keep as many factors as possible constant, while sampling 
the same subjects at different time points. 
The next step after further tests involving a larger number of test subjects 
would be targeted analysis involving the compounds of interest. The extraction 
method could potentially be improved to focus on certain groups of compounds, 
especially in the proteomics approach. All of the compounds of interest should 
be evaluated separately, as well as collectively, as perhaps a ratio between 
certain compounds would be a better indicator of PMI than a single compound 
alone. Targeted analysis would be the key; however, only semi-quantitative 
approaches will be useful. As discussed in the previous chapter, concentrations 
of the same compounds between different people will most certainly vary, 
therefore, similar trends or rates of change will be more useful to try to 
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establish any possible mathematical formulae describing these trends. Finally, 
after all of these compounds are appropriately verified and tested, the results of 
the study should be translated to a much faster and more easily applied 
approach. If this test was to be implemented in forensic mass-spectrometry 
laboratories, then a fast, high throughput, possibly automated approach would 
be the best. This project was the first step in a long process of implementing a 
new method of PMI estimation. However, it was a big step, bringing us closer to 
achieve this goal. 
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Appendices 
Please see the attached files. 
I. Supplementary data: List of proteins identified in the trial proteomics 
experiment (beef tissue) – Excel spreadsheet 
 
II. Supplementary data: List of proteins identified in the second proteomics 
experiment (beef tissue) – Excel spreadsheet 
 
III. Supplementary data: List of proteins identified in the 2DE proteomics 
experiment (rat tissue) – Excel spreadsheet 
 
IV. Supplementary data: List of proteins identified in the 2DE proteomics 
experiment (human tissue, subject 2) – Excel spreadsheet 
 
V. Supplementary data: Metabolomic dataset comparing all beef samples 
collected at various times post-mortem (LC-MS, pHILIC separation) – 
IDEOM macro-enabled spreadsheet 
 
VI. Supplementary data: Metabolomic dataset comparing all beef samples 
collected at various times post-mortem (LC-MS, HILIC separation) – IDEOM 
macro-enabled spreadsheet 
 
VII. Supplementary data: Metabolomic dataset comparing all rat samples 
collected at various times post-mortem (LC-MS, pHILIC separation) – 
IDEOM macro-enabled spreadsheet 
 
VIII. Supplementary data: Metabolomic dataset comparing all rat samples 
collected at various times post-mortem (LC-MS, HILIC separation) – IDEOM 
macro-enabled spreadsheet 
 
IX. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 1 (LC-MS, pHILIC separation) – IDEOM macro-
enabled spreadsheet 
 
X. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 1 (LC-MS, HILIC separation) – IDEOM macro-enabled 
spreadsheet 
 
XI. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 2 (LC-MS, pHILIC separation) – IDEOM macro-
enabled spreadsheet 
 
XII. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 2 (LC-MS, HILIC separation) – IDEOM macro-enabled 
spreadsheet 
 
XIII. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 3 (LC-MS, pHILIC separation) – IDEOM macro-
enabled spreadsheet 
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XIV. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 3 (LC-MS, HILIC separation) – IDEOM macro-enabled 
spreadsheet 
 
XV. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 4 (LC-MS, pHILIC separation) – IDEOM macro-
enabled spreadsheet 
 
XVI. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 4 (LC-MS, HILIC separation) – IDEOM macro-enabled 
spreadsheet 
 
XVII. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 5 (LC-MS, pHILIC separation) – IDEOM macro-
enabled spreadsheet 
 
XVIII. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 5 (LC-MS, HILIC separation) – IDEOM macro-enabled 
spreadsheet 
 
XIX. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 6 (LC-MS, pHILIC separation) – IDEOM macro-
enabled spreadsheet 
 
XX. Supplementary data: Metabolomic dataset comparing all samples 
collected from subject 6 (LC-MS, HILIC separation) – IDEOM macro-enabled 
spreadsheet 
 
XXI. Supplementary data: Metabolites of interest detected in rat tissue using 
the GC-MS approach – Excel spreadsheet 
 
XXII. Supplementary data: Metabolites of interest detected in human tissue 
using the GC-MS approach – Excel spreadsheet 
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